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One of the most important aspects of atherogenesis is the 
metabolism and transport of lipids, which are the major 
components of arterial plaques. Several studies have indicated 
that some of the plaque lipids are derived from plasma 
(Zilversmit and McCandless, 1959; Zilversmit, et al., 
1961; Newman and Zilversmit, 1962). It has been 
assumed that the degree of deposition may, in part, depend upon 
the structure of the fatty acids (Sinclair, 1956). 
It is well known that certain abnormalities in plasma lipids 
occur in patients with ischaemic heart disease. The correlation 
between high levels of plasma cholesterol and the incidence of 
ischaemic heart disease has been widely reported (The Cooperative 
Study of Lipoproteins and Atherosclerosis 1956, Doyle et al., 
1957; Keys et al., 1958; Epstein et al., 1959; Kannel et al., 
1961). Increased plasma triglyceride concentrations have also 
often been observed (Albrink and Man, 1959; Antonis and Bersoht1, 
1960; Brown et al., 1965), and different types of hyperlipo- 
proteinaemia seen in this disease have been described (Havel and 
Carlson, 1962; Fredrickson et al. , 1967a. b. c. d. e.). Attention 
has recently been focussed upon the observation that patients with 
a history of myocardial infarction have increased levels of plasma 
free fatty acids (Kershbaum and Bellet, 1964; Rifkind, 1966) 
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and that these increases may be particularly marked immediately 
after the myocardial infarction (Kurien and Oliver, 1966). 
Comparatively little is known about the role which structural 
differences between individual free fatty acids play in the 
development of hyperlipidaemia and ischaemic heart disease. 
Recent views on the role of plasma free fatty acids in the 
transport of lipids (Gordon and Cherkes, 1956; Dole, 1956) and in 
the pathogenesis of hyperlipidaemia (Rudman, 1963; Sternberg, 
1963), as well as on their possible influence in the development of 
atherosclerotic vascular disease (Carlson et al., 1965) indicate 
that qualitative as well as quantitative considerations are of 
importance. 
It is now well known that fatty acid mobilisation is controlled 
directly or indirectly by both neural and hormonal factors. The 
endocrine influences upon coronary atherogenesis considered 
earlier by Oliver and Boyd (1955, 1956, 1958, 1959) thus 
acquire new importance. The concept that fatty acid 
mobilisation is the "spiritus moyens" in the transportation of 
lipids raises several questions: 
1. Do different adipokinetic agents increase the 
concentrations of individual fatty acids according to a 
common pattern or specifically? 
2. How are the changes in fatty acid mobilisation reflected 
in the fatty acid composition of serum triglycerides, 
phospholipids and cholesterol esters? 
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3. If such a relationship exists, is it common to the different 
adipokinetic agents? 
4. Do patients with hormonal abnormalities such as 
thyrotoxicosis, myxoedema or acromegaly show any 
alteration from normal in the fatty acid composition of 
their serum lipids? 
5. If so, are the changes consistent with those observed 
during administration of the relevant hormones? 
6. Are the changes observed in patients with chronic 
ischaemic heart disease or in patients immediately after 
acute vascular occlusion comparable to those produced 
by endocrine influences? 
Many workers have been discouraged from conducting 
investigations in this particular field on account of the long and 
laborious procedures involved. An attempt has therefore been 
made to develop a technique which is relatively rapid and 
suitable for routine use. This will be described in detail. It 
has been applied in order to obtain answers to some of the above 
questions. Greater knowledge of these problems will advance 
our understanding of the factors leading to disordered lipid 
metabolism in patients with ischaemic heart disease, as well as 
in those with endocrine abnormalities. 
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I N T R O D U C T I O N 
REVIEW OF LITERATURE ON SERUM FATTY ACIDS 
Historical 
With the development of new techniques during the last 
decade, knowledge about the fatty acids of human tissues has 
increased. It has been known since 1907 that the fatty acids 
that are components of animal cells usually have an even 
number of carbon atoms and include saturated and unsaturated 
derivatives (Raper, 1907). As early as 1902, Jaecle reported 
the presence of palmitic, stearic and oleic acids in human 
fat by the application of a method based upon the different 
solubilities of their lead salts. The presence of fatty acids with 
two and four double bonds was recognised later, employing a 
method based upon the different solubilities of the brom 
derivatives (Eckstein, 1925; Wagner, 1926). 
Information regarding the degree of unsaturation of human 
serum lipids came first from the measurement of iodine values. 
Wilson and Hansen (1935), using pyridine sulphate dibromide 
as the halogenising agent, first suggested an iodine value of 108 
for the fatty acids of human serum. The presence of linoleic 
and arachidonic acids in human serum was first reported by 
Brown and Hansen (1937), who separated the polybromides of 
arachidonic acid and the tetrabromides of linoleic acid on the 
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basis of their different solubilities in ether. 
Between the years 1956 and 1958 many investigators 
provided more detailed information by the use of spectrophoto- 
metric methods preceded by alkaline isomerisation. In this 
method, the polyunsaturated acids were subjected to alkaline 
isomerisation and were thus transformed into conjugated fatty 
acids. These have specific absorption bands in the ultraviolet 
region and could therefore be measured by spectrophotometric 
techniques. In this way, Evans and his coworkers (1956) were 
the first to show that linoleic acid is the major unsaturated acid 
of human serum fatty acids. Others, employing the same 
technique, were concerned with the relation of plasma esterified 
fatty acids to atherosclerosis and hyperlipidaemia (Luddy et al., 
1958; Lewis, 1958; Tuna et al., 1958; Wright et al., 1959) 
or with the effects of experimental diets (Michaels et al., 1959; 
Alfin ..Slater and Jordan 1960). These studies gave evidence of 
the degree of unsaturation but did not lead to full structural 
identification of the fatty acids. 
Eventually, with the application of various chromatographic 
techniques for the separation of lipids, together with the 
introduction of gas..liquid chromatography for the analyses of 
fatty acids (James and Martin, 1952), a key was provided to the 
knowledge of fatty acid composition. The principle and the 
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application of the method have been widely described (Phillips, 
1956; Keuleman, 1959; Purnell, 1962; Buchfield and Storrs, 
1962; Knox, 1962.). Gradually, more information has been 
gathered, and this will be reviewed in the following paragraphs. 
The free fatty acids (FFA). 
The importance of this small fraction of serum lipids 
(accounting for approximately 10% of total fatty acids) has been 
appreciated with the development of accurate methods for the 
measurement of serum FFA concentrations (Dole, 1956; 
Gordon, 1957). 
Serum FFA concentrations are now known to be influenced 
by many factors. Increases in serum FFA levels have been 
reported after prolonged fasting (Dole, 1956; Recant et al., 1963), 
emotional stress (Bogdonoff et al., 1959), physical activity 
(Carlson and Pernow, 1959, 1961, Carlson et al., 1963), 
cigarette smoking (Kershbaum et al., , 1961, 1962; Murchison and 
Fyfe , 1966), exposure to cold (Nutritional Rev. 1965, Glem non 
et al., 1967) and following the administration of several 
hormonal agents. Within an hour after the administration of 
noradrenaline or adrenaline to men, the serum FFA increased 
sharply (Gordon and Cherkes, 1956; Dole, 1956; Havel and 
Goldfien, 1959). Similar observations were made 4 hours after 
the injection of human growth hormone (HGH) to fasting men 
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(Raben and Hollenberg, 1959) and 6 hours after administration of 
thyroid hormone (Rich et al. , 1959). 
Several pathological conditions have been reported to lead to 
increased levels of serum FFA. Many authors have called 
attention to the increased fasting concentrations of serum FFA 
in patients with a history of myocardial infarction (Schrade et al., 
1961; Kershbaum and Bellet, 1964; Rifkind, 1966). While 
very high levels were observed immediately after acute myocardia 
infarction (Kurien and Oliver, 1966), normal levels are said to 
be present three weeks after the acute event (Rifkind, 1966). 
In view of the great interest focussed upon the levels of 
serum FFA and their responses to various influences, it is 
surprising that so little is known about the participation of 
individual fatty acids in increases or decreases of serum FFA 
concentration. 
Only a few authors employing gas -liquid chromatographic 
techniques have described the composition of serum FFA in 
health (Lindgreen and Nichols, 1961; Dole et al., 1959; 
Schrade et al., 1961; Böttcher and Woodford, 1961) and found 
that oleic, palmitic and stearic acids are the main components 
of this fraction. The composition of serum FFA has been 
estimated in certain pathological conditions such as ischaemic 
heart disease (Schrade et al., 1961; Böttcher and Woodford, 
1961) diabetes mellitus (Schrade et al., 1963), pancreatic cystic 
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fibrosis and in liver disease (Caren and Corbo, 1966). In 
patients with ischaemic heart disease, Schrade et al., (1961) 
observed lower proportions of polyunsaturated acids, while 
Bottcher and Woodford (1961) did not find any significant changes 
from normal, although small increases were observed in the 
percentages of the cc-lipoprotein FFA oleic acid. Dole et al., 
(1959) studied the changes during alimentary hyperlipidaemia, 
and observed that both oleic and palmitic acids decreased in this 
situation together with the total FFA concentration. Soloff and 
Schwartz (1966) recently studied changes during the glucose 
tolerance test in normal and post myocardial infarct patients. The 
data of these authors show that the decrease in serum FFA that 
occurred i to 3 hours after the glucose load were accompanied 
by an increased percentage of stearic acid and a decreased 
percentage of oleic acid in the total FFA fraction. More recently, 
Murchison and Fyfe (1966) reported increased percentages of 
serum FFA monounsaturated acids after cigarette smoking. 
From these few publications, it is difficult to conclude 
whether any relationship exists between total serum FFA levels 
and their fatty acid composition, and no evidence is available 
concerning the effects of hormones or other adipokinetic agents. 
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The fatty acids of esterified lipids. 
Dole et al. , (1959) stated that "the blood plasma of a 70 kg. 
man contains about 50 mEq of fatty acids (approximately 25 mEq 
in phospholipids, 12 mEq in cholesterol esters, 10 mEq in 
triglycerides and 3 mEq in nonesterified fatty acids) ". It is 
beyond the scope of this chapter to describe the conditions 
associated with increased concentrations of esterified lipids 
since these have been largely described elsewhere. 
There now exists a mass of data on the fatty acid composition 
of serum esterified lipids in various conditions. The fatty 
acid composition of the individual lipid fractions represents a 
pattern which is fairly constant in normal physiological conditions 
(Hallgreen et al., 1960; Lindgreen et al., 1961; Schrade et al., 
1961; Lawrie et al., 1961; Caren and Corbo, 1966; Laudat et al. 
1966). 
Palmitic acid is incorporated mainly into the phospholipid 
fatty acids, oleic acid mainly into triglyceride fatty acids, and to 
a lesser extent into phospholipid and cholesteryl fatty acids, 
while linoleic and arachidonic acids are mostly distributed 
between the cholesteryl and phospholipid fatty acids. 
The fatty acid composition of esterified serum lipids has 
been shown to depend on several factors, which will be reviewed 
below. 
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Age differences 
Several studies have revealed differences in the fatty acid 
composition of individual esterified lipid fractions in relation 
to age. Swell et al., (1960) have reported that children have 
significantly more linoleic acid in their serum cholesteryl fatty 
acids than do adults. Schrade et al., (1961) compared the 
fatty acid composition of normal males in the two age ranges 
1942 and 46-71 and found that the older group had higher 
percentages of saturated and monounsaturated acids and lower 
percentages of polyunsaturated acids in all lipid fractions. 
Sex differences 
Information on this matter is fragmentary. Lawrie et al., 
(1961) reported higher triglyceride palmitate and linoleate in 
women than in men. The authors, however, point out 
that the differences observed may in part be due to a difference 
of one decade between the mean ages of the groups studied. The 
study of Baker et al., (1966) strongly suggests that women have 
more palmitic and oleic acid in their total lipid fatty acids than 
do men. 
Genetic and environmental factors 
Dole et al., (1959) observed that Americans appear to have a 
higher content of linoleic acid in the combined cholesterol r 
triglyceride fraction than their British contemporaries (33.5 per 
cent against 12.4 per cent). The British group showed somewhat 
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higher levels of oleic acid in the combined fraction (34.7 per cent 
against 26.4 per cent). The authors assumed that these 
differences were due to higher cholesterol /triglyceride ratios in 
the American subjects. In the phospholipid fatty acids the 
authors observed that palmitic acid was somewhat higher and 
arachidonic acid lower in the American group. Scott et al., 
(1963) reported differences in fatty acid composition between New 
Yorkers and East Africans. The New Yorkers had higher 
percentages of cholesteryl,triglyceride and phospholipid 
linoleate than East Africans of both upper and lower classes. 
These differences were particularly interesting, because the 
East Africans belonging to the "upper class" did not differ from 
the New Yorkers in their average levels of serum cholesterol. 
The factors responsible for the differences have been attributed 
either to genetic or to environmental causes (Goodman, 1965). 
Experimental diets. 
Several studies, which will be cited below, have revealed 
that a diet rich in linoleic acid causes the relative percentage 
of linoleic acid in the esterified lipids to increase and the serum 
cholesterol concentration to fall, whereas diets rich in saturated 
and monounsaturated acids and in carbohydrate have an 
opposite effect. 
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Studies employing alkali isomerisation techniques and 
iodine value measurements provided some evidence on this 
matter. Michaels et al., (1959) observed that a diet rich in 
ethyl linoleate resulted in an increase of cholesteryl diunsaturated 
acids, and a decrease in saturated and monounsaturated acids. 
On the other hand, a diet rich in ethyl oleate or in carbohydrate 
resulted in a decrease in cholesteryl diunsaturated fatty acids, and 
an increase in saturated and monounsaturated acids. In another 
study it has been shown that the addition of safflower oil (rich 
in unsaturated acids) to the usual diet, resulted in an increase 
in the value of the cholesteryl fatty acid iodine number (Alfin Slater 
and Jordan 1960). 
This information was confirmed by studies employing gas- 
liquid chromatographic techniques (Okey et al., 1960; Swell et al., 
1962; Gunning et al., 1963). During these dietetic experiments, 
elevation of the serum cholesterol concentrations were found 
to be associated with an increase in the monounsaturated and a 
decrease in the diunsaturated fatty acids in the cholesterol ester 
fraction. 
Pharmacological agents. 
The effects of compounds which lower the concentration of 
serum cholesterol were investigated. Treatment with ethyl - ct.- 
para- chloro- phenoxyisobutyrate (Atromid S) leads to increases 
in monounsaturated acids and decreases in linoleic acid in 
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serum cholesteryl, triglyceride and phospholipid fatty acids 
(Jurand and Oliver, 1963). Similar effects in the cholesteryl 
fatty acids were reported after treatment with Atromid (Berry 
et al., 1963), neomycin alone and neomycin with nicotinic acid 
(Goldsmith, 1962). These observations are clearly in contrast 
to those described in the final paragraph of the section relating 
to the effects of experimental diets, since pharmacological 
agents which lower serum cholesterol affected the fatty acid 
pattern in the same direction as diets which led to elevation of 
serum cholesterol. 
In patients with ischaemic heart disease the earlier reports 
were conflicting. James (1957), in a study of ischaemic heart 
disease, did not observe any significant difference in the fatty 
acids of the combined cholesterol and triglyceride fraction 
compared with normals. He suggested, however, the possibility 
of a small increase in oleic acid in this combined fraction. 
Böttcher and Woodford (1961) studied the fatty acids of lipids 
extracted from the protein precipitates of Cohn fraction 1 -111 and 
of fraction 1V-.V and observed differences of no statistical 
significance between normal and atherosclerotic patients. Other 
studies, carried out by Schrade et al., (1958, 1959, 1961) and by 
Swell et al., (1960), provided evidence that atherosclerosis, 
particularly if associated with hyperlipidaemia, is accompanied 
by a decrease in polyunsaturated acids and by an increase in 
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saturated and monounsaturated acids. Similarly, in diabetes 
mellitus, increased percentages of cholesteryl saturated and 
monounsaturated acids and decreased percentages of unsaturated 
acids were reported (Schrade et al. , 1963), although, earlier, 
Hallgreen et al., (1961) had not found any changes in this disease. 
Recently, similar changes in the fatty acid composition have also 
been observed in multiple sclerosis (Baker et al., 1964), in 
familial hypercholesterolaemia (Laudat et al., 1966), and also 
in pancreatic cystic fibrosis and liver disease (Caren and 
Corbo, 1966). 
Hormonal agents. 
Hitherto, the influence of hormone administration or of 
endogenous hormonal abnormalities upon the fatty acid 
pattern of all four serum lipid fractions have not been described 
in human or animal studies. However, Boyd (1963) has 
studied the cholesterol ester fraction and has reported that 
treatment of males with D- thyroxine (3, 5, 3'5'-tetraiodo-D- 
thyronine) resulted in an increase in cholesteryl palmitate, 
palmitoleate and arachidonate and a decrease in cholesteryl 
linoleate. This author also observed that treatment of males 
with ethinyloestradiol resulted in greater decreases of 
cholesteryl linoleate than those induced by D- thyroxine treatment. 
Changes in other lipid fractions were not reported. 
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The above review demonstrates that most investigators 
apart from Boyd have studied the fatty acid composition of serum 
lipids only in relation to hyperlipidaemia or disease. The 
effects of hormones or other factors promoting an increased 
mobilisation of serum FFA remain largely unelucidated. 
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PLAN OF THE STUDY 
The present study comprised investigations into changes 
in the composition of free fatty acids, the fatty acids of 
triglycerides, phospholipids and cholesterol esters in serum 
following mobilisation of free fatty acids. The following agents 
influencing the mobilisation of free fatty acids were studied. 
1. Thyroid hormones 
The relation between fatty acid mobilisation and 
composition was studied with respect to thyroid activity. For 
this purpose the changes which occurred after the administration 
of thyroid hormones to both normal and hypothyroid subjects were 
investigated. In addition, studies were undertaken of the 
changes occurring in thyrotoxic patients as a result of 
antithyroid therapy. 
2. Human growth hormone (HGH) 
Changes occurring in the fasting state as a result of daily 
administration of HGH were investigated. Effects of HGH were 
studied also hourly after HGH injection. In addition, the fatty 
acid pattern was studied in patients with acromegaly. 
3. Noradrenaline 
Changes induced during infusion of noradrenaline were 
studied. 
4. Fasting 
Effects induced by an 8 -hour prolongation of a normal 
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overnight fast were investigated. 
5. Acute and chronic ischaemic heart disease 
The pattern of serum lipid fatty acids was studied within 
12 hours after the onset of myocardial infarction, when the serum 
FFA levels are known to be very high (Kurien and Oliver, 1966). 
In addition the changes occurring during the next two days 
were followed using fasting blood samples. 
The characteristics of the fatty acid composition in patients 
with chronic ischaemic heart disease were reinvestigated by a 
comparison of diseased patients with normal healthy subjects 





Numerous investigations were made in order to study 
physiological influences and hormone -induced changes in serum 
lipids and their fatty acid composition. All the observations 
reported here were made in healthy subjects or in patients 
in the wards of the Royal Infirmary of Edinburgh. 
INVESTIGATIONS ON THE EFFECTS OF THYROID 
HORMONES AND THYROID STATUS 
Thyroid hormone administration to normal humans 
Daily doses of 100 pg. of 3, 5, 3'- triiodo -L- thyronine (LT3) 
were administered for a period of seven days to two healthy 
men aged 23 and 30. For three weeks both men were kept 
on a diet with fixed calorie, carbohydrate, protein and fat intake. 
This dietetic control was begun five days prior to the control 
estimations and seven days prior to the administration of the 
hormone. Blood specimens were taken twice before, on two or 
three occasions during, and twice after the administration of 
LT3. 
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(ii) Myxoedema and the response to treatment with thyroid 
hormones 
Nine patients suffering from myxoedema (8 post »menopausal 
females and 1 male aged 60) were studied before and during 
treatment with LT3 or L- thyroxine (LT4). The serum lipids 
were studied at intervals from two weeks to eleven months. 
Two of the women (R. J. , and L. J.) received a 
controlled balanced diet during the study. In the pretreatment 
period they were in hospital for one week and after treatment 
for one week. During the period of their stay in hospital their 
diet consisted of a fixed calorie intake, and the proportions of 
carbohydrate, fat and protein remained constant. The 
remaining subjects were out..patients on a free diet; blood 
samples were always obtained at the same time after an 
overnight fast. 
(iii) Thyrotoxicosis and the response to treatment with 
antithyroid therapy 
Seven thyrotoxic patients were studied, two men and two 
women between 50 and 60 years of age and three women between 20 
and 30 years of age. The effects of antithyroid therapy with 
carbimazole or with radioactive iodine were studied for periods 
of up to eleven months. In addition one thyrotoxic male aged 
65 was studied in the untreated state. One of the male 
subjects (W. H.) was kept in hospital during the period of study, 
for one week prior to treatment and for a further week after 
attainment of the euthyroid state, and during this time strict 
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dietetic control was exercised. The patients received a 
diet of constant calorie, carbohydrate, fat and protein 
composition. The remaining subjects were out -patients on a 
free diet. Blood specimens were taken after an overnight fast 
at the same time each morning. 
INVESTIGATIONS ON THE EFFECTS OF THE 
ADMINISTRATION OF HUMAN GROWTH HORMONE 
(HGH) AND THE EFFECTS OF ACROMEGALY 
(i) Experiment designed to study long-term effects of HGH 
injection 
The long-term effects of HGH injection were studied 24 
hours after each daily injection. Four men were selected for 
this study. Three were between 50 and 60 years of age and 
suffered from ischaemic heart disease. The fourth was an 
18 -year old volunteer. They were in hospital for 4 weeks and 
were maintained during the study on a diet resembling as closely 
as possible their usual calorie intake, but with a constant 
carbohydrate and constant animal and vegetable fat composition. 
After a control period of one week three of the men received 
intramuscularly 25 mg of HGH daily for three days, and 
one for four days. The injections were given after an overnight 
fast and after the withdrawal of fasting blood samples. 
Additional blood samples were taken at noon and at 4 p.m.; 
these latter samples were analysed only for the concentrations 
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of serum FFA whereas the fasting samples were submitted to the 
full analytical procedure. Blood samples were withdrawn at the 
same time each morning, at noon and in the afternoon during the 
pretreatment period, during administration of the hormone and 
in the post -treatment period (3 »5 days after cessation of HGH). 
(ii) Experiment designed to study short and long-term effects of 
HGH injection 
This experiment was designed to study those effects of HGH 
produced within a few hours of the injection and those produced 
after 24 hours. 
Three men between 50 and 60 years were selected for the 
study. All three were convalescents after renal colic, 12-15 
days after the event. The patients were confined to hospital 
for the duration of the study. Their diet was designed to 
approximate to their usual calorie intake, and consisted of fixed 
amounts of carbohydrate, fat and protein. The patients started 
on this diet four days before the first blood samples were taken 
and one week before the beginning of hormone injection. Each 
subject received an intramuscular injection of 25 mg of HGH on 
two consecutive days after an overnight fast. The first injection 
was followed by an 8-hour fast during which the short term effects 
of HGH were investigated. The second injection was followed 
by the usual daily meals from the balanced diet. Blood specimens 
taken every morning following the overnight fast were analysed 
for the long-term effects of the injection administered 24 hours 
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previously. For control purposes, blood specimens were 
obtained during the pretreatment period at 15, 19 and 23 hours 
after the commencement of fasting. 
The human growth hormone used in studies (i) and (ii) was 
obtained from the Medical Research Council's Department of 
Biological Standards. Concerning the possibility of TSH 
contamination, the Department states: "The method of 
extraction is such that it is most unlikely that TSH contamination 
occurs; assays performed on batches prepared by the Raben 
method have confirmed that there is little if any (TSH activity)* 
detectable ". 
(iii) Acromegaly 
Three women aged 50 - 60 were studied. The clinical 
diagnosis was supported in each patient by elevation of the levels 
of HGH to between 62 and 94 m )ag /ml (Growth hormone 
estimations were kindly performed by Dr. W. M. Hunter in the 
M. R. C. Clinical Endocrinology Research Unit by the method of 
Hunter and Greenwood (1962). The patients under investigation 
were in hospital, and were kept on a normal hospital diet. 
*Authors insert 
.. 23 - 
INVESTIGATION ON THE EFFECTS OF NORADRENALINE 
Six subjects were investigated; two were normal, two were 
hypertensive, and two had ischaemic heart disease. All were age 
between 26 and 45 years. Fasting blood specimens from these 
subjects were obtained before and after the infusion of 100 g 
of noradrenaline given over a period of 15 minutes. 
INVESTIGATION ON THE EFFECTS OF FASTING 
The effects of prolongation of an overnight fast by a 
further 8 hours were studied in 12 subjects, 3 healthy 
volunteers and 9 hospital patients. The period of fast 
started after the evening meal at 6 p. m. and lasted until 5 p. m. 
on the next day. All subjects were resting during the period of 
fast. Free access to water was allowed during the fasting period. 
The hospital patients were subjects with ischaemic heart disease, 
and those convalescent following renal colic. 
INVESTIGATIONS ON THE EFFECTS OF 
ISCHAEMIC HEART DISEASE (IHD) 
(1) Acute myocardial infarction 
A study was carried out on 8 patients admitted to the Coronary 
Care Unit of the Royal Infirmary, Edinburgh within 12 hours of 
the onset of pain. All had electrocardiographic signs of myocardi 
infarction according to the W.H. O. criteria (World Health 
Organisation, 1959) together with a rise in serum creatine kinase 
1 
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(Smith, 1967) and glutamic- oxaloacetic -transaminase (Reitman 
and Frankel, 1957). In 7 of 9 patients, estimations were 
carried out on the day of admission and on two consecutive 
subsequent days, the second and third samples being taken after 
an overnight fast. The remaining two patients had samples 
taken only on the day of admission and on the next day, after an 
overnight fast. 
(ii) Patients with angina or post -acute myocardial infarction 
In all, 23 men aged 33-51 were examined; 13 had angina, 
and 10 had had a myocardial infarction in the past (more than two 
months prior to the study). All the subjects were on a free diet. 
Blood specimens were taken after an overnight fast at the same 
time each morning. 
(iii) Control groups 
The control group for the above study,(ii), comprised 12 
healthy men aged 26 - 51 years, the average age in this control 
group being 3 years less than in the group with ischaemic 
heart disease (33 against 36). 
The control group for the studies of hormonal influences 
comprised four healthy post -menopausal women aged 50-60 years. 
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GENERAL COMMENTS ON THE EXPERIMENTAL CONDITIONS 
AND ON THE CHOICE OF PATIENTS 
Clinical investigations should be undertaken in individuals 
who are sufficiently similar that they can be grouped into one 
category e.g., they should all be healthy or all have the same 
disease or disorder. This principle could not always be 
observed in the present work; for example, the studies whose 
aim was to elucidate the effects of fasting, of growth hormone 
and of noradrenaline have some weaknesses. The subjects 
investigated consisted of healthy members of staff, patients 
convalescing after renal colic, hypertensive subjects and 
subjects with ischaemic heart disease. 
There were difficulties in the standardisation of conditions 
for the growth hormone study. Only one healthy 18 -year old 
male volunteer agreed to stay in hospital for 4 weeks under 
controlled dietary conditions for the purpose of the growth 
hormone study. It is most probable that if this experiment had 
been carried out on two groups of subjects, one healthy and one 
with ischaemic heart disease, some differences would have 
been noted, which could not be elucidated in this limited study. 
The same suggestions apply to the studies on the effects of 
fasting and on the effects of noradrenaline. 
The studies on the effects of thyroid hormones were 
performed in more homoger ous groups and the results can be 
-26 -- 
regarded as more conclusive. It was not always possible to 
observe strict conditions of dietary control in all subjects. 
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METHODS 
CONSIDERATION OF ANALYTICAL TECHNIQUES 
When this study was begun in January 1963, the gas -liquid 
chromatographic analyses of fatty acids in the four main lipid 
fractions in a single specimen of serum required fourteen days 
(Böttcher et al., 1959). Only very slow progress can be 
expected with such a time -consuming technique. The procedure 
consists of many steps, including preparation of the total lipid 
extract, separation of lipids into chemical classes, isolation of 
fatty acids from their esters by means of hydrolysis, the 
removal of fatty acids from their soaps by acidification and 
re- extraction, the methylation of fatty acids and the gas -liquid 
chromatographic analysis of the resultant fatty acid methyl 
esters. 
The separation of lipids into each class is the most time - 
consuming step in the preparatory techniques since column 
chromatography is required. The more rapid technique of 
thin -layer chromatography has the disadvantage that the amounts 
of lipid separated are quantitatively insufficient for further 
analyses. In addition, losses of polyunsaturated acids during 
chromatography on thin -layer plates have been reported 
(Nichanan et al., 1963; Malins and Mangold, 1960; Imaichi 
et al., 1966). 
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The present study is concerned with the problem of 
separation of lipids by column chromatography, employing a 
system of two small rapidly running columns. The purpose of 
the first column is to separate phospholipids from the remainder 
of the lipids, and that of the second column is to separate 
cholesterol esters, triglyceride esters and free fatty acids. 
For the separation of phospholipids from the rest of the 
lipids the original method of Borgström (1952) was reinvestigated 
In this method a silicic acid column is used as a selective filter 
which retains phospholipids, while neutral lipids and free fatty 
acids are eluted from the column with chloroform. The use of 
a silicic acid column for the separation of phospholipids from 
the rest of the lipids has been criticised on several grounds. 
Artifact formation has been observed during lipid chromatography 
on silicic acid (011ey, 1956; Collins, 1960). Some 
phospholipids may be irreversibly adsorbed (Luddy et al., 1958) 
or, alternatively, prematurely eluted (Lipsky et al., 1957). 
In addition, the separation requires a large volume of solvent 
for the elution of adsorbed phospholipids (Bottcher, personal 
communication). 
In the techniques described, silicic acid was dehydrated 
either by oven heating (Borgström, 1952) or by pre -washing with 
dehydrating solvents (Hirsh and Ahrens, 1958) in order to increaso 
its adsorptive strength (Trueblood and Malmberg, 1954). 
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However, the use of silicic acid in a highly activated state has 
been reported to result in reduced reproducibility of 
chromatograms, due to increased activity of "side-effects" 
such as irreversible adsorption and catalytic transformations 
of lipid molecules (Böttcher et al. , 1959). 
The present study attempted to overcome these weaknesses 
in the method by the application of silicic acid of a higher degree 
of hydration and of a coarser mesh. For this purpose a study 
was made of the effects of hydration of the silica gel (mesh 
60-100) on the accuracy of separation, of the adsorption 
capacity and of the hazard of "side -effects" on the fatty acid 
components. 
For the separation of the remaining lipid fraction, 
comprising cholesterol esters, triglyceride esters and free 
fatty acids, column chromatography using Florisil (synthetic 
magnesium silicate) has been investigated. This adsorbent 
was chosen since Carrol (1960) has shown that palmitic acid 
esters of different lipid classes can be separated successfully 
with Florisil and the procedure requires only one -sixth of the 
time and one -third of the solvents necessary for the 
separation of the same quantity of lipids from a similar amount 
of silicic acid. This method had already been proposed for 
the separation of serum lipids (Carrol, 1960) but it had not 
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previously been studied in detail for this purpose. Neither 
was completeness of the separation demonstrated, nor were 
the recoveries of the relevant fractions determined. The 
existence of any selective effect upon the structure of individual 
fatty acids during passage through the column was also not 
determined. The chromatographic properties of Florisil in 
respect of serum lipids were studied here in order to determine 
the optimal conditions for the separation of triglycerides, 
cholesterol esters and free fatty acids for the purpose of the 
gas liquid chromatographic analyses of fatty acid components 
of the relevant lipids. 
Apart from the separation techniques, the other steps in 
the procedure, such as preparation of total lipid extract, 
preparation of fatty acid methyl esters and gasliquid chromato- 
graphic analysis were adopted from the methods recommended 
by other authors as described in the following paragraphs. 
The adopted sequence of the procedure is demonstrated on 
the following diagram. 
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L A Y - O U T 
O F T H E P R O C E D U R E 
SERUM 
1 
CRUDE LIPID EXTRACT 
PURIFIED LIPID EXTRACT 
(Column chromatography on Silicic acid) 




NEUTRAL LIPIDS + FFA 






Trans- Trans - 
methylation methylation 
1 
METHYL ESTERS METHYL ESTERS METHYL ESTERS METHYL ESTERS 
OF OF OF OF 
PHOSPHOLIPID CHOLESTERYL TRIGLYCERIDE FFA 
FATTY ACIDS FATTY ACIDS FATTY ACIDS 
GLC GLC GLC GLC 
Abbreviations: GLC - Gas -liquid chromatography. 
FFA - Free fatty acids 
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METHODS USED FOR THE DETERMINATION OF 
SERUM LIPIDS 
The following colorimetric methods were used for the lipid 
analyses during the study of methods: 
Total cholesterol Abell et a_1_. , (1952) or 
Jurand and Recht (1962) 
Free and esterified Sperry and Webb (1950) 
cholesterol 
Glycerides 
Pho s pholipids 
Free fatty acids 
Carlson (1963) 
Allen (1940) 
Dole (1956) with modification 
of Trout et al., 1960, or 
Mosinger, 1965 
The serum lipid analyses in clinical studies were determined 
by the same methods, except for the determination of serum 
total cholesterol, which were all estimated by the method of 
Jurand and Recht (1962). 
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GENERAL RULES FOLLOWED IN THE 
ANALYTICAL PROCEDURE 
The following rules in all analytical procedures were 
adhered to: 
1. Serum lipid extracts were prepared within one 
hour after withdrawal. 
2. Extracts of lipids in all analytical stages 
were stored at -10°C. 
3. Evaporation of solvents from lipid extracts 
was carried out under nitrogen. 
4. All solvents were Analytical Grade. Hexane 
and petroleum ether were free from aromatic 
compounds. Except for diethyl ether, peroxide 
free, all solvents were re- distilled from glass 
prior to use. 
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PREPARATION OF TOTAL LIPID EXTRACT 
The crude lipid extract was prepared according to the 
recommendations of Folch et al., (1957) using for one volume 
of serum 25 volumes of chloroform methanol 2:1 (v /v). 
(Authors recommended the use of 1 volume of serum and 
17-25 volumes of solvent mixture). The lipid extract 
was refluxed for 30 minutes at 63°, since Böttcher et al., (1959) 
have shown that refluxing is essential to obtain higher than 
98 -99% yield of lipids. 
The non -lipid components were removed by the technique 
of Folch et al., (1957) with the difference that the volume of 
saline employed was 16 per cent instead of 20 per cent of the 
volume of extract. This was done on the basis that the serum 
itself contributes 4 per cent of the water phase, (the authors' 
experience was derived from work with dry tissue). In fact, 
other authors have found that, in the case of serum lipid extract, 
the reduction of the water phase to as low as 10 per cent, gave 
a more efficient extract (Iongh&Van Pelt, 1962) than the use of 
20 per cent of water phase as proposed by Folch et al. , (1957). 
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THE SEPARATION OF PHOSPHOLIPIDS FROM THE REST 
OF THE SERUM LIPIDS 
(i) Description of the procedure finally adopted 
Silica Gel "Davison 950" mesh 60-100 was used. 
Portions containing a few grams of silicic acid were roasted on 
a mild flame for 10 minutes, and cooled for 10 minutes. 4cc of 
adsorbent were poured into 20 ml of chloroform containing 0. 2 ml 
of water. The slurry was mixed for a few minutes and columns 
measuring 7 mm in diameter and 17 cm in length were packed 
with the slurry. 
2 ml of the total lipid extract in chloroform were applied to 
the top of the column. Neutral lipids and free fatty acids (FFA) 
were eluted from the column with 50 ml of chloroform. The 
column was then washed with 10 ml of acetone and the 
phospholipids eluted with 20 ml of methanol -chloroform 4:1 (v /v), 
followed by 100 ml of methanol. 
The above conditions were selected on the basis of the study 
described below. 
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(ii) Description of the study 
Preconditioning of silica gel 
Silica Gel "Davison 950" mesh 60 -100 was employed in the 
three following ways: (1) Adsorbent was dried by roasting 
on a mild flame for 10 minutes, and cooled in contact with air, 
using a standardised time of 10 minutes. (2) Adsorbent was 
dried by heating in an oven at 120° for 24 hours and cooled in 
contact with air using a standardised time of 10 minutes. 
(3) Adsorbent was prepared as in (1) and was hydrated with 8% 
of water as follows: a volume of 4 cc (corresponding to a weight 
of 2. 5 g of silicic acid) was poured into approximately 20 ml 
of chloroform containing 0. 2 ml of water (8% by weight). The 
slurry of silicic acid with chloroform was stirred for one minute 
before the columns were packed. 
It appeared that the procedure of roasting did not destroy the 
gel, since its physical properties in relation to its capacity to 
adsorb water after the roasting procedure were in no way 
different from those observed after oven drying. Roasting was 
therefore preferred, since it reduced the risk of accidental 
adsorption of unidentified materials in the vapour phase in the 
atmosphere within the oven. 
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Columns for chromatography 
The columns employed measured 0.7 cm in diameter 
and 17 cm in length, were constricted at their lower extremity and 
had an expanded solvent reservoir to hold 50 ml. They were 
packed with the prepared slurry of silicic acid in chloroform 
and the walls of the column were washed down several times with 
small portions of chloroform. The columns were neither 
temperature controlled nor run under pressure. 
Solvent system 
The total lipid extract was applied in 2 ml of chloroform. 
The neutral lipids were eluted with 50 ml of chloroform, and the 
phospholipids with 20 ml of methanol- chloroform 4:1, and 
subsequently with 100 ml of pure methanol. Between the first 
and second fractions the columns were washed with 10 ml of 
acetone. (This acetone wash was recommended by Nelson (1962) 
for the removal of products of oxidation from the columns). 
Elution curves of serum lipids from columns containing dried 
silicic acid and from columns containing silicic acid hydrated 
to 8% 
Fig. 1 illustrates the pattern of the elution of serum lipids 
(cholesterol containing compounds, glycerides and phospholipids) 
from 2. 5 g. silicic acid columns, which in one case contained 
silicic acid dried by mild roasting, and in the second, silicic 
acid hydrated to 8%. Hydration has a negligible effect on 
elution curves of total cholesterol (esters and free) and 
glycerides, but influences the elution curves of phospholipids. 
Fig. 1 Elution curves of serum lipids from columns containing 
dried silicic acid and silicic acid hydrated to 8% 
Extracts A, B and C represent the total serum lipids 
from 3 ml of normal serum, 3 ml of hyperlipidaemic 
serum and 6 ml of hyperlipidaemic serum respectively, 
each dissolved in 2 ml of chloroform. Each of these 
extracts was applied to two columns (0. 7 x 17.0 cm), 
one containing silicic acid dried by roasting, and the 
other, silicic acid hydrated to 8 %. The elution curves 
of cholesterol and glycerides are illustrated separately, 
although they emerge from the column together. The 
solvent system applied was chloroform (50 ml) for elution 
of neutral lipids (and FFA), acetone (10 ml) for washing 
out the column, and methanol - chloroform 4:1 (20 ml) 
followed by methanol (140 ml). Each tube collected 
contained 5 ml of eluant. The lipids were determined 
by the following methods: 
total cholesterol - Abell et al., 1952, glycerides (as 
triglycerides) - Carlson, 1963, and phospholipids Allen, 
1940. 
O---O 
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These differences in the elution curves of phospholipids from 
those columns containing dried silicic acid and from those 
containing hydrated silicic acid occur despite the fact that, 
in theory at least, the acetone wash employed before phospholipid 
elution should have effectively "dehydrated" the silicic acid. 
With the use of the dried silicic acid, only 60 -65% of phospholipids 
emerge with the first 30 ml of methanol -containing solvents. 
With the use of silicic acid hydrated to 8 %, 85 -90% of 
phospholipids emerge with the same volume of solvent. 
Moreover, the tailing of the phospholipid elution was slightly 
reduced by the use of the hydrated silicic acid which has been 
described. 
Adsorption capacity for serum phospholipids of silicic acid 
dried or hydrated to 8% during column chromatography 
The columns containing 2.5 g of silicic acid dried either 
by roasting or by oven -heat were not capable of adsorbing amounts 
of phospholipids exceeding 1112 mg. When the load of 
phospholipids was greater, premature elution of phospholipids 
together with the fraction of the neutral lipids took place 
(Table 1). On columns containing 2.5 g of silicic acid hydrated 
to 8 %, amounts of phospholipids up to 23.8 mg were successfully 
adsorbed without premature elution. Thus, the silicic acid 
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phospholipids under the described conditions approximately 
twice as great as that of the silicic acid dried in the oven or by 
mild roasting. Untreated silicic acid had approximately the 
same adsorptive capacity as the dried material (Table 1). This 
represents another advantage of the hydrated silicic acid. 
The recoveries of lipids from columns containing hydrated 
silicic acid 
Columns containing 2. 5 g of silicic acid hydrated to 8% 
were capable of separating the serum neutral lipids from 
phospholipids with satisfactory recoveries (Tables 1 and 2) 
within the tested ranges of the quantities of lipids. 
Changes in the fatty acid composition of lipids occurring during 
the column chromatography on the dried and on the hydrated 
silicic acid 
The results of the comparative runs of the known mixtures 
of FFA and cholesteryl fatty acids through columns containing 
silicic acid dried by mild roasting or silicic acid hydrated to 8% 
are presented in Table 3. Hydrated silicic acid does not 
appreciably change the composition of fatty acids, whereas the 
dried silicic acid does change that composition. In addition, the 
losses of the individual acids on the dried silicic acid were 
inconsistent. 
When studies of serum lipids were undertaken on both types 
of adsorbent the differences were less marked than those noted 
TABLE 2. 
Recoveries of serum neutral lipids and free fatty acids from columns 
containing 2.5 g silicic acid hydrated to 8 %. 
Kind of 
lipids 







Cholesterol- Total 4.37 4.15 95 
containing Ester 2.97 2.79 94 
lipids Free 1.40 1.39 99 
Total 8.50 8.25 97 Sperry and Webb (1950) 
Ester 6.38 6.17 97 
Free 2.12 2.20 104 
Total 13.50 13.00 96 
Ester 10.40 9.60 96 
Free 3.10 3.40 110 
Total 12.00 12.20 102 
Total 15.12 15.70 104 Jurand and Recht (1962) 
Total 19.90 18.90 95 
Triglycerides µ moles µmoles 
2.74 2.75 100 
10.00 9.50 95 
10.60 9.96 94 
3.89 3.78 97 Carlson (1963) 
4.20 4.05 96 







(FFA) 1.13 1.10 97 Dole (1956) 
2.62 2.55 97 
2.43 2.01 83 
3.13 2.94 94 
2.52 2.84 113 Mosinger (1965) 
1.31 1.25 95 
3.09 2.91 94 
mg of lipids in total serum lipid extract. 
TABLE 3. 
The effect of h dration of silicic acid on changes in the percentage 
composition of free and cholesteryl fatty acids resulting from passage 
through the column. 
A- columns packed with silicic acid hydrated to 8 %, B- columns 
packed with silicic acid dried by roasting. Charge on 
column: standard mixtures of cholesterol esters, standard 












Charge Fatty acid Percentage composition 
on column short hand Before After 
mg. design* chromatography chromatography 
A B 
9 18:0 45 48 52 
18:2 39 38 37 
20:4 16 14 12 
6.5 18:0 60 61 60 
18:2 26 25 29 
20:4 14 14 11 
7.0 18:0 52 52 53 
18:2 48 48 47 
Approx. 12 18:0 62 64 59 
20:4 37 36 41 
Jig. 







16:0 n- Hexadecanoic 
16:1 cis- L9Hexadecenoic 
18: O n- Octadecanoic 
18 : 1 cis - LeOctadecenoic 
18: 2 cis _ ngnOctadecadienoic 
20:4 Q5,8,11,14 Eicosatetraenoic 
(i) (ii) (i) (ii) (i) (ii) 
18 19 18 19 13 15 
5 5 5 4 3 3 
5 5 5 6 7 7 
23 23 20 23 24 24 
43 41 44 44 44 40 
7 6 8 7 8 10 
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above for the standard mixtures. However, in two of the three 
sera tested, lower percentages of free palmitoleic acid were 
observed, and in one, lower percentages of triglyceride 
palmitoleate were observed in the eluate from the dried silicic 
acid, which may be attributed to a "side -effect" of the 
activated adsorbent (Table 4). 
This study thus shows a further advantage of hydrated 
silicic acid. 
Conclusions from the studies on separation of serum 
phospholipids by silicic acid chromatography 
In summary, the use of silicic acid hydrated to 8% according 
to the technique described has the following advantages when 
compared to dried silicic acid: 
(1) the adsorptive capacity is increased by a factor of two 
(2) the "tailing" phenomenon observed with phospholipid 
elution is somewhat less marked, thus reducing the 
risk of loss of material 
(3) the hazards of molecular destruction, or rearrangement 
and of irreversible adsorption are diminished. 
TABLE 4, 
Effect of hydration of the silicic acid used for column chromatographic 
separation of serum phospholipids on the percentage composition of fatty 
acids in all four lipid fractions. 
A- Columns packed with silicic acid hydrated to 8 %. 
B- Columns packed with silicic acid dried by roasting. 
Charge on columns:lipid extract from 3 ml. of normal serum 
(Serum No. 1 and No. 2) and 3 ml. of hyperlipidaemic serum 
(Serum No. 3 and No. 4). The cholesterol esters, triglycerides 
and FFA were separated on Florisil columns according to the 
conditions described in the procedure finally adopted. 
Fatty acid 
short hand Serum No. 1 Serum No. 2 Serum No. 3 Serum No. 4 
design 








Phospholipid fatty acid 
16:0 23 23 26 26 33 33 31 
16:1 2 2 1 1 2 2 2 
18:0 19 19 15 15 17 17 17 
18:1 21 19 14 15 15 16 12 
18:2 21 21 32 30 23 22 23 
20:0 1 1 Tr Tr Tr Tr Tr 
20:4 9 10 8 9 9 9 11 
Cholesteryl fatty acids 
Serum No. 1 Serum No. 2 Serum No. 3 
A B A B A B 
16:0 7 8 10 10 9 9 
16:1 3 3 3 4 3 4 
18:0 1 1 Tr 1 1 1 
18:1 16 17 22 24 17 15 
18:2 68 66 59 57 62 62 
20:4 6 5 6 5 8 9 
Triglyceride fatty acids 
Serum No. 1 Serum No. 2 Serum No. 3 
A B A B A B 
16:0 25 26 24 23 28 27 
16:1 5 7 6 6 4 4 
18:0 5 5 3 3 3 2 
18:1 41 43 51 50 40 42 
18:2 23 19 15 16 23 23 
Free fatty acids (FFA) 
Serum No. 1 Serum No. 2 Serum No, 3 
A B A B A B 
16:0 30 30 19 18 33 34 
16:1 2 3 2 4 5 8 
18:0 20 20 22 20 15 12 
18:1 30 32 42 41 34 34 
18:2 14 12 13 15 14 12 
20:4 4 3 2 2 1 1 
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SEPARATION OF CHOLESTEROL ESTERS, TRIGLYCERIDES 
AND FREE FATTY ACIDS 
(i) Description of the procedure finally adopted. 
The phospholipid free misture of serum lipids' (after passage 
through the silicic acid column) dissolved in chloroform was 
dried under nitrogen at 60oC, re- dissolved in 2 ml of hexane 
and applied to the top of the Florisil column. A column 
measuring 0.7 x 17 cm was packed wit1_4 g of Florisil of mesh 
about 100 and hydrated to 8% (see next paragraph in the section 
entitled "Preparation of Florisil). The fractions of separated 
lipids were collected simultaneously with the changing of solvents 
applied to the columns. The solvents applied were as follows: 
Solvent Volume (ml) Fraction eluted 
Hexane 50 hydrocarbons (discarded) 
4% ether in hexane 50 Cholesterol esters 
(collected) 
15% ether in hexane 50 Triglycerides 
(collected) 
20%o ether in hexane 20 
Ether 20 Diglycerides (discarded) 
Acetone 20 Some organic compounds 
probably products of the 
oxidation of lipids 
(dis carded) 
4% acetic acid in ether 50 Free fatty acids 
(collected) 
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(ii) Description of the study 
Preparation of Florisil 
Florisil, a product of the Floridin Company (mesh 60 -100) 
activation temperature 649 °C) was employed in this study. To 
select the optimal conditions for lipid chromatography the 
following fractions of adsorbent were tested: 
(1) Adsorbent mesh 60100 (total fraction) 
(2) Adsorbent mesh about 100 (obtained by rejecting 
that portion of the material which did not pass through 
a sieve of 100 mesh. 
The adsorbent was used in dried or in hydrated form. Drying 
of the adsorbent was carried out by mild roasting for 10 minutes, 
followed by cooling for a standardised time of 10 minutes in 
contact with air. Hydration of the adsorbent was carried out 
after the drying procedure by a technique analogous to that 
described for silicic acid, the only difference being that the water 
required for hydration was added not to chloroform but to the 
hexane in which the slurry was prepared. The quantities of 
Florisil were measured in calibrated tubes (a volume of 8 cc 
corresponded to 4 g of adsorbent). 
Chromatographic procedures 
Two sizes of columns were tested. Large columns 
measuring 1.5 gm x 35 cm and small columns measuring 0.7 x 
17 cm. The shape of the column was the same as that described 
for the separation of phospholipids. 
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The dry residue of serum lipids (previously freed from 
phospholipids by passage through a silicic acid column) was 
applied to the top of the Florisil columns in 2 ml of hexane. As 
proposed by Carrol (1961), the ether -hexane solvent system was 
employed for elution of lipids, and the hydrocarbons were 
removed with hexane. The proportions of ether in hexane require 
for elution of a particular lipid fraction were dependent upon the 
degree of hydration of the Florisil, while the required volumes 
of these solvents were dependent upon the amount of adsorbent 
used. 
Selection of the optimal degree of hydration of Florisil for 
separation of serum cholesterol esters from triglycerides 
Florisil mesh 60 -100 was used for the study. Untreated 
Florisil, when used from a freshly opened bottle, gave 
satisfactory separation. However, a few months after the bottle 
had been in use, the characteristics of the elution diagram change 
entirely (Fig. 2). 
Elution diagrams for serum lipids were drawn for columns 
packed with Florisil hydrated to 7 or 10%, and with Florisil 
dried by roasting (see the paragraph entitled "Preparation of 
Florisil"), to select optimal conditions for the separation of 
cholesterol esters from triglycerides (Fig. 3). The presence 
of free cholesterol in the triglyceride fraction did not 
interfere with the estimation of triglyceride fatty acids, therefore 
Fig. 2 Separation of serum lipids on columns containing 
untreated Florisil 
A and B represent the elution diagrams of lipids from 
5 ml of serum (phospholipid free) during chromatography 
on columns (1.5 x 35.0 cm) packed with 12 g of untreated 
Florisil. The A column contained Florisil from a freshly 
opened bottle, the B column contained Florisil from the 
bottle which had been in use for several months. Each 
tube collected contained 25 ml of eluant. The optical 
densities of colorimetric reactions were determined 
for cholesterol by the method of Sperry and Webb (1950), 
and for glycerides by the method of Carlson (1963). 
Cholesterol (ester, 1st peak; 
free, 2nd peak) 
glycerides (triglycerides, 1st peak; 
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complete separation of cholesterol from the triglyceride fraction 
was not essential. 
Fig. 3 demonstrates that, with increased degree of hydration, 
lipids are eluted with solvents of lower polarity. On columns 
containing dried Florisil, cholesterol esters are eluted with 
15% ether in hexane, while on columns containing Florisil 
hydrated to 7% or 10 %, cholesterol esters are eluted with 5% ether 
in hexane. The same observation has been made by Carrol 
(1961) on diagrams obtained with the mixtures of different esters 
of palmitic acid. The only difference between the diagrams which 
Carrol obtained and those presented here is that, in the case of 
serum lipids, the dried Florisil does not separate the cholesterol 
esters from the triglycerides, whereas in the case of the mixture 
of palmitic acid esters, used by Carrol, separation was complete. 
The columns packed with dried Florisil caused a broad tailing 
peak of cholesterol esters which overlapped the sharp peak 
of triglycerides. Higher degrees of hydration (10%) resulted in 
a sharp peak of elution of cholesterol esters, with an overlap 
between the cholesterol and triglycerides caused by too rapid 
elution of triglycerides. The optimal conditions for the 
separation of cholesterol esters from triglycerides were obtained 
with Florisil hydrated to 7 %. 
Selection of the amount of adsorbent and size of the column 
The separation of serum lipids on the 12 g columns 
illustrated in Figs. 2 and 3 were carried out with 500 ml of 
Fig. 3 Separation of serum lipids on columns containing Florisil 
of different degrees of hydration 
A, B and C represent elution diagrams of lipids from 
5 ml of serum (phospholipid-free ) during chromatography 
on columns (1.5 x 35.0 cm) packed with 12 g of Florisil. 
A --- column with Florisil dried by roasting for 10 
minutes, B --- column with Florisil hydrated to 7 %, 
C - column with Florisil hydrated to 10 %. Each tube 
collected contained 25 ml of eluant. The optical 
densities of the colorimetric reactions were determined 
as shown in Fig. 2. 
- - - cholesterol (ester, 1st peak; free, 2nd peak) 
A glycerides (triglycerides, 1st peak; partial 
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solvents and required 4 hours for operation; therefore, further 
investigations were directed to an attempt to decrease the time 
required and the amount of solvents used. This was achieved 
by the use of shorter, narrower columns containing 4 g of 
Florisil. Fig. 4 demonstrates the separation diagram 
obtained when equal aliquots of serum lipids were applied to the 
two types of column, a large one containing 12 g of Florisil, 
and a small one containing 4 g of Florisil. In both cases the 
adsorbent was hydrated to 8%. It has been shown that, on the 
smaller columns, separation could be achieved with smaller 
volumes of solvent, without an overlap between the relevant 
fractions. In addition, the duration of the procedure could be 
reduced from 4 hours to 75 minutes. 
Selection of size of mesh 
The effectiveness of separation was studied by the 
application of three varying quantities of lipids to each pair 
of columns (0. 7 x 17 cm), one of which was packed with Florisil 
mesh 60- 100 and the other with Florisil mesh 100. As 
demonstrated in Fig. 5, the columns with more finely divided 
adsorbent gave sharper elution curves, as would be expected from 
basic chromatographic principles. However, it appears that the 
elution diagram of triglycerides is more affected by the size of 
Fig. 4 Separation of serum lipids on columns differing in 
size and in the amount of Florisil used for packing 
A and B represent elution diagrams of lipids 
from 3 ml of serum (phospholipidwfree) during 
chromatography on columns containing Florisil 
hydrated to 8 %. A - large column (1.5 x 35.0 cm) 
packed with 12 g of Florisil, B small columns 
(0.7 x 17 cm) packed with 4 g Florisil. Each tube 
collected contained 10 ml of solvent. The optical 
densities were determined as shown in Fig. 2. 
- - -s cholesterol (ester, 1st peak; free, 2nd peak). 
glycerides (triglycerides, 1st peak; partial 
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Fig. 5 Separation of lipids on columns containing Florisil 
of different mesh sizes 
A, B and C represent elution diagrams of lipids 
(phospholipid -free) from 3 ml, 5 ml and 12 ml of 
serum respectively, during chromatography on small 
columns packed with 4 g of Florisil differing in mesh 
size. 
- - -+ --- 
o--- -0 ar---r 
columns with Florisil mesh 60 -- 100 
columns with Florisil mesh 100 
The broken line is the elution curve of cholesterol-. 
containing compounds and the unbroken line is the elutinn 
curve of glycerides. Each tube collected contained 
10 ml. of eluant. The optical densities were 
determined according to the methods described in Fig. 2. 
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mesh than is that of cholesterol esters. There is a 
considerably greater tailing of the triglyceride fraction from the 
columns with the unsieved Florisil (mesh 60 -100) than from the 
columns with Florisil containing the finer particles. These 
observations prove that the use of the finer mesh is 
advantageous. 
Recoveries of lipids from Florisil column 
The above experiments led to the selection of small columns 
containing 4 g of Florisil of mesh about 100 hydrated to 8 %. 
The recoveries of lipids were estimated under these conditions 
and employing the solvent systems described in Figs. 4 and 5. 
The recoveries of the relevant lipids eluted with the appropriate 
solvent fraction are summarised in Table 5. The recoveries of 
cholesterol esters estimated by the digitonin precipitation method 
varied from 98 to 100%. The recoveries of total cholesterol 
varied from 97 to 106%. An additional check on recovery of 
cholesterol esters was carried out by adding cholesteryl 
palmitate 1-C14 to the extract of serum lipids, and by measuring 
the radioactivity in all fractions that were passed through the 
column (Table 6). The fraction (defined as that) containing the 
cholesterol esters contained 103% of the total radioactivity. The 
apparently high recovery is within the limits of the counting 
procedure. It is important that negligible amounts of 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The recovery of cholesteryl palmitate -C14 from Florisil column. 
(4 g. of Florisil mesh 100) 
Charge on column: Lipid extract from 3 ml. of serum 
(phospholipid free), and cholesteryl -palmitate -1 -C14 (0.02 Ac) 
Solvents Radioactivity Radioactivity Per cent of the 
applied in the lipid in the eluants radioactivity 
to column extract applied 
to the column 
cpm 









(50 ml.) 7,933 103.60 
15% ether 
in hexane 
(50 ml.) and 
ether (20 ml.) 186 2.41 
Acetone 
(20 ml,) 16 0.21 
4% acetic 
acid in ether 
(50 m1.) 7 0.09 
Total radioactivity recovered 8,142 106.3 
.,47.. 
The recoveries of triglycerides estimated by the method of 
Carlson (1963) varied from 94 to 104%. In the ether fraction 
1 .- 8% of the total glycerides loaded were recovered (Table 5). 
They were identified as diglycerides by thin -layer chromatography 
Recovery studies in relation to serum FFA are unfortunately 
vitiated by the relative inaccuracy (+ 10%) of the available 
methods of FFA estimation. It is impossible, therefore, to 
assert with certainty that artifacts due to losses of FFA during 
chromatography, or indeed addition of FFA due to partial 
hydrolysis of triglycerides, do not occur. In order to prove 
that the composition of the FFA recovered from the Florisil 
column is a true reflection of the composition of the FFA present 
in the unseparated lipid mixture, the following experiment was 
carried out. 
The FFA were removed from the phospholipid free fraction 
of serum lipids by shaking with aqueous NaOH (0.05N). The 
isolated FFA were divided into two equal parts. One was 
methylated and analysed by GLC, and the other was added to the 
neutral lipids, partly to reconstitute the serum lipids. The 
reconstituted mixture was then processed in the usual way, and 
a comparison was made between the fatty acid compositions of 
the chromatographed and unchromatographed FFA by GLC 
Table 7a. No difference was detected, showing that passage 
through the Florisil column did not appear to affect the fatty acid 
composition of the FFA fraction in any way. This also implies 
TABLE 7a. 
Chances in the .ercentaae com osition of serum FFA after column 
chromatograghy on Florisil 
(4g. of Florisil mesh 100 hydrated to 8%) 
Charge on column: A -lipid extract from 3 ml., B -lipid 
extract from 6 ml. of the same serum, each re- constituted 
by adding half of the amount of FFA, which were previously 




The percentage composition of serum FFA 
Before column chromatography 
(FFA separated by shaking with 
Na OH) 
After column chromatography 
(FFA eluted from columns 
loaded with the re- constituted 
A B A 
lipid extract) 
"B 
16:0 30.1 29.6 32.0 33.0 
16 :1 4.2 4.0 4.3 5.1 
18:0 12,5 11.9 13.0 11.6 
18 :1 39.1 39.7 36.9 38.3 
18:2 14.1 14.8 13.8 12.0 
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that no breakdown of ester linkages occurs during the 
chromatographic separation. 
An additional experiment was carried out with a mixture of 
standard fatty acids. The fatty acid composition of this mixture 
was estimated by GLC before and after the mixtures were run 
through two columns, one of silicic acid and one of Florisil. 
Solvents identical to those described for the serum lipids were 
applied. The results presented in Table 7b show that passage 
through the two columns, under the conditions described for the 
two duplicated experiments with the same standard mixtures, did 
not change the composition of the standard mixture of fatty acids 
in any way. 
Investigations on possible selective effects on percentage 
composition of free and esterified fatty acids during passage 
through Florisil columns 
When the final procedure for the fatty acid analyses was 
adopted, it was tested with standard mixtures of lipids to 
investigate whether the passage through Florisil columns changed 
the composition of fatty acids in the relevant lipids. Therefore, 
the standard mixtures of different cholesterol esters and different 
FFA were run in parallel through two columns, one containing 
Florisil mesh 100, and the other containing Florisil mesh 60 -100, 
in both cases hydrated to 8% (solvents as in Figs. 5 and 6). The 
results presented in Table 8a show that the run through the Florisil 
TABLE 7b. 
Changes in the percentage composition of standard mixture of free fatty 
acids after chromatography on two columns, one with silicic acid and the 
other with Florisil 
Silicic acid column: 2.5g. of silicic acid- mesh 60 -100 hydrated to 8%. 
Florisil column: 4 g. of Florisil mesh 100 hydrated to 8 %. 




The percentage composition of free fatty acids in 
the standard mixture 
Before chromatography After chromatography 
A B A B 
16:0 20.2 19,6 20.5 19.1 
18:0 16.8 18.3 17.8 18.8 
18:1 24.7 24,5 22.5 23.9 
18:2 38.3 37.6 39.2 38.3 
TABLE 8a. 
Changes in the percentage composition of cholesteryl fatty acids resulting 
from passage through the Florisil column 
A - 4 g. Florisil hydrated to 8 %, mesh 100. 
B - 4 g. Florisil hydrated to 8 %, mesh 60 -100. 






The percentage composition of fatty acids 
mg. design. Before chromatography After chromatography 
A B 
Mixture 1. 6 18:0 81.4 83.5 82.8 
20:4 18.6 16.5 17.2 
Mixture 2. 9 18:0 48,8 51.4 51.0 
18:2 37.3 35.1 36.0 
20;4 13.9 13.5 13.0 
Mixture 3. 2.5 18:0 62.5 64.0 62.2 
18:2 24.2 24.2 24.4 
20:4 13.3 12.8 13.4 
-49-. 
column of either mesh did not influence the fatty acid 
composition of the relevant fractions. 
Similar observations were made when lipids from two different 
sera were analysed for their fatty acid composition by application 
to columns with the two different mesh sizes of Florisil. The 
results obtained were nearly identical (Table 8b). 
These results further suggest that no molecular "damage" 
occurs during chromatography on Florisil. 
The importance of the acetone wash on the Florisil columns for 
the accuracy of GLC analyses of serum FFA 
The application of an acetone wash to the Florisil columns 
following elution of cholesterol esters, triglycerides, free 
cholesterol and diglycerides, and before the elution of free fatty 
acids has been found to be absolutely necessary, since a clear 
spectrum of free fatty acids by the GLC analyses could not 
otherwise be obtained. Omission of the acetone wash leads to the 
appearance on the gas liquid chromatograms of a large amount of 
interfering components, and, in addition, the amount of the methyl 
esters of the relevant fatty acids was greatly reduced. These 
interfering components were successfully removed by the washing 
down of the column with 20 ml. of acetone. The dried residue of 
the acetone wash, after transmethylation, was analysed by GLC and 
found to contain all the components which interfered with the GLC 
analyses of the free fatty acids (Fig. 6). 
TABLE 8b. 
Changes in the percentage composition of serum lipid fatty acids resulting 
from passagze through the Florisil columns. 
A- columns packed with 4 g. Florisil mesh 100, hydrated to 8%. 
B- columns packed with 4 g. Florisil mesh 60 -100, hydrated to 8%. 
Charge on column: lipid extract from 3 ml. of normal serum 





Serum No 2 
A 
16:0 9.4 9.7 9.4 10.4 
16:1 3.4 3.1 3.0 3.0 
18:0 0.5 0.3 0.8 0.4 
18:1 18.0 18.0 18.9 18.0 
18:2 64.0 65.0 61.9 62.6 
20:4 5.0 4.2 6.4 5.4 
Triglyceride 
fatty acids 
16:0 25.7 25.0 27.6 26.6 
16:0 6.7 5.5 4.8 5.1 
18:0 5.1 4.9 3.9 3.8 
18:1 43.2 42.6 44.1 43.6 
18:2 19.3 22.0 19.6 20.1 
FFA 
16:0 29.7 30.4 30.0 32.0 
16:1 5.5 5.9 8.4 7.5 
18:0 17.8 18.0 10.4 9.3 
18:1 36.0 35.6 36.3 37.0 
18:2 10.1 10.0 11.2 11.3 
20:4 T T 3.8 3.0 
Fig. 6 The effect of application of acetone wash to Florisil 
column on the gas -liquid chromatographic tracing 
of methyl esters of FFA 
A ® Gasilliquid chromatogram of methylated contamination 
of acetone wash 
B » Gas .liquid chromatogram of methyl esters of FFA;FFA 
separated on Florisil column without application of 
acetone wash. 
C .. Gas -liquid chromatogram of methyl esters of FFA;FFA 
separated on Florisil column after application of 
acetone wash. 
IP - Interfering peak 
Operating conditions: Columncharacteristics and the supporting 
phase described in text: liquid phase: Ethylene Glycol Succinate 
(20 %); column temperature 159°C; Argon flow rate: 45 cc /min. 
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Neither the presence of cholesterol nor glycerides nor free 
fatty acids could be detected in the dry residue of the acetone wash 
by the appropriate colorimetric reactions. The infra -red 
analyses showed that (independent of the mesh used) the acetone 
washings contained mostly absorption bands characteristic of 
carboxylic groups present in cholesterol esters (frequency 1730 cm 
rather than absorption bands characteristic of triglycerides 
(frequency 1742 cmw1;. Fig.7). 
PREPARATION OF FATTY ACID 
METHYL ESTERS 
In a few early analyses only, the methyl esters of fatty acids 
were prepared according to the method described by Bottcher 
et al., (1959), which comprised a two -step technique of 
saponification of lipids and of subsequent methylation of the 
separated fatty acids. In the majority of studies methylation was 
carried out according to the method of Stoffel et al., (1959) with the 
following modifications. Hydroquinone (about 2% of the weight 
of lipids) was added to the methylation medium as antioxidant. The 
microsublimation step was omitted,as proposed by Geyer and 
Bennet (1962), in order to shorten the procedure. It appeared not 
to be essential, reproducibility of results being satisfactory (see 
the section, "Reproducibility of overall procedure "), with no 
peaks appearing on GLC apart from those of the fatty acids. 
Fig. 7 The infrared analysis of contamination of acetone 
wash from Florisil column 
A d Solvent blank 
B Dry residue from acetone wash 
C - 5.cholesten- 3- ol- linoleate 
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The change in the methylation technique from a two -step to a 
one -step procedure has considerably shortened the time required, 
and it did not significantly alter the results of GLC analyses 
(Table 9). 
GASLIQUID CHROMATOGRAPHY (GLC) 
GLC analyses were performed on Pye Argon Chromatographs 
using ionisation detectors containing Sr90. The analysing units 
consisted of glass columns (4 foot x 1/6 inch) packed with Ethylene 
Glycol Succinate polyester supported on Celite 545 (not pre -washed 
of mesh 100-120. Columns packed with other liquid phases such 
as Reoplex 400 and Apiezon L were often used in addition. The 
columns with Ethylene Glycol Succinate polyester (20 %) were 
operated at 159.160°C, columns with Reoplex 400 (1015 %) at 
165-175°C and columns with Apiezon L (10 %) at 180 ..190 °C. The 
flow rate varied from 35 to 45 cc /minute. The detectors were 
operated at 1250 V. 
The sample to be analysed was introduced to the column by 
the magnetic injection system (Pye Cat. No. 12580) in a modified 
way. The original glass micropipette fixed to the end of the metal 
rod was removed. Solution of methyl esters of fatty acids in 
hexane (0. 2 « 0.4 ml) was pipetted into the space previously 
occupied by the capillary pipette, the solvent being allowed to 
evaporate under nitrogen. The dry esters were then introduced 
by the magnetic device into the column without interrupting the 
flow of argon. 
TABLE 9. 
Comparative analyses of serum lipid fatty acids applying two different 
techniques for the preparation of fatty acid methyl esters 



















16:0 31 28 31 32 27 26 
16:1 2 2 1 2 1 1 
18:0 16 17 17 17 18 16 
18:1 16 15 19 20 16 17 
18:2 22 24 21 21 26 28 
20:4 12 13 9 8 11 12 
CHOLESTERYL 
FATTY ACIDS 
16:0 12 11 15 13 13 12 
16:1 8 7 6 6 6 5 
18:0 1 1 1 T 1 T 
18:1 25 24 26 27 26 27 
18:2 48 51 46 48 49 50 
20:4 6 7 5 6 5 6 
TRIGLYCERIDE 
FATTY ACIDS 
16:0 33 32 29 29 27 26 
16:1 5 4 7 7 5 4 
18:0 5 6 5 4 3 4 
18:1 45 44 46 45 50 50 
18:2 12 13 13 15 14 15 
The composition of fatty acids is expressed as a percentage 
of total fatty acids in the fraction. 
Abbreviation: T = trace. 
w. 52 .- 
The quantitative GLC analyses were controlled according to 
the 
recommendations of4National Heart Institute (Horning et al., 1964). 
Multiplication of peak height by width of half height was used for 
area calculations, measurements of peak width having been made 
with the help of a magnifying glass with fixed scale (Magniray Major, 
Verebles & Co. Ltd.). If changes in fatty acid composition were 
small, but uniformly present in all gas-liquid chromatograms, the 
gas -liquid chromatograms were also calculated, using 
triangulation and planimetry, to confirm the suspected trend. 
If possible, the total procedure was repeated using the initial 
extract. 
the 
Fatty acid standard mixtures fromANational Heart Institute 
were used to estimate the accuracy of GLC analyses. (Mixture 
"C" contains myristic, palmitic, stearic, and oleic acids and is 
used to establish the linearity of detector responses with respect 
to molecular weight. Mixture "D" contains myristic, palmitic, 
palmitoleic, stearic and oleic acids and is used to study the 
column efficiency.) Quantitative results using National Heart 
Institute fatty acid standard mixtures ( "C" and "D ") agreed 
with the stated composition with a relative error of less than 
3% for major components (more than 10% of total mixture), and 
less than 10% for minor components (less than 10% of total 
mixture). A standard mixture was always run as an external 
standard between the analyses of serum fatty acid methyl esters. 
Each final extract of fatty acid methyl esters was analysed 
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by GLC on at least three occasions, often using two different 
liquid phases. During the study, when sequential changes were 
investigated, care was taken that calculations were made from 
gas chromatograms from the same analysing unit, operated under 
standard conditions. Care was taken also that the amount of 
sample loaded was as similar as possible on each occasion, 
since it is known that the response of detectors to increases 
in fatty acids is often not linear but differs predictably for 
components with different retention times. Particularly erratic 
results could be obtained for the palmitic and arachidonic acids 
when these precautions were not strictly adherred to. 
Since the amount of eicosanoic and docosanoic acids in the 
phospholipid fraction, and of linolenic acid in the cholesterol ester 
fraction, as well as of pentadocosanoic in both phospholipid and 
cholesterol ester fractions were small, and since no significant 
changes were observed in any of the clinical investigations, they 
have not been included in the data presented. Myristic acid is 
usually present in phospholipids in trace amounts, in cholesterol 
esters to the extent of only 0. 5 - 2% and in triglycerides and 
free fatty acids to the extent of only 2 - 4%. It was not 
uniformly altered during the investigations; therefore, it was 
also omitted from the calculations because of the relatively 
high standard error involved. Linolenic acid was calculated 
from chromatography on columns packed with Reoplex 400 and 
not from those packed with ethylene glycol succinate, where it 
54 - 
coincides with eicosanoic acid. 
SOURCE OF REFERENCE COMPOUNDS 
Most of the compounds used were supplied by Sigma 
Chemical Company Ltd., London. Compounds from other 
sources were as follows:- 
Methyl arachidonate Roche Products Ltd., 
Welwyn Garden City, 
England 
The Radiochemical Centre, 
Amersham 








Koch -Light Laboratories Ltd. 
Colnbrook, Bucks. England 
W. G. Pye & Co. Ltd. , 
Cambridge, Engl and. 
REPRODUCIBILITY OF THE OVERALL PROCEDURE ADOPTED 
The reproducibility of the overall procedure, starting from the 
initial total lipid extract, was estimated by ten complete analyses 
of one serum. Table 10 demonstrates the reproducibility of the 
overall procedure. For those components whose percentage 
composition lies between 25 and 50% of the total, the coefficient 
of variability is 4.4.5. 
The cholesteryl fraction is an exception. Cholesteryl oleate 
and palmitate had relatively higher coefficients of variability: 
6. 14 and 5. 61 respectively. Cholesteryl palmitate is present in 
the same concentrations as phospholipid arachidonate, although 
* The coefficient is expressed as percentage of the mean. 
TABLE 10. 
Reproducibility of the analytical nrocedure. 
Replicate analysis of one serum. 
T,inid Fatty acid Mean Number Standard Coefficient 
fraction short hand percentage Range of deviation of 
design. composition observa- variability 
tions 7 
0 
Phos'iho- 16:0 31.1 29.0 -33.0 10 1.15 3.70 
livid 16:1 1.5 1.1 -2.0 10 0.33 21.90 
Fatty 18 :0 16.1 15.0 -17.0 10 0.66 4.12 
Acids 18:1 14.0 13.4 -15.1 10 0.63 4.49 
18:2 25.7 24.4 -28.0 10 1.10 4.22 
20:3 1.6 1.3 -2.0 10 0.33 20.30 
20:4 10.1 9.6 -11.0 10 0.42 4.15 
Choleste- 16:0 9.8 9.2 -10.7 8 0.55 5.61 
ryl 16 :1 3.3 2.9 -3.5 8 0.21 6.27 
Fatty 18:0 0.7 0.5 -0.9 8 0.15 21.30 
Acids 18:1 1.8.7 17.4 -20.5 8 1,15 6.14 
18:2 59.5 58.2 -61.4 8 0.96 1.61 
20:4 6.5 5.8 -7.3 8 0.49 7.55 
Tri- 16 :0 26.1 25.0 -27.2 8 0.78 2.79 
glyceride 16:1 5.6 5.1 -6.4 8 0.46 8.27 
Fatty 18:0 3.3 2.8 -3.8 8 0.36 10.90 
Acids 18:1 46.6 45.8 -47.1 8 0.96 2.00 
18:2 18.2 17.1 -19.8 8 0.83 4.50 
20:4 T - - 8 T 
Free 16:0 30.6 29.0 -32.4 10 1.09 3.56 
Fatty 16:1 4.7 4.0 -5.4 10 0.46 9.15 
Acids 18:0 13.5 12.9 -14.1 10 0.58 4.36 
(FFA) 18:1 39.4 38.2 -41.3 10 0.85 2.15 
18:2 11.5 10.9 -12.1 10 0.35 3.04 
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the coefficient of variability for the latter is lower (C = 4. 15). 
Components between 3 and 10% of the total fatty acids have 
coefficients of variability proportionally greater (C= 6. 14 and 
C= 10.90) in all lipid fractions studied. 
DISCUSSION OF THE METHODOLOGICAL STUDY AND 
OF THE OVERALL TECHNIQUE ADOPTED 
The overall procedure described for analyses of serum fatty 
acids in four lipid fractions requires approximately two days, 
and, in this time, simultaneous analyses of two serum samples 
can be carried out by one person. The separation of lipids into 
four chemical classes can be performed in 2 -22 hours by 
applying the two - column system here described. 
Since column adsorption chromatography was first used for 
lipid analyses by Trappe (1940), who separated the hepatic 
cholesterol esters from triglycerides on alumina columns, this 
technique has been widely employed. The most widely used 
adsorbent for this purpose is silicic acid, since Borgström (1952) 
demonstrated that it exhibits a greater resolving power than does 
alumina. Hirsh and Ahrens (1958) elaborated a standard 
technique for the separation of lipids on silicic acid columns, 
and Ikels (1961) elaborated a modification of this method on a 
micro -scale. 
The use of a single silicic acid column required laborious 
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preparation of the silica gel, together with complicated 
chromatographic equipment involving temperature and pressure 
control. Even in the micromodification (Ikels, 1961), the 
separation of four lipid classes required 5 hours, with 
additional time necessary for the preparation of the silicic acid. 
The use of a single silicic acid column for the separation of 
various lipid classes has been criticised (Böttcher et al., 1959) 
on the grounds that FFA could not be separated from triglycerides 
and sterols, and that phospholipids could not be recovered 
quantitatively. Irreversible adsorption, premature elution 
and artifact formation on silicic acid columns were earlier 
reported (see the paragraph in this section entitled "Consideration 
of analytical techniques). The separation of phospholipids and of 
FFA was recommended before chromatography on silicic acid 
(Böttcher et al., 1959). 
The use of Florisil as an adsorbent for the separation of 
lipids by Carrol (1960) provided the prospect of a more rapid 
separation technique, although the separation of phospholipids 
before the chromatography on Florisil was also shown to be 
essential (Carrol 1960). 
The investigations reported here set out to study optimal 
conditions for the separation of serum lipids on Florisil and for 
the subsequent analysis of their fatty acid components by GLC. 
Under the conditions described, no untoward effects upon the 
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fatty acid molecules were observed. It has been demonstrated 
that Florisil columns containing 4 g of Florisil hydrated to 8% 
can successfully separate lipids from 3 ml of serum within 
;net odu r:11 
60 w 70 minutes For patients with normal or only qty elevated serum 
lipids. For patients with extreme hyperlipidaemia, however, it is advisable to use an 
extract- prepared from less than 3 m( of serum , It has been shown also that 
the FFA can be successfully separated from other lipids on 
Florisil columns, provided that the columns are cleared before 
the elution of this fraction by an acetone wash to remove 
impurities (probably products of cholesterol ester oxidation). 
The removal of water from the column may also play some role, 
the nature of which is unknown. 
It appears that the techniques described here have 
significant advantages when compared with other methods used 
for the separation of FFA from other lipids. The use of an ion 
exchange resin (Amberlite IRA 400), as proposed by Savary and 
Desnuelle (1954) and Borgström (1952), implies the use of 
another column chromatographic separation, and was reported 
to lead to partial decomposition of fatty acids ( Bottcher et al., 
1959). An alternative method of shaking lipid extractswith 
aqueous KOH and recovery of the FFA after acidification of 
soaps, was preferred by Bottcher and his co-workers, but there 
are difficulties in the separation of the aqueous and organic 
phases due to the formation of emulsions. 
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Since the Florisil column is not capable of separating 
phospholipids and individual neutral lipids (Carrol, 1960) 
simultaneously, the phospholipids must be removed prior to 
chromatography on Florisil. 
In the present study a modification of the method of 
Borgstrom (1952) is presented. It has been demonstrated that the 
hydration of silicic acid by the technique described has increased 
the capacity of the silica gel to adsorb serum phospholipids by 
a factor of two. It was accepted that adsorption usually attains 
its maximum when all free water is removed (Trueblood and 
Malmberg, 1954). However, it has already been demonstrated 
(Kay and Trueblood, 1949) that in some conditions an unusual 
increase of adsorptive strength of silica gel on columns occurs 
with an increased amount of adsorbed water. These authors 
explained this behaviour either on the basis of the hydrogen 
bonding capacity of water or by the overlap of the phenomena of 
adsorption and partition chromatography on hydrated gel. It is 
likely that a similar explanation may apply to the chromatographic 
properties of silicic acid toward the polar molecules of the 
phospholipids observed here. 
As compared to the methods of Van Beers et al., (1958), which 
employ the dialysis of lipids for 24 hours across a rubber 
membrane, the method described here appears to be better suited 
-59- 
for routine analysis by virtue of being less time - consuming. 
The method of Van Beers et al. , (1958) has been criticised, in 
addition, because loss of some cholesterol ester retained on the 
rubber membrane has been observed (Böttcher et al. , 1959). 
It has been suggested (Böttcher et al. , 1959) that active 
silicic acid deteriorates, but this was not observed in the 
present study on serum lipids, probably because of the use of small 
columns, or because of the use of coarser mesh. The 
differences observed between the fatty acid composition of the 
lipid fractions by the application of either dried or hydrated silicic 
acid were negligible. It is, however, interesting that these 
differences were considerable when mixtures of free or cholesteryl 
fatty acids were passed through the columns. In this case, the 
dried, but not the hydrated, adsorbent led to alterations in the 
fatty acid composition of the relevant mixtures, indicating a 
greater risk of untoward effects on columns with the dried 
adsorbent. It is likely that the absence of these effects during 
chromatography of serum lipids may be attributed to the fact 
that the phospholipids adsorbed on silicic acid columns acted in 
this case as a'de- activator' . 
The procedure adopted here gave satisfactory recoveries and 
reproducibility. Although the time taken for a single analysis 
has been shortened as compared to that required by other methods 
-60-- 
described, it does not mean that the entire method, including GLC 
analysis, is simple. It remains laborious, and will give good 
results only in the hands of an experienced and careful worker. 
- 61 - 
RESULTS 
PRESENTATION OF DATA 
As an introduction to the study, the composition of fatty acids 
in healthy men is compared with similar data from five other 
laboratories (Tables 11 and 12). The day-to-day variation 
in the percentage composition is calculated by an approximate 
method from paired estimations in subjects kept on a free diet 
(Table 13). 
The actual study, which includes investigations on effects 
produced by different influences upon fatty acid mobilisation, 
is described separately for each lipid fraction (Tables 14 - 21). 
The effects of hormonal influences and of fasting are presented 
in separate tables (Tables 14, 16, 18 and 20) as are the effects 
of the diseases studied (Tables 15, 17, 19 and 21). The 
differences between the data obtained in diseased and healthy 
groups were processed statistically by Student's t test. The 
changes which occurred after treatment with hormones, and those 
due to fasting, were processed by the application of Student's t 
test to paired comparisons. 
The detailed results obtained from these studies are included 
in the Appendix, Tables 1 - 10. 
THE PERCENTAGE COMPOSITION OF SERUM LIPID FATTY 
ACIDS IN HEALTH 
When the data concerning the composition of serum lipid 
fatty acids in healthy males were compared with those for 
- 62 - 
individuals of similar age reported from five other laboratories 
some differences were noted (Tables 11 and 12). 
The results of this study provide the highest values for the 
mean percentage of free stearic acid; the levels for free oleic 
acid are also higher than those observed by some other authors, 
but are similar to those reported by Caren and Corbo (1966). 
The present results are similar to those of the Swedish 
group, Hallgreen et al., (1960), in respect of serum 
triglyceride fatty acids, and similar to those of the 
Californian group, Caren and Corbo (1966), in respect of serum 
cholesteryl fatty acids. The only difference in the phospholipid 
fatty acids in that the present observations show slightly lower 
values for phospholipid palmitate than those observed by other 
authors. 
THE DAY -TO -DAY VARIATION IN THE PERCENTAGE 
COMPOSITION OF SERUM LIPID FATTY ACIDS 
These values were calculated from random subjects who had 
taken a free diet, and were investigated after an overnight fast 
on two different occasions at intervals of between 1 day and 3 
months. 
The results (Table 13) show that the fraction which shows 
the largest day -to -day variation is the serum FFA. The 
percentage of FFA oleic acid is the most variable, and that of 
FFA linoleic acid is least variable. 
The stability of the pattern of serum triglycerides, 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.. 63 .. 
CHANGES IN THE COMPOSITION OF SERUM FREE FATTY 
ACIDS (FFA) IN RESPONSE TO DIFFERENT FACTORS 
INFLUENCING FATTY ACID MOBILISATION 
Thyroid hormone 
(i) Thyroid hormone treatment in normal and hypothyroid 
subjects 
The serum FFA concentrations were not uniformly changed 
in the two normal men under study. The serum FFA increased 
in one, and decreased in the other man during the 7-day period 
of administration of 100 lag of LT3 (Appendix Table 1). Since 
this experiment was carried out early in the study, it does not 
include information about the composition of serum FFA. 
Significant changes were observed in the hypothyroid patients 
following treatment with thyroid hormone (Table 14). The 
fasting levels of serum FFA increased as a result of the 
treatment (P < 0.05). In the treated state, as compared to the 
untreated, higher percentages of FFA oleic acid (P t 0. 005) and 
lower percentages of saturated acids (mainly palmitic acid, 
P < 0. 005) were found (Table 14, Appendix Fig. 1, Appendix 
Table 2). Thus, after thyroid hormone therapy the FFA showed 
an increase in monounsaturated and a decrease in saturated 
fatty acids (Fig. 8). 
(ii) Antithyroid therapy in thyrotoxic subjects 
Changes in the concentration and composition of serum FFA 
were for the most part opposite to those observed when thyroid 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 8 Thyercentages of FFA and triglyceride saturated and 
monounsaturated acids in relation to thyroid function and 
in response to treatment with thyroid hormones or 
antithyroid the rapy (Mean ± 1S.D.) 
Saturated acids: palmitic and stearic acids 
Monounsaturated acids: oleic and palmitoleic acids. 
hypothyroid subjects 







B and C changes accompanied by increases in serum FFA 
concentrations 
D changes accompanied by decreases in serum FFA 
concentrations 
FREE FATTY ACIDS 
A B D 
TRIGLYCERIDE FATTY ACIDS 
Na OF SUBJECTS 9 10 G 5 9 9 G G 
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Antithyroid therapy significantly lowered the levels of serum 
FFA (P < 0.05). The percentage level of FFA oleic acid 
decreased (P < 0.05) and the percentage level of FFA palmitic 
acid increased (P < 0.05; (Table 14). The average decrease 
in the concentrations, as well as the average percentage decrease 
of oleic and increase of palmitic acid, were nearly of the same 
magnitude as the corresponding changes observed in 
hypothyroid patients treated with thyroid hormones. Thus, 
after antithyroid therapy, the FFA showed a decrease in 
monounsaturated acids and an increase in saturated fatty acids 
(Fig. 8). 
Diseases of the thyroid 
The difference in the average levels of serum FFA, as 
recorded in the groups of hyper- and hypothyroid patients, were 
not significant. The composition of FFA in these two groups, 
however, differed significantly, and independently of age and 
sex. The FFA of hypothyroid patients had a higher percentage 
of palmitic (P <0.001) and lower percentage of oleic acid 
(P < 0.001) than those of hyperthyroid patients (Table 15). 
Of all the groups studied, hypothyroid patients had the 
highest percentage of free palmitic acid. The values were 
significantly higher than those of normal middle -aged males 
and those of older females. This observation on the effects 
-.65- 
of spontaneous hypothyroidism is in agreement with that made 
on the effect of antithyroid therapy. Similarly antithyroid 
therapy results in higher percentages of FFA palmitic acid. 
Of all the groups studied, hyperthyroid patients had one of 
the highest percentages of free oleic acid. Similarly high 
levels were seen in patients after myocardial infarction, 
(Table 15). This observation on the effects of spontaneous 
hyperthyroidism is in agreement with the observation made 
on the effects of thyroid hormone therapy in hypothyroid 
subjects, where thyroid hormone therapy has also led to 
higher percentages of free oleic acid. 
Human growth hormone (HGH) 
(i) Effects produced within hours after the injection 
The evidence on the effects of HGH given by intramuscular 
injection derives from two experiments. In one, which was 
performed in the early course of the study, the composition of 
esterified fatty acids only, but not of the FFA, was investigated. 
In this early experiment, each daily injection was followed by a 
normally distributed and carefully controlled balanced diet. 
The serum FFA were measured 3 hours after the administration 
of HGH (approximately 3 hours after the first meal) and 7 hours 
after the HGH injection (approximately 4 hours after the second 
meal). The results illustrated in Fig. 9 show that almost all 
daily levels are elevated during the period of HGH administration. 
Fig, 9 Changes in the daily levels of serum FFA 
concentrations in response to HGH injections 
(Mean values from three patients; who received three 
daily HGH injections followed by meals ,and range of 
values ) 
EiFasting blood sample (taken at 9 a. m. 
Blood sample taken 3 hours after HGH injection 
and 3 hours after the first meal (12 noon) 
Blood samples taken 7 hours after the 
HGH injection and 4 hours after the second 
















PRE -TREATMENT Ist. DAY 2nd DAY 3rd. DAY POST- TREATMENT 
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The highest levels occurred 7 hours after the first two daily 
injections. 
The second experiment gives more information on the 
"short- terxn'effects of HGH injection, since both the 
concentrations and composition of FFA were investigated hourly 
after the injection. In this experiment, the first of the two 
daily injections (given after an overnight fast) was followed by a 
further 8 hours of fasting, during which time the short-term 
effects of HGH injection were compared with the effects of 
fasting alone. The results illustrated on Fig. 10 (and in 
Appendix Table 6) show that all three men studied had a marked 
increase in serum FFA, and these increases were most marked 
8 hours after injection. These levels were on average twice 
as high as those observed in the morning. The FFA most 
affected by this rise was oleic acid: 8 hours after injection, 
in the three men the increase of oleic acid concentration alone 
was responsible for 74, 82 and 61 per cent of the rise in serum 
total FFA respectively. 
(ii) Effects of daily injections of 'HGH 
The "long- term" effects of HGH injection were studied 24 
hours after the administration of the last injection, following 
an overnight fast. When the values so obtained were compared 
with the fasting values during the pre -treatment period, various 
responses were observed with respect to the fatty acid 
concentrations and composition (Appendix Table 5). 
Fig, 10 Changes in percentage composition of 
serum FFA in relation to changes in 
absolute concentrations 4 and 8 hours 















15 19 23 
Hrs of fasting 
15 19 23 
Hrs of fasting 
0 4 8 
Hrs after HGH inj. 
SUBJECT W.G. 
15 19 23 
Hrs of fasting 
15 19 23 
Hrs of fasting 
0 4 B 
Hrs after HON inj. 
SUBJECT W.L. 
HIGH 
15 19 23 
Hrs of fasting 
15 19 23 
Hrs of fasting 
0 4 8 
Hrs otter HGH inj. 
SUBJECT A.N. 
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In the group of patients investigated early in the study, 
evidence is available only on the concentrations of serum FFA . 
Of the four patients in this group, elevated serum FFA levels 
were noted in three men during the first two days of the 
administration of HGH. 
In three patients studied later (who received a first 
injection followed by an 8 hour fast), one showed an 
elevated serum FFA level 24 hours after the first injection, 
and none 24 hours after the second injection. A decrease in 
the percentage of free stearic acid was noted in all three men 
24 hours after the first and second injections and in two men 
48 hours after the second injection. An increase in the 
percentage of FFA oleic acid was noted in two men 24 hours 
after the first and 24 hours after the second injection. These 
changes were present in spite of the fact that the total levels 
of serum FFA had returned to normal, or indeed had fallen 
below normal levels (Appendix Table 6b). 
(iii) Acromegaly 
The serum FFA concentrations were unusually low in two 
out of the three patients with acromegaly (Appendix Table 7); 
therefore, the average levels in this group were lower than in 
any other group under study. There was a lower than normal 
percentage of FFA oleic acid (P < 0.02), and a higher than 
normal percentage of FFA stearic acid (P < 0.025, Table 15). 
- 68 - 
Noradrenaline 
During the infusion of 100 jag of noradrenaline, over a 
period of 15 minutes the serum FFA increased (P < 0.02) and 
changed in composition significantly. The FFA oleic and 
linoleic acids were increased (P < 0.01 and P < 0.05 
respectively) and the FFA stearic acid was decreased 
Appendix Table 8) 
(P < 0.005, Table 14, There was an increase in the 
monounsaturated and a decrease in the saturated acids (Fig. 11). 
Fa sting 
As shown in the data for individual subjects (Appendix 
Table 9), the changes in fatty acid composition were not 
related to the original fasting concentrations, either of serum 
FFA or esterified lipids; therefore, all subjects were regarded 
as one group. The prolongation of an overnight fast by 8 hours 
induced a rise in serum FFA concentrations (P < 0. 005), an 
increase in the percentage of FFA oleic acid (P < 0.05), a 
decrease in the percentage of FFA stearic acid (P < 0.02), 
and a decrease in the percentage of FFA linoleic acid 
(P < 0.025, Table 14, Appendix Table 9, Appendix Fig. 2). 
Thus the prolongation of fasting, as all the other stimuli of 
fatty acid mobilization described above, caused the FFA 
monounsaturated acids to rise and the FFA saturated acids to 
fall (Fig. 11). 
Fig. 11 Changes in percentages of FFA saturated and 
monounsaturated acids in response to treatments 
influencing fatty acid mobilisation and in relation 
to ischaemic heart disease and diseases of hormonal 
disorder ( Mean it S.D. ) 
Saturated acids: palmitic and stearic acids 






normal middleaged males 
normal postmenopausal females 
diseased subjects 
A » D Changes accompanied by increases in serum 
FFA concentrations: 
A » After treatment of hypothyroid subjects with 
thyroid hormones 
B 8 hours after HGH injection followed by prolonged 
fasting 
C » After a 15 minute infusion of noradrenaline 
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Ischaemic heart disease (IHD) 
(i) Acute myocardial infarction 
Patients who had blood taken within 32 hours after an acute 
myocardial infarction had, on average, higher levels of serum 
FFA than patients with chronic ischaemic heart disease. In 
addition, the mean increase of FFA oleic acid (10% against 4 %), 
and the mean decrease of FFA stearic acid (7% against 5 %), were 
higher in patients immediately after an acute myocardial 
infarction than in those with IHD (Table 15). The statistical 
significance of these changes was at a higher level than those 
observed in patients with chronic IHD (Table 15). The possibility 
can not be excluded that the difference in results is in part due 
to the different ages of the two groups studied. 
Comparison of patients who had recently sustained an acute 
myocardial infarction with those with thyrotoxicosis reveals a 
striking similarity in the pattern of the FFA changes. 
The sequential changes between the first, second and third 
day after the onset of myocardial infarction were not uniform in 
all subjects studied. Increases in percentages of FFA oleic 
and decreases in percentages of palmitic acids, accompanied 
by lowering of serum FFA concentrations were observed in 4 out 
of the 8 patients under study. In two other patients (J. Co., and 
J. M.) there were marked changes in the opposite direction, leading 
to a higher degree of saturation (Appendix Fig. 3 Appendix Table 10) 
These/ 
- 70 - 
two patients represented clinically the most severe cases (one 
died on the third day, and one developed a cerebral vascular 
episode with hemiplegia on the second day). 
(ii) Chronic ischaemic heart disease 
Consistently with the higher than average levels of serum FFA 
in patients with LHD, percentages of serum FFA oleic acid higher 
than normal (P < 0.02) and percentages of FFA stearic acid 
lower than normal (P < 0.05) were observed in this group 
(Table 15). 
CHANGES IN THE COMPOSITION OF SERUM TRIGLYCERIDE 
FATTY ACIDS IN RESPONSE TO DIFFERENT FACTORS 
INFLUENCING FATTY ACID MOBILISATION 
Thyroid hormone 
(i) Thyroid hormone treatment in normal and hypothyroid 
subjects 
After the administration of 100 fag of LT3 daily for seven days, 
to two men, one whose FFA increased) showed a change in 
triglyceride composition, but neither showed any substantial 
change in total triglyceride level. In this one subject changes in 
composition were in the same direction as those described below 
for the hypothyroid patients following treatment with thyroid 
hormones: an increase in triglyceride oleate (by 5% of the total 
fatty aci ds in the triglyceride fraction) and a decrease in 
triglyceride stearate (by 2% of the total fatty acids in the 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Administration of thyroid hormone to hypothyroid subjects 
resulted in a significant lowering of serum triglyceride 
concentrations (P G 0.02, Table 16). A statistically significant 
decrease occurred in the percentage of triglyceride stearate 
(P < 0.005). Although increases in triglyceride oleate were 
observed in 7 out of the 9 subjects (Appendix Table 2), these 
were not statistically significant. 
(ii) Antithyroid therapy in thyrotoxic subjects 
Antithyroid therapy given to thyrotoxic subjects induced 
significant increases in serum triglyceride concentrations 
(P < 0. 025), with significant decreases in the percentages of 
triglyceride oleate (P < 0.02, Table 16). 
(iii) Disease of the thyroid 
Considering the wide differences in the mean values of the 
serum triglyceride concentrations between the hyper- and 
hypothyroid patients (values being twice as high in the 
hypo- as in the hyperthyroid patients), the differences in the 
fatty acid composition were comparatively small (Table 17). Of 
all the groups studied, the hyperthyroid group showed the 
highest values for mean percentage of triglyceride oleate, and 
these values were considerably higher than those observed in 
either the normal male group (P < 0. 02) or in the normal female 
group (P < 0.02). 
Human growth hormone (HGH) 
(i) Effects produced within hours after the injection 
., 72 .. 
No significant change in the concentrations of serum 
triglycerides was found within a few hours after the HGH injection 
in either of the two groups of patients studied. Neither were 
changes observed in the triglyceride fatty acid composition 
of fasting blood specimens taken 4 and 8 hours after the 
injection of HGH. 
(ii) Effects of daily injections of HGH 
Since the trends with respect to the esterified lipids were 
similar in the subjects in the two experiments all subjects were 
regarded as a single group with respect to the changes found 24 
hours after the first, second and third injections. The 
amalgamation of these groups must, however, be regarded 
critically, since in one the first HGH injection was followed by 
meals and in the second by prolonged fasting. In the entire 
accumulated group, however, similar changes, which were 
noticeable in patients belonging to both groups, became statistically 
significant. The imperfection of this statistical approach must 
be stressed, and its significance must therefore be accepted 
as an indication of a trend only, rather than as conclusive 
evidence. 
No significant changes were observed in triglyceride 
concentrations, although it appears that in the 3 older subjects, 
who received HGH injection on each of 3 or 4 days, the serum 
triglyceride concentrations were somewhat higher during the 
period of HGH administration (Appendix Table 5). During the 
- 73 .. 
administration of HGH, the percentages of triglyceride 
palmitate were, on average, higher than those recorded in the 
pretreatment period (P < 0.02). 
(iii) Acromegaly 
Patients with acromegaly (who had elevated levels of serum 
HGH) showed slightly higher than normal levels of serum 
triglycerides. These were accompanied by a high percentage 
of saturated acids in the triglyceride fraction. Of the 
groups studied, these subjects had the highest observed values 
for triglyceride palmitate and stearate and the lowest values 
for triglyceride oleate (Table 17). The triglyceride palmitate 
was particularly high in acromegalic women and, in spite of 
the small numbers of subjects under observation, the 
differences were statistically significant (P < 0.005).. 
No radr enaline 
No changes were observed either in triglyceride 
concentration or triglyceride fatty acid composition 15 minutes 
after the commencement of noradrenaline infusion (Table 16). 
Fasting 
No significant changes were observed in serum triglyceride 
concentrations, but small significant decreases in triglyceride 
stearate (P < 0. 001) were found when the overnight fast was 
prolonged by 8 hours (Table 16). Although these decreases 
were small, and within the range of error of the analytical 
a 74- 
procedure, the high level of significance suggests that they 
are real. 
Ischaemic heart disease 
(i) Acute myocardial infarction 
The available data on triglyceride concentrations in these 
patients do not show any significant differences from normal. 
The pattern of triglyceride fatty acids was characterised by 
somewhat higher percentages of oleic acid, as compared to 
chronic IHD (Table 17). These values increased between the 
first and second day or second and third day after myocardial 
infarction (Appendix Table 10). 
(ii) Chronic ischaemic heart disease 
There were no differences in triglyceride composition 
between the healthy group of males and males with IHD, 
although the diseased group had higher than average 
concentrations of serum triglycerides (P < 0.02 ) When 
however, from the entire group of diseased males, those with 
the higher serum FFA concentrations were selected into one 
group, and those with the higher serum triglyceride concentration 
into a second group, in these groups (each composed of a smaller 
number of subjects) decreases in triglyceride linoleate were 
found to be of statistical significance compared with normal 
subjects. It appears therefore that high concentrations of both 
serum FFA and serum triglycerides are associated with lower 
percentages of triglyceride linoleate (Table 17). 
-75-. 
CHANGES IN THE COMPOSITION OF SERUM PHOSPHOLIPID 
FATTY ACIDS IN RESPONSE TO DIFFERENT FACTORS 
INFLUENCING FATTY ACID MOBILISATION 
Thyroid hormone 
(i) Thyroid hormone treatment in normal and hypothyroid subjects 
During the 7 -day period of administration of 100 jig of LT3 
to two men, and one week after cessation of treatment in one 
man (J. P. ), there were increases in phospholipid arachidonate 
(representing 2 -6% of the total phospholipid fatty acids). The 
phospholipid linoleate decreased by approximately the same 
amount (Appendix Table 1). 
Following thyroid hormone therapy, the hypothyroid patients 
showed, on average, a significant decrease in phospholipid 
concentrations (P .< 0.02). These changes were associated 
with increases in phospholipid arachidonate (P < 0. 01) and 
decreases in phospholipid oleate (P < 0. 025 Table 18, 
Appendix Table 2). 
(ii) Antithyroid therapy in thyrotoxic subjects 
The treatment resulted in significant increases in serum 
phospholipid concentrations (P < 0. 01) associated with increases 
in phospholipid linoleate (P < 0. 001 Table 18). 
(iii) Diseases of the thyroid 
The concentration of serum phospholipids were found to be 
nearly twice as high in patients with myxaedema compared 
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arachidonate was approximately 50% higher in hyperthyroid than 
in hypothyroid patients (Table 1 :9). 
As compared to the normal male or female groups, 
hyperthyroid patients had somewhat higher, and hypothyroid 
patients somewhat lower percentages of phospholipid 
arachidonate, (Fig. 12). 
Human Growth Hormone 
(i) Effects produced within hours after injection of HGH 
It was noted that, during the time of acute mobilisation of 
serum FFA, e.g., 4 hours after the administration of HGH to 
fasting men, there was a short -lived decrease in phospholipid 
concentrations, which had returned to normal 8 hours after 
treatment. These changes were accompanied by somewhat 
higher percentages of phospholipid palmitate in all three men 
under observation. (Appendix Table 6a ). 
(ii) The effects of daily injections of HGH 
Serum phospholipid concentrations were investigated in only 
5 out of the 7 subjects under study (Appendix Tables 5 and 6b). 
During the daily administration of HGH, considerable decreases 
in serum phospholipid concentration were observed in 4 out of the 
5 subjects. On average, in the group studied, phospholipid 
concentrations were significantly decreased during the daily 
administration of HGH (P <0.025, Table 18). Also, during 
Fig, 12 Changes in percentages of cholesteryl and phospholipid 
arachidonate and linoleate in relation to thyroid function 
and in response to treatment with thyroid hormones, 
antithyroid therapy and noradrenaline infusion (Mean 
± 
1 S.D.) 
3 hypothyroid subjects 
rieuthyroid subjects 
l'" I (middleaged males) 
Fi" (postmenopausal females) 
III hyperthyroid subjects 
after treatment c:%%; 
::;:. ! 
B, C and E changes accompanied by increases of serum 
FFA concentrations 




PHOSPHOLIPID FATTY ACIDS 
A B C D E 




CHOLESTERYL FATTY ACIDS 
A B C D E 
THYROID HORMONES NORAOREN. 
M F 
P<0-005 P<0-01 
P < 0-001 
NO OF SUBJECTS 9 12 L B 9 9 
P.0 01 
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the days following the cessation of HGH administration, these 
patients continued to exhibit reduced concentrations of serum 
phospholipids (Appendix Table 5). 
Compared with the large observed changes in total serum 
phospholipid concentrations, changes in phospholipid fatty acids 
were small. Of statistical significance were the decreases in 
phospholipid oleate (P < O. 001) observed during the period of 
HGH administration.( Appendix Table 5,6b , Table 18 
(iii) Acromegaly 
No specific changes in serum phospholipid concentrations or 
in the composition of phospholipid fatty acids were observed in 
these patients (Table 19). 
Noradrenaline 
15 minutes after the commencement of the infusion of 
noradrenaline, no significant changes in phospholipid 
concentrations were observed but a significant alteration was 
noted in phospholipid fatty acid composition (Table 18). 
Phospholipid arachidonate increased in all patients under 
observation by an average of 50% above the original value, 
while phospholipid palmitate decreased. These changes are 
statistically significant (P < 0.005, P < 0.001, respectively). 
Fasting 
When the overnight fast was prolonged by 8 hours, no change 
of statistical significance occurred in serum phospholipid 
concentrations, but the phospholipid fatty acid composition was 
.. 78 - 
significantly altered (Table 18, Appendix Table 9). The 
phospholipid linoleate decreased, (P G 0.005) and the phospholipid 
palmitate increased (P .< 0.05). 
Ischaemic heart disease 
(i) Acute myocardial infarction 
Twentyfour to 32 hours after acute myocardial infarction 
levels of serum phospholipids were variable (Appendix Table 10). 
The most significant difference in the phospholipid fatty acid 
composition of this group as compared to either the normal 
male or female group, was the higher observed percentage of 
phospholipid palmitate (P < 0.001) and lower percentage of 
phospholipid linoleate (P G 0.05, Table 19). With respect to 
the average percentages of individual phospholipid fatty acids, 
there is a similarity in the fatty acid composition of these patients 
with the hyperphospholipidaemic ones. 
(ii) Chronic ischaemic heart disease 
When the entire group of 23 male subjects was compared with 
the normal group of healthy male subjects, no significant 
differences were found to exist in the phospholipid fatty acids. 
However, significant elevation of phospholipid palmitate was 
noted in two selected groups of diseased patients, one with high 
serum phospholipid concentrations and the second with high serum 
FFA concentrations (Table 19), and these also had significantly 
lower phospholipid linoleate percentages. 
..79.. 
CHANGES IN THE COMPOSITION OF SERUM CHOLESTERYL 
FATTY ACIDS IN RESPONSE TO DIFFERENT FACTORS 
INFLUENCING FATTY ACID MOBILISATION 
Thyroid hormone 
(i) Thyroid hormone treatment in normal and hypothyroid subjects 
In the two normal men to whom 100)1g of LT3 was given on 
each of the 7 days, it was observed that the serum cholesterol 
concentrations during the week of administration of LT3, and 
during the following week, decreased slightly but steadily. 
Cholesteryl arachidonate was elevated by treatment, but since only 
two subjects were under study, no significance could be proved 
statistically for these increases (Appendix Table 1). 
In the hypothyroid subjects, serum cholesterol concentrations 
were significantly decreased as a result of treatment with 
thyroid hormone (Table 20). The cholesteryl arachidonate was 
significantly increased (P < 0. 005). Two patients who were 
studied under balanced dietetic conditions showed, in addition, 
decreases in cholesteryl linoleate (Appendix Table 2). 
(ii) Antithyroid therapy in thyrotoxic subjects 
Thyrotoxic subjects treated with antithyroid therapy showed 
significant changes in serum cholesterol concentrations and in the 
composition of all major fatty acid components (Table 20, 
Appendix Tables 3 and 4). The increases in serum cholesterol 
concentrations (P < 0. 005) were accompanied by increased 
proportions of cholesteryl linoleate (P G O. 01), and decreased 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(P < 0.05) and arachidonate (P < 0.01). 
(iii) Diseases of the thyroid 
more than 
The average levels of serum cholesterol werentwice'as high 
in the hypo- as in the hyperthyroid patients. The greatest 
differences in the fatty acid spectrum of the cholesterol esters 
were between the levels of cholesteryl arachidonate, which were, 
on average, twice as high in hyper- as in hypothyroid patients 
(Table 21, Fig. 12). As compared to the normal male or 
female groups, hyperthyroid patients had somewhat higher, and 
hypothyroid patients somewhat lower percentages of cholesteryl 
arachidonate. 
Human growth hormone 
(i) Effects produced within hours after the injection 
No significant changes were observed in either the cholesterol 
concentration or the cholesteryl fatty acid composition during 
fasting, 4 and 8 hours after HGH injections (Appendix Table6a). 
(ii) The effects of daily injections of HGH 
There were no significant changes in the fasting serum 
cholesterol concentrations during the period of HGH 
administration (Appendix Tables 5 and 6b). When the 
fasting results from all subjects during the period of HGH 
administration were compared with those (also fasting) obtained 
during the pretreatment period (Table 20), it was found that the 
cholesteryl oleate had significantly increased (P G 0.05) and the 
cholesteryl linoleate had significantly decreased (P -4 0.05). 
- 81 .. 
(iii) Acromegaly 
There were no differences to be observed either in levels of 
cholesterol or in the cholesteryl fatty acids (Table 21). 
Noradrenaline 
No significant changes were observed either in the 
concentration or in fatty acid composition of cholesteryl esters 
during the noradrenaline infusion. In 3 out of the 6 men under 
observation, there were small increases in cholesteryl 
arachidonate (Appendix Table 8). 
Fasting 
When fasting was prolonged by 8 hours, there were no 
significant changes either in serum cholesterol levels or in 
cholesteryl fatty acid composition (Table 20, Appendix Table 9). 
Ischaemic heart disease (IHD) 
(i) Acute myocardial infarction 
The serum cholesterol concentrations of this group did not 
differ from those of the normal healthy group. The fatty acid 
composition, however, was significantly altered (Table 21, 
Appendix Table 10). Decreases in cholesteryl linoleate and 
increases in cholesteryl oleate were statistically significant 
(P < 0.005 and P . 0. 001 respectively). It has been observed 
that the described changes increased between the first and 
second, or second and third days after the onset of pain. 
Cholesteryl linoleate was lowered and cholesteryl oleate was 
increased during these days in 6 out of the 8 subjects under 
- 8 2 - 
study (A. B. , J. G. , J. H. , J. Cl. , J. C. , J. S. ; Appendix 
Table 10). 
(ii) Chronic ischaemic heart disease 
As compared to the normal healthy male group, patients 
with ischaemic heart disease had significantly higher levels of 
serum cholesterol. Cholesteryl fatty acids were characterised 
by significantly increased percentages of cholesteryl 
palmitate (P G 0.01) and oleate (P < 0.02), and by decreased 
percentages of cholesteryl linoleate (P <0.01; Table 21). 
When, from the entire group of 23 male patients with IHD, 
subjects were selected according to the levels of serum FFA 
or serum cholesterol, the smaller groups with hyper - 
cholesterolaemia or high serum FFA levels did not differ 
significantly from the entire group. However, in the group 
with high serum FFA levels the statistical significance of 
increases in oleic acid percentages reached a higher level 
(Table 21). 
INTERRELATIONSHIP BETWEEN THE CONCENTRATIONS OF 
SERUM FFA AND PERCENTAGES OF FFA MONOUNSATURATED 
ACIDS 
Since it has been observed that increases in serum FFA 
concentrations were generally associated with increased 
percentages of FFA oleic acid, and in some cases also 
palmitoleic acid, the coefficient of correlation was calculated 
»83.. 
between the sum of percentages of these two acids and between 
the serum FFA concentrations in all estimations performed. A 
highly significant correlation was obtained. The coefficient of 
correlation r = 0. 64, was 7 times higher than its standard error: 
1 /lrn..1 = 0.084. 
No significant correlation, however, was obtained when the 
coefficient of correlation was calculated for levels of serum FFA 
ranging from 500 to 1000 p.Eq /l. The scatter diagram (Fig. 13) 
shows that, although high levels of serum FFA are usually 
accompanied by higher percentages of monounsaturated acids 
(44 - 62), within the middle range the points show a wide 
variation. 
THE DEGREE OF DIFFERENCE BETWEEN PERCENTAGES 
OF FFA OLEIC ACID AND PERCENTAGES OF TRIGLYCERIDE 
OLEIC ACID 
The mean values of oleic acid percentages in the free and in 
the triglyceride fatty acids are illustrated by histograms in 
Fig. 14. It is shown that the magnitude of the difference 
between the mean percentages of oleic acid in the FFA and 
triglyceride fractions were about the same in healthy males as 
in hypothyroid patients. The difference between the percentage 
level of FFA and triglyceride oleic acid shown in thyrotoxic 
patients is very small, and nearly nonexistent in patients after 
acute myocardial infarction. The treatment of hypothyroid 
Fig. 13 Correlation between the serum FFA 
concentrations and between the 
percentages of FFA monounsaturated 
acids 
Monounsaturated acids; oleic and palmitoleic acids 
The coefficient of correlation r = 0.64, its standard 
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Fig. 14 Percentages of FFA and triglyceride oleic acid 
in relation to thyroid status, acromegaly and 
ischaemic heart disease 
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patients with thyroid hormones led to a decrease, and 
antithyroid therapy given to thyrotoxic patients to an increase, 
in the degree of these differences. 
THE ASSOCIATION OF INCREASES IN FFA CONCENTRATION 
WITH INCREASE IN OLEIC ACID PERCENTAGES IN THE 
TRIGLYCERIDE AND IN THE CHOLESTERYL FATTY ACIDS 
It has been observed that changes in the fasting concentrations 
of serum FFA during antithyroid therapy in thyrotoxic patients 
(in all subjects) and during thyroid hormone therapy in 
hypothyroid and normal subjects (only those on the balanced diet) 
were accompanied by changes in oleic acid percentages, not 
only in the FFA fraction but also in the triglyceride and 
cholesteryl fractions. Usually changes in 'percentages of 
cholesteryl and triglyceride oleate were directly related 
to the changes in serum FFA, while corresponding changes in 
the percentages of linoleic acid were inversely related to the 
changes in serum FFA concentrations (Figs. 15 and 16). 
Similarly, it has already been demonstrated that 
cholesteryl oleate increased between the second and the third 
day of HGH administration in mostpersons who showed elevated 
levels of serum FFA 24 hours after the first injection (Fig. 17). 
The changes in percentages of cholesteryl oleate were 
accompanied by reciprocal changes in percentages of cholesteryl 
linoleate. The daily administration of HGH did not, however, 
Fig. 15 Changes in FFA concentrations and corresponding 
changes in oleic and linoleic acid percentages in 
lipid fractions in response to the treatment with 
thyroid hormones 
Increases are shown over the line in 
white bars 
Decreases are shown under the line in 
black bars 
Abbreviahons: 
TG - triglycerides 
PL - phospholipids 
C E - cholesterol esters 

















TG PL CE 
20- 
O 300- 200- 
+ n + 10- n - c2 R . 100- 
_ -M- 
I- 200- -10- 
O 
? 400- - 20- -1 
2 
L 
+200- + 10- 
rl n n 
- 
-100- 
200- - 0- 
400- 20- - 
+200- + 10- n - 4 
a 







200- -10- - 
20- - 
+200- + 10- - 
J P - N.E. 
-200- , -10- - 
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Fig. 17 Changes in FFA concentrations and subsequent changes 
in oleic and linoleic acid percentes in lipid fractions 
in response to HGH daily injections 
Changes in FFA concentration -, after 1 day of 
treatment (24 hours 
after first injection 
Changes in oleic and linoleic .. mean values from second 
acid percentages and third day of treatment 
Increases are shown over the line in white bars 
Decreases are shown under the line in black bars 
Abbreviations : 
TG - t-iglycerides 
P L - pllospholipids 
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influence the percentages of triglyceride oleate. 
Similarly, when compared to normal persons, patients 
in the days following myocardial infarction showed increases 
in cholesteryl and triglyceride oleate (Table 21,17)and these 
changes were intensified between the first and second, or 
second and third day after the onset of the acute event 
(Appendix Table IO). In these circumstances also a 
reciprocal relationship of changes in the percentages of 
cholesteryl (but not triglyceride) linoleate was observed. 
- 86 - 
D I S C U S S I O N 
THE CONCENTRATION OF SERUM LIPIDS IN RELATION TO 
THYROID HORMONE 
Thyroid hormone therapy in hypothyroid subjects induced 
significant increases in serum FFA, and significant decreases 
in serum triglyceride, phospholipid and cholesterol 
concentrations. Antithyroid therapy in thyrotoxic subjects induce 
significant changes in the opposite direction. These 
observations have not previously been reported in similar studies 
but could be expected from the following evidence. 
Rich et al., (1959) reported that endogenous or induced 
thyrotoxicosis is accompanied by increases in the levels of 
fasting serum FFA. The authors observed also an increase 
in the levels of serum FFA 6 hours after the injection of 
L- triiodothyronine. Harlan et al., (1963)showed that the fasting 
levels of serum FFA and mobilisation after catecholamine 
stimulation are dependent upon the clinical status of thyroid 
function. Feldman and Carter (1963) reported that treatment 
with sodium -D- thyroxine in subjects with hyperlipidaemia was 
effective in lowering serum triglycerides and total cholesterol. 
Along the same lines, Moses and Danowski (1963) have reported 
decreases in serum cholesterol (both oa and 13 -lipoprotein) and 
phospholipids (total and 3 -lipoprotein) after the treatment 
of normal subjects with desiccated thyroid. The last -named auth. rs 
- 87 
did not find alterations in serum triglyceride and FFA 
concentrations; however, in other experiments carried out on 
hyperlipidaemic patients the serum triglycerides were found to 
be reduced (Moses et al. , 1964). 
The present results do not support the suggestion of 
Harlan et al., (1963) that the hypothyroid state is accompanied 
by lower than normal resting levels of serum FFA. The average 
level of serum FFA in myxoedematous patients was rather high. 
The results in individual subjects obtained on various occasions 
suggest wide variability in serum FFA levels in these patients. 
After treatment with thyroid hormones, the serum FFA levels 
in these patients reached the levels observed in hyperthyroid 
subjects, although treatment led to the euthyroid state. These 
results indicate an increased rather than a reduced ability for 
FFA mobilisation in these patients. 
THE CONCENTRATION OF SERUM LIPIDS IN RELATION 
TO HUMAN GROWTH HORMONE (HGH) 
Human growth hormone injections administered to fasting 
men induced increases in serum FFA levels within hours. This 
had been reported previously by Raben and Hollenberg (1959) 
who described changes only up to 4 hours and did not establish 
the time of maximal effect. In the present study, the increases 
were greater at 8 than at 4 hours after the injection, but the time 
. 88 
of maximal increase was again not established, since estimations 
were not performed between 4 and 8 hours, nor at longer 
intervals. Raben and Hollenberg reported that serum FFA 
levels returned to normal 24 hours after HGH administration. 
In the present study, 4 out of the 7 subjects had higher levels 
of serum FFA 24 hours after the injection than before. Rises 
were observed after the first and second, but not after the 
third injection. Raben and Hollenberg reported also that food 
completely abolished the effects of HGH. The present study 
showed that all daily levels were raised during the first two 
days of HGH injections, in spite of daily meals. The greatest 
rise was observed 7 hours after HGH injection (approximately 
4 hours after the second meal). 
The difference between the present observations and those of 
Raben and Hollenberg may be due, in part, to the larger doses 
of HGH used in this experiment (25 mg against 3 - 8 mg). 
Recently, Landon et al., (1966) suggested that abnormally 
high fasting levels of serum FFA occur in patients with 
acromegaly. The present findings do not confirm this 
observation, and in fact levels of serum FFA lower than normal 
were noted in two out of the three acromegalic women 
under study. 
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are no reported studies on the effects of HGH on the 
concentration of esterified lipids in man. The present study 
indicates the effectiveness of HGH injections in lowering serum 
phospholipid concentrations. 
STUDIES ON FREE FATTY ACIDS (FFA) 
(i) Similarities and differences in the effects of various factors 
inducing FFA mobilisation 
The results presented here have demonstrated that many of 
the changes in the composition of serum FFA induced by 
different mobilising influences have common characteristics. 
Oleic acid was always the predominant participant in increases 
in serum FFA concentrations. The increase in serum FFA 
induced by thyroid therapy in hypothyroid patients was 
associated with a large increase in oleic acid, and the decrease 
in serum FFA induced by antithyroid therapy in thyrotoxic 
patients was associated with particularly low levels of oleic 
acid. Small increases in the percentage of oleic acid occurred 
when fasting was prolonged by 8 hours, and the increases were 
greatly intensified 8 hours after the administration of HGH under 
similar fasting conditions. Of the diseases studied, those with 
the highest levels of serum FFA (thyrotoxicosis and acute 
myocardial infarction) were accompanied by the highest 
percentages of serum free oleic acid. 
These increases in the percentage of oleic acid 
were accompanied by a simultaneous decrease in percentages 
90- 
of stearic and palmitic acid. The same inverse relationship 
holds after antithyroid therapy. 
Changes induced by hormonal agents or by fasting have, 
to my knowledge, only been reported in animal studies. 
Feigelson et al., (1961) injected dogs with noradrenaline and 
observed increases in the percentages of oleic acid and decreases 
in stearic acid 8 hours after the injection. Norcia and Evans 
(1964) injected adrenaline into rabbits and, although there was 
no increase in total FFA in one of the groups of animals studied, 
there were increases in the percentages of oleic acid observed. 
The literature provides little evidence concerning the 
composition of human serum fatty acids and, so far, the 
relationship between the increases in serum FFA concentrations 
or high fasting levels of serum FFA with high percentages of 
oleic acid and low percentages of saturated acids has not been 
stressed. One of the factors which is known to raise serum 
FFA concentrations is cigarette smoking. In one study, an 
increase in the proportions of free monounsaturated and a 
decrease in free saturated acids following smoking have been 
reported (Murchison and Fyfe, 1966), such as one might 
expect if the FFA rise were to be a noradrenaline -.induced 
response. Along the same lines, changes have been reported 
in fatty acid composition during glucose tolerance tests 
(Soloff and Schwartz, 1966). When the data presented by 
these authors concerning the concentrations of individual serum 
»91.. 
FFA were recalculated as percentages of total composition, it 
was observed that the decrease in FFA which followed i hour 
to 3 hours after the glucose load was associated particularly 
with decreases in oleic acid percentages (with inverse changes 
in stearic acid), while the increases in FFA which followed 
5 hours after a glucose load, and which exceeded the original 
values, were accompanied by increases in oleic acid 
percentages (with inverse changes in stearic acid). Evidence 
concerning the composition of serum FFA in atherosclerosis 
also supports the observations presented here. According 
to the data of Böttcher and Woodford (1961), patients with aortic 
atherosclerosis had higher percentages of oleic acid in the FFA 
of lipids extracted from protein fraction IV ., V separated by 
Cohn's method. The data presented by Soloff and Schwartz 
(1966) on the fasting concentrations of total and individual 
serum FFA in normal subjects and patients convalescing from 
myocardial infarction show (after being recalculated as 
percentages of composition) that compared with normal controls 
ischaemic patients had higher concentrations of serum FFA and 
higher percentages of FFA oleic acid. These increases in oleic 
acid percentages were higher in the ischaemic patients with 
a diabetic -like response than those with a normal response to 
glucose tolerance tests. In another report, Schrade et al., 
(1963) stated that very large increases in free oleic acid were 
92 
associated with very high levels of serum FFA in diabetic coma. 
The direct relationship between concentrations of FFA and 
percentage composition does not, however, always hold. Caren 
and Corbo (1966) have reported greatly elevated percentages 
of free oleic acid in pancreatic cystic fibrosis, a condition 
not associated with elevated fasting levels of serum FFA. 
(ii) Interpretation of results 
(a) Stimulation of FFA release from adipose tissue 
There is overwhelming evidence to support the view that, 
in the postabsorptive state, plasma FFA derive exclusively 
from adipose tissue (Dole, 1956; Gordon and Cherkes, 
Gordon, 1957; Fredrickson and Gordon, 1958). 
Fatty acid mobilisation from adipose tissue is known to be 
under neural and hormonal influences. Several reviews on this 
subject have been published (Wertheimer and Shafrir, 1960; 
Steinberg, 1963; Rudman, 1963; Randle, 1964; Chalmers, 
1964; Carlson et al., 1965). Steinberg (1963) has cited eleven 
different hormones which have been shown in vitro and in vivo 
to have lipolytic activities. 
Carlson et al., (1965) stated, "Hormonal factors may act 
on adipose tissue by stimulation of the lipolytic process, for 
example, catecholamine and glucagon, or by promoting glucose 
entry into adipose tissue cells as in the case of insulin" and 
1956; 
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The mode of action of the sympathetic nervous system in lipid 
mobilisation is perhaps by control of norepinephrine release 
which stimulates the lipolytic activity in adipose tissue ". 
The evidence that adrenaline stimulates lipolysis of 
triglycerides in adipose tissue comes from numerous experiments 
in vitro (Leboeuf et al., 1959; Lynn et al., 1959; Vaughan and 
Steinberg, 1963) and in vivo (Dole, 1956; Gordon and Cherkes, 
1956; Havel and Goldfien, 1959; Nestel, 1964). In the in vitro 
studies, the results with noradrenaline were quantitatively 
similar to those obtained with adrenaline (Vaughan and 
Steinberg, 1962; Vaughan and Steinberg, 1963). In the in vivo 
experiments, noradrenaline was found to elicit more sustained 
FFA elevation, but without the hyperglycemia (Goldfien and 
Havel, 1959) that was observed after adrenaline administration 
(Shafrir and Steinberg, 1960). 
An indirect or "permissive" action has been ascribed to 
thyroid hormone. Debons and Schwartz (1961) found that fat 
show 
pads from hypothyroid animals did not4increased release 
of FFA after addition of adrenaline to the incubation medium; 
on the other hand, the fat pads from hyperthyroid animals 
showed an exaggerated FFA release in response to adrenaline. 
The authors observed also that adipose tissue from animals 
treated with triiodothyronine released FFA at a higher rate 
-94w 
than normal, and showed an exaggerated response to 
adrenaline in vitro. Along the same lines, Deykin and Vaughan 
(1963) reported that adipose tissue from animals treated with 
triiodothyronine contained more FFA than tissue from euthyroid 
animals. Steinberg (1963) suggested that the effects of 
thyroid hormones may be due to a potentiation of the action of 
the endogenous catecholamines. 
The mode of action of HGH is not known (Steinberg,1963; 
Chalmers, 1964). It produces lipolytic effects when 
administered in vivo (Raben and Hollenberg,1959), but 
in vitro high concentrations are required to produce any 
lipolytic effects (Raben, 1959). Vaughan and Steinberg (1963) 
suggested that HGH may not produce any lipolytic effects in 
in vitro experiments, and that the observed lipolytic action in 
these experiments may be attributed to trace contamination 
of the HGH preparation with TSH. 
The prolongation of fasting also stimulates an 
adipokinetic response. Increases in serum FFA after the 
prolongation of fasting have been reported previously (Dole, 
1956; Gordon, 1956; Recant et al., 1963). It is not known 
what role hormones play in the mobilisation of fatty acids 
during fasting. Chalmers et al., (1960) have reported that, 
during fasting or the restriction of carbohydrate intake, human 
»95.a 
urine contains a potent fat mobilising substance (FMS). The 
FMS increases the release of FFA from adipose tissue in vitro. 
An intact pituitary gland is necessary for the appearance of 
FMS in the urine (Chalmers et al. , 1960). The active principle 
has, however, not yet been obtained in pure form, and its 
chemical nature is unknown (Chalmers, 1964). 
(b) Differential FFA release from adipose tissue 
In normal healthy subjects, the fatty acid composition of 
serum FFA, and of adipose tissue triglycerides from which they 
are derived differ mainly in their relative proportions of oleic 
and stearic acids. Plasma FFA contains proportionally more 
stearic and less oleic acid than adipose tissue fatty acids 
(Cornwell et al., 1962). During the acute mobilisation of 
serum FFA (8 hours after noradrenaline injection given to dogs), 
the composition of plasma FFA resembles that of adipose tissue 
triglyceride fatty acids (Feigelson et al., 1961). 
Many authors have tried to explain why the composition of 
plasma FFA normally differs from that of adipose tissue, since 
adipose tissue is the main source of plasma FFA. It has been 
suggested that the specificity of tissue lipases for certain ester 
linkages may be of importance in determining the pattern of 
mobilised FFA (Hollenberg and Douglas, 1962). The lipolytic 
enzymes catalyse hydrolysis of the ester linkage in the 
o -position of the triglyceride molecule, which is mainly 
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occupied by saturated acids. Mattson and Lutton (1958) have 
found that the specific localisation of fatty acids in the 
triglyceride molecule varies from species to species. In human, 
horse, and beef adipose tissue the cc positions carry mainly 
the saturated acids, while the f3 - position carries the 
unsaturated ones. In the rat and dog the distribution is more 
random. 
Preferential release of saturated acids during the hydrolysis of 
various fats was observed in a number of in vitro studies. 
Meursing (1962) observed that the products of hydrolysis of 
natural fats and oils were more saturated than the fats from which 
the fatty acids were derived. Meinertz (1962, 1963) reported 
that, in the fatty acid mixture that is released from epididymal 
pads incubated with adrenaline,there are found lower 
proportions of oleic acid than in the fats from which the fatty 
acids are derived. Simultaneously, an accumulation of oleic 
acid occurred in the adipose tissue diglycerides. Meinertz 
(1962) observed that the magnitude of the differential release of 
the saturated and unsaturated acids' was the same regardless of 
their position. This author suggested that the differential release 
of fatty acids is not due to the positional localisation, but to the 
specificity of fatty acids in the mechanism of release. 
It is not known at present what is the precise role of 
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lipolytic enzymes in determining plasma FFA composition. 
Little is known about the intracellular pool of adipose tissue 
FFA (Jeanrenaud 1965). Hollenberg and Douglas (1962) 
have reported that the intracellular pool of rat adipose tissue 
contains more palmitic and palmitoleic,and less oleic and 
linoleic acids, than adipose tissue triglycerides. Miller et al., 
(1962) have made different observations with regard to dog 
adipose tissue; these authors have found the fatty acid 
composition of the total fraction to be similar to that of the 
FFA fraction. 
In addition to the hypothesis discussed above on the 
influence of lipolytic enzymes on the composition of plasma FFA 
another theory has been advanced to explain the differences in 
the composition of adipose tissue fatty acids and plasma FFA. 
Miller et al., (1962) and Goldrick and Hirsh (1964) suggested 
that the differences are due to the fact that the fatty acids are 
modified in composition during their passage through the cell 
membrane. The work of Hollenberg and Angel (1963), however, 
indicates strongly that the transport of fatty acids through the 
cell membrane shows a preference for polar fatty acids, thus 
leading to increased proportions of unsaturated acids. These 
authors reported that when adipose tissue was incubated with 
corticotropin in medium containing albumin short -chain 
fatty acids were released faster than 
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long »chain, and that fatty acids with high degrees of 
unsaturation were released in preference to those with low 
degrees of saturation or to saturated fatty acids. According 
to these authors' opinion, the differences between the acids 
in their solubility in the medium provides the most obvious 
explanation for their results. 
The mobility of individual fatty acids depends upon their 
affinity for albumin. Goodman (1958) has demonstrated that the 
affinity of fatty acids for albumin is influenced by the chain-length 
and by the degree of unsaturation. He studied the binding of a 
number of fatty acids in a partition system made up of an 
aqueous solution of albumin and ndheptane and observed three 
classes of binding sites. The first consisted of two sites, 
the second of five sites and the third of a number of sites 
arbitrarily assumed to be twenty. The association constants of 
fatty acids were in decreasing order of magnitude for oleic, 
stearic, palmitic and linoleic acid respectively. 
It has been demonstrated in in vitro studies that the presence 
of albumin in the incubation medium is essential for fatty acid 
release from adipose tissue to occur. Even in the presence of 
the most powerful lipolytic hormones, no release of fatty acids 
could be obtained in the absence of albumin (Raben and Hollenberg, 
1959). 
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(c) Efflux of FFA from the blood stream 
Studies which employ isotope dilution techniques have shown 
that plasma FFA enter and leave the circulation in as short a 
time as 1 - 2 minutes (Fredrickson and Gordon, 1958a). 
Robinson (1964) summarised the evidence that,in the fasting 
state, about 40% of the fatty acids mobilised from adipose tissue 
are taken up by the liver. The remainder are taken by the 
peripheral tissues and directly oxidised. Originally, in their 
studies on humans, Fredrickson and Gordon (1958b) did not 
notice any differences between the rates of disappearance of 
palmitic, oleic and linoleic acids. Later, Usava et al., (1964) 
reported preferential removal of oleic acid. Studies of 
Göransson and Olivecrona (1964, 1965) and Göransson 
(1965 a, b, c) have established that, in the rat, the rate of 
disappearance of fatty acids from the serum increases with 
chain -length and saturation, and that the unsaturated 18 carbon 
fatty acids are extracted more readily than stearic or palmitic 
acids. Göransson (1965c) attributed this difference in the rates 
of disappearance to the more hydrophilic properties of 
unsaturated acids compared with saturated acids. According 
to these authors, the fact that fatty acid molecules have to 
pass through a water phase when transferred from the proteins 
in plasma to the surface of the cell causes the solubilities of 
individual fatty acids to determine their activity in the 
transportation system. So far, it is not known whether the 
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fatty acids pass the cell membrane protein -bound to 
albumin or as free fatty acids (Robinson, 1964). Göransson 
(1965c) suggested that the greater hydrophilic property of 
oleic acid, as compared with stearic or palmitic acid, might 
determine its more rapid disappearance from the blood. 
(d) Extraction of FFA by different tissues 
The rate of uptake of FFA by the liver is a function of 
plasma FFA concentrations (Stein and Shapiro, 1959; Kabal 
and Ramey, 1965). No differential uptake of fatty acids by 
the liver has yet been reported. Miller et al., (1962) 
did not observe any differences in the rate of uptake of 
stearic and oleic acids by dog liver. Differential 
uptake of fatty acids does, however, occur in the myocardium. 
Rothlin and Bing (1961), from in vivo studies, observed that, 
in the postabsorptive state, dog and human myocardium 
extracted higher percentages of oleic acid than any other fatty 
acid present in the arterial blood. This observation has been 
confirmed by in vitro studies (Evans et al., 1963; Evans 
1964a, 1964b). The extent of myocardial extraction of 
individual fatty acids was inversely related to chain -length, and 
the monoenoic acids were extracted in preference to the 
saturated and dienoic acids. Evans (1964b) stated that the 
human heart, under conditions of hypoxia, did not show the 
preferential uptake of oleic acid that is usually present; all 
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acids were extracted at an equally slow rate. 
Among other body tissues, electrically stimulated skeletal 
muscle has also been reported as taking up oleic acid in 
preference to other acids (Miller et al., 1962). 
Concluding remarks 
A number of metabolic functions other than those 
connected with the mechanism of the rate of influx and efflux 
may influence plasma FFA composition (incorporation into the 
various lipid classes, interconversion to other acids, 
synthetic and oxidation reactions etc.). It appears, however, 
reasonable to assume that, in the very first instance of fatty 
acid mobilisation, the changes in rate of transportation may 
play a predominant role in determining the pattern of serum 
FFA. Similarly, increased thyroid activity may stimulate, 
and decreased thyroid activity may inhibit, the rates of 
transportation of fatty acids between adipose tissue and the 
liver. 
The following hypothesis is advanced as being the most 
likely explanation. Differences in the physical properties 
of fatty acids are of first importance in determining changes in 
plasma FFA composition. As proposed by Hollenberg and 
Angel (1963) and by Görans son (1965c), the fact that the fatty 
acid molecule has to pass from an aqueous compartment of the 
cell into plasma when released from adipose tissue, and in the 
opposite direction when extracted from plasma, may cause 
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the hydrophilic properties of fatty acids to decide on the 
relative rates of transportation. In this way, both oleic and 
linoleic acids should be transported in preference to saturated 
acids, and palmitic acid in preference to stearic acid. When 
the influx of FFA exceeds the efflux, it is likely that 
accumulation of acids preferentially released will result in 
increased percentages of these acids within the FFA fraction. 
In fact, the observations made immediately after noradrenaline 
infusion have shown parallel increases in FFA oleate and 
linoleate, and decreases in FFA stearate. These changes 
would be expected from the increased rate of FFA influx. 
The absence of parallel increases in FFA linoleic acid 
percentages in other conditions followed or accompanied by 
increases in serum FFA can be explained by the high 
metabolic activity of linoleic acid compared to oleic acid 
(incorporation into phospholipids, metabolism to arachidonic 
acid) or alternatively by its lower affinity for albumin 
compared with oleic acid. 
STUDIES ON TRIGLYCERIDE FATTY ACIDS 
Similarities and differences in the effect of various factors 
inducing fatty acid mobilisation 
Changes in the percentage of triglyceride fatty acids (except 
those induced by antithyroid therapy in thyrotoxic patients) were 
much smaller than the corresponding changes in serum FFA. 
The results obtained from various studies are somewhat 
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conflicting. Higher degrees of monounsaturation of serum 
triglyceride fatty acids were observed in thyrotoxicosis and after 
acute myocardial infarction. Higher degrees of saturation 
were observed after a daily dose of HGH and in acromegaly. 
One could assume that thyroid hormones promoted the increases 
of triglyceride oleate, while HGH did not. However, the results 
of the effects of thyroid hormones are not completely clear. 
Antithyroid therapy induced a significant lowering of 
triglyceride oleate associated with decreases in serum FFA 
concentrations, but no statistically significant increases in 
triglyceride oleate were found when hypothyroid subjects 
were treated with thyroid hormones. It appears that some 
persons may not be capable of raising the triglyceride oleate in 
response to increases in serum FFA to the same extent as 
others. This inability to raise triglyceride oleate in parallel 
with increases in serum FFA has been observed in patients 
suffering from chronic ischaemic heart disease. 
To my knowledge, the effect of hormones on the 
composition of serum triglyceride fatty acids has not yet been 
described. The effects of hormones were studied in relation 
to adipose tissue triglycerides, and these will be discussed in 
the next paragraph. 
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In ischaemic heart disease, the present results agree with 
those reported by Bottcher and Woodford (1961) and do not 
show any significant differences in the pattern of the 
triglyceride fatty acids from the healthy controls, but they do 
show differences in the relative pattern of serum FFA and 
triglyceride fatty acids. No increases corresponding to 
those in free oleic acid percentages are found in triglyceride 
oleate, hence the smaller difference between the percentage levels 
of triglyceride and FFA oleic acid in the diseased group. 
Bottcher and Woodford (1961) observed somewhat less oleic 
acid in the triglycerides in the combined 1..111 Cohn fractions 
and somewhat more oleic acid in the FFA in the combined IV -V 
Cohn fractions in diseased subjects. Thus,their results agree 
with those presented here in indicating a smaller difference 
between the percentage levels of triglyceride and FFA oleic 
acid in the diseased subjects. 
Interpretation of results 
(a) Influence of serum FFA on serum triglyceride levels 
Evidence from numerous isotopic studies has demonstrated 
that, in the fasting state, serum triglycerides derive mainly 
from the liver (Lauren, 1960; Ravel and Goldfien, 1961; 
Robinson, 1963), where they are synthesised from plasma FFA 
and glycerophosphate,and released again into the plasma as 
part of the circulating low density lipoproteins (Stein and 
Shapiro, 1960; Havel and Goldfien, 1961; Borgstrom and 
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Olivecrona, 1961). After the injection of animals with labelled 
acetate (Harper et al., 1953) or labelled fatty acids (Havel and 
Goldfien, 1961; Borgstrom and Olivecrona, 1961; Orth et al., 
1961) radioactivity appears in the plasma triglycerides. The 
maximum radioactivity after the injection of labelled fatty acids 
was recovered in plasma triglycerides after 40 minutes in rats 
(Laurell, 1959), after 30 to 60 minutes in dogs (Orth et al., 
1961), and after 2 hours in man (Nestel, 1965). 
The stimulation of mobilisation of serum FFA from adipose 
tissue by hormones has been shown to influence the 
concentrations of hepatic and serum triglycerides. Large 
increases in the hepatic triglyceride content were observed one 
hour after the administration of noradrenaline to rats, (Dury 
and Treadwell, 1958) and within 6 hours after the administration 
of growth hormone (Greenbaum and McLean, 1953). Elevation 
of plasma triglycerides after infusion of noradrenaline was 
reported in dogs (Feigelson et al., 1961) and in human subjects 
(Dury and Treadwell, 1958). More recently, Grasso et al., 
(1963) observed that these increases were higher in hyperlipid- 
aemic subjects and in subjects with biliary cirrhosis (Grasso 
et al., 1964). Nestel (1964) gave evidence for the concept 
that the levels of plasma triglycerides in any individual are 
related to the responsiveness of the adipose tissue to 
catecholamines. A relationship was found between the fasting 
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plasma triglyceride concentrations and the increments in serum 
FFA after a 15- minute infusion of noradrenaline. 
(b) Differentiation in the turnover rate of plasma FFA to 
plasma triglycerides 
Little is known about the metabolic differences in conversion 
rates of individual plasma FFA to plasma triglyceride fatty 
acids. Orth et al., (1961) reported that both linoleic - C14 and 
palmitic W C14 acids, injected to dogs, were incorporated into 
plasma triglycerides at comparable rates and continued at 
similar concentrations for 72 hours. Nestel (1965), also 
using isotopic studies, reported different fractional turnover 
rates for palmitic and linoleic acids. That of linoleic only 
was inversely related to triglyceride concentrations. He 
concluded that some forms of hyperlipidaemia were accompanied 
by a corresponding increase in the turnover rate of palmitate, 
but not of linoleate. Whyte et al., (1963) showed that, during 
fat absorption in rats, triglyceride incorporation had a marked 
preference for stearic and linoleic acids compared with palmitic 
acid, and a relative discrimination against oleic acid. The 
authors showed that the of and 
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positions of triglyceride 
were nearly identical with regard to fatty acid distribution of 
mass and radioactivity (which is not the case with lecithins). 
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(c) Efflux of triglycerides from the plasma 
It is generally accepted that the fatty acids of plasma 
triglycerides represent the form in which fatty acids are 
transported from the liver to adipose tissues and other body sites 
(Carlson and Ekelund, 1963). In the rat, it has been shown 
that injected labelled triglycerides have a rapid turnover rate 
with an initial half -life of 3 - 5 minutes (Laurell, 1959). 
Recent studies have suggested that the disappearance rate of 
plasma triglycerides varies between subjects and depends upon 
the size of triglyceride lipoproteins (Quarfordt and Goodman, 
1966). At normal plasma triglyceride concentrations the rate 
of removal has been calculated to be about 2 g per hour (Reaven 
et al., 1965). The isotopic studies revealed that much of the 
low density triglyceride lipoproteins circulated back and forth 
between the plasma and the liver (Carlson and Ekelund, 1963). 
(d) Hormones and adipose tissue fatty acids 
It has already been stated that adipose tissue triglycerides 
derive partly from synthesis within adipose tissue, and partly 
from synthesis in the liver, since they are transported in the 
blood stream from the liver to adipose tissue. A change in the 
composition of adipose tissue fatty acids might, therefore, be 
expected under the influence of agents promoting a higher 
mobilisation of serum FFA. This suggestion has been 
confirmed by studies on adipose tissue fatty acids. Rabinowitz 
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et al., (1965) reported small increases of adipose tissue oleic 
acid after treatment of obese men with thyroid hormones. 
Ellefson and Mason (1964) found that rat adipose tissue 
contained a higher percentage of oleic acid in the hyperthyroid 
state and a lower percentage in the hypothyroid state; the 
decreases in hypothyroid animals were particularly marked. All 
these observations demonstrate that thyroid hormone controls 
the proportion of adipose tissue oleic acid along the same lines 
as it controls the proportions of serum free and triglyceride 
fatty acids, as shown in the present investigation. Thus oleic 
acid, compared to saturated acids, is more rapidly transported, 
and one could speculate that such a trend in the FFA and 
triglyceride fatty acids might represent a more rapid rate of 
recycling of fatty acids between adipose tissue and liver. 
As far as adipose tissue oleic acid is concerned, it is of 
particular interest that Krut and Bronte -Stewart (1963) 
reported that females had higher percentages of oleic and 
palmitoleic acids in their adipose tissue than males. If the 
suggestion that adipose tissue oleic acid represents a measure 
of the rate of fatty acid recycling is true, it would be expected 
that in females there should be a greater response to the 
influence of fatty acid mobilisation than in males. No such 
observation has so far been reported. Evidence provided by one 
study, however, indicates such a possibility: Quabbe et al., 
(1966) found that in females, during a 24 -hour fast, both serum 
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FFA and serum HGH were at peak levels more frequently than 
in males. 
Suggestion of a more probable explanation for the different 
effects of thyroid hormone and of HGH on triglyceride fatty acids 
Higher triglyceride oleate was observed in the present work 
as a result of an excess of thyroid hormone and as a'result of 
acute myocardial infarction, while higher triglyceride 
saturation (palmitate and stearate) was observed as a result of 
daily doses of HGH and in acromegaly. One speculative 
explanation for these observations is provided by the different 
effects of thyroid hormones and of HGH upon carbohydrate 
metabolism. For example, an excess of thyroid hormones leads 
to increased glucose utilisation nd increased insulin degradatk ri 
(Danowski et ái.,(964). DìFferent trends were described after daily 
administration of HGH. Wallace and Basset (1966) have 
recently observed that the daily administration of HGH causes 
rises in blood glucose and insulin. Patients with acromegaly 
are reported to be more resistant to insulin than normals in 
respect of plasmaglucose levels (Landon et al., 1966). Thus, it is 
possible that higher concentrations of glucose and insulin in plasm 
will promote the saturation of triglyceride fatty acids, while 
hypermetabolic conditions will promote a relatively lower 
degree of saturation of triglyceride fatty acids. 
The different influences on the rates of transportation, as 
already discussed, may additionally influence the pattern of 
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triglyceride fatty acids in different states of thyroid activity. 
STUDIES ON PHOSPHOLIPID FATTY ACIDS 
Similarities and differences in the effects of various factors 
inducing fatty acid mobilisation 
No common pattern of change in the fatty acid composition 
of serum phospholipids can be recorded for those influences 
studied. It is of interest that under some conditions, 
accompanied by increases in serum FFA and by increased 
serum FFA oleic acid percentages, the percentages of 
phospholipid oleate were decreased. This was observed in 
hypothyroid patients following the treatment with thyroid 
hormones; daily injections of HGH produced a similar effect. 
Changes in the FFA concentrations appear to be associated 
mostly with changes in phospholipid palmitate and phospholipid 
arachidonate in certain conditions. Increases in phospholipid 
palmitate were observed when an overnight fast was prolonged 
by 8 hours. High phospholipid palmitate percentages were 
recorded in patients with chronic ischaemic heart disease and 
with hyperlipidaemia, as well as immediately after an acute 
myocardial infarction. The similarity of trends in the two 
conditions, accompanied by different concentrations of serum 
phospholipids, indicates that the levels of plasma FFA may 
influence the described change in composition more than serum 
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phospholipid concentration. 
The percentage of phospholipid arachidonate appears to be 
associated with the activity of thyroid hormones, as well as 
with the activity of noradrenaline. Since changes in the 
percentage of phospholipid arachidonate were accompanied, 
in most conditions, by changes in the percentage of cholesteryl 
arachidonate, they will be discussed together in the paragraph 
entitled "Studies on cholesteryl fatty acids ". 
I could not find similar studies on the effect of hormones or 
of fasting on the composition of serum phospholipid fatty acids, 
nor have changes immediately after myocardial infarction been 
reported. However, the pattern of phospholipid fatty acids in 
chronic ischaemic heart disease and in hyperlipidaemia have 
been reported (Schrade et al., 1961) and the significant 
increases in phospholipid palmitate and decreases in 
phospholipid linoleate observed here confirm these earlier 
findings. 
Interpretation of results 
Factors influencing the composition of serum phospholipids 
There is little evidence concerning the various factors which 
determine the composition of serum phospholipids. Ansell 
and Hawthorne (1964) have recently summarised evidence for 
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the concept that plasma lipoprotein phospholipids are formed 
in the liver, removed from plasma by the liver and destroyed 
in the liver. In the liver the phospholipid lecithins are 
synthesised via the choline-cytidine pathway or via the 
methylation pathway and, in the latter, sex differences were 
observed (Bjornstad and Bremer, 1966). The turnover of 
hepatic phospholipids was reported to be under hormonal 
influences. Thyroid hormone was reported to increase the 
turnover of phospholipids in the liver of adult rats (Flock et al., 
1948), and noradrenaline in the rabbit liver (Dury, 1955). 
Little is known about the specificity of enzymes 
catalysing the esterification of hepatic lecithins. Dustin et al., 
(1961) have shown preferential incorporation of linoleic rather 
than palmitic acid into hepatic lecithins when dogs were injected 
simultaneously with 1-C14 -linoleic and with 9, 10-H3- palmitic 
acid. Nestel and Steinberg (1963) have shown that rat liver 
perfused with high concentrations of palmitic and linoleic acids 
incorporates palmitic acid at a greater rate into hepatic 
triglycerides, and linoleic acid into hepatic phospholipids. 
Specificity for esterification of phospholipids was also 
reported for intestinal phospholipids, during fat absorption: 
Whyte et al., (1963) showed that esterification was highest for 
stearic and linoleic acids, lower for palmitic acid, and lowest 
for oleic acid. 
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The composition of plasma phospholipids can also be 
influenced by transesterification reactions between the lecithins 
and free cholesterol which takes place in the plasma. Glomset 
and his associates (1962, 1963) have reported the existence of 
a lecithin:cholesterol acyltransferase in plasma which stimulates 
the transfer of fatty acids from the fi .position of lecithin to 
the cholesterol molecule. Since the ß -position of lecithin 
is mostly occupied by the unsaturated acids, such as linoleic 
and arachidonic, the presence of this enzyme in plasma will 
result in a decrease in phospholipid unsaturated acids and in 
an increase in cholesteryl unsaturated acids. 
Concluding remarks 
The explanation of the changes in phospholipid fatty acids is 
more difficult than for the other fractions of serum lipids. 
It is not known whether the changes observed during the 
present studies were due solely to changes in the fatty acid 
composition of lecithins, or to changes in the relative 
proportions of lecithins, sphingomyelins, phosphatidylethanol-. 
amine or lysolecithins. Even assuming that they result from 
changes within the lecithin fraction only, evaluation of the 
mechanism is difficult. The different pathways of hepatic 
synthesis, turnover rates of hepatic phospholipids, rates of 
efflux from plasma, specificity for esterification and many 
other factors may account for the percentages in the fatty acid 
moiety in serum lecithins. 
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It islhowever,noteworthy, that it has been recently reported 
that the ratio of lecithin palmitate to stearate accounts for one 
of the sex characteristics in the rat: male rats had a higher ratio 
of palmitate to stearate than females (Aftergood and Alfin-Slater , 
1967). The same characteristic increases in palmitic /stearic 
ratios were observed in the present study in the hypothyroid 
group and in the group of subjects with ischaemic heart disease, 
both chronic and acute. Thus, the hypothyroid state in the 
rat was accompanied by a decreased turnover of hepatic 
phospholipids (Flock et al., 1948). By comparison, one could 
speculate that the high ratio of phospholipid palmitate to stearate 
reflects the lower turnover rate of hepatic phospholipids. 
Alternatively, one can accept the explanation offered by Aftergood 
and Alfin.Slater (1967) for the similar characteristics in the 
rat. According to these authors, the differences observed in 
male and female rats reflect the different pathways of hepatic 
synthesis. 
STUDIES ON CHOLESTERYL FATTY ACIDS 
Similarities and differences in the effect of various factors 
inducing fatty acid mobilisation 
Increases in serum FFA levels due to thyroid activity, or due 
to an induced mobilisation of serum FFA on the previous day 
either by HGH or myocardial infarction, have in most cases led 
to increases in cholesteryl oleate and decreases in cholesteryl 
linoleate. Patients with higher than normal levels of serum FFA, 
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such as those with chronic ischaemic heart disease,also have an 
increased percentage of cholesteryl oleate and a decreased 
percentage of cholesteryl linoleate. The opposite changes 
occurred as a result of antithyroid therapy in all thyrotoxic 
subjects, irrespective of their diet (when the serum FFA were 
significantly reduced). An increase in cholesteryl oleate was 
often associated with a rise in cholesteryl palmitate. 
Increases in cholesteryl saturated and monounsaturated acids 
and decreases in di. and tetraunsaturated acids generally occur in 
conditions associated with hypercholesterolaemia (Goodman, 1965) 
and can be induced by dietetic experiments (see Introduction). 
These characteristics, if exaggerated, lead to an essential fatty 
acid deficiency. Not all stimuli of fatty acid mobilisation studied 
here act in this manner. Thyroid hormone activity does not 
lead to an essential fatty acid deficiency, since decreases in the 
percentage of linoleic acid are compensated by increases in the 
percentage of arachidonic acid, another essential fatty acid. High 
levels of cholesteryl arachidonate characterised the hyperthyroid 
state, and could be significantly reduced by antithyroid therapy. 
Low levels of cholesteryl arachidonate characterised the 
hypothyroid state, and could be significantly increased by 
treatment with thyroid hormones. These changes occurred 
irrespective of the diet of the patients under study. 
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Changes producing higher percentages of cholesteryl or 
phospholipid arachidonate, or both, have been observed in the 
present work in other conditions, such as during the infusion of 
noradrenaline, occasionally after prolonged fasting, and after 
myocardial infarction. 
I could find only one report dealing with the effects of 
hormones on the composition of cholesteryl fatty acids. Boyd 
(1963) reported that thyroid hormone therapy in men increased 
the percentage of cholesteryl palmitate, palmitoleate and 
arachidonate, but not of oleate. With respect to the increases 
in cholesteryl arachidonate the present results are in agreement 
with those reported by Boyd. 
Interpretation of results 
Factors influencing the composition of serum cholesteryl fatty acids 
The turnover of plasma FFA into cholesterol ester fatty acids 
measured by isotopic studies is slower than into triglyceride or 
phospholipid. After the injection of labelled palmitate or 
linoleate into dogs, the peak of radioactivity appears after 30 - 60 
minutes in plasma triglycerides, after 4 - 8 hours in plasma 
phospholipids and after 25 .. 36 hours in plasma cholesteryl fatty 
acids (Orth et al., 1961). 
Factors which govern the composition of serum cholesteryl 
fatty acids are largely unknown. Some of these factors were 
recently studied in rat and man, and these studies are helpful in 
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the understanding of the present observations. 
Plasma cholesterol esters derive from two main sources 
the liver and the plasma. The liver serves as a chief source of 
plasma cholesterol ester synthesis (Friedman and Byers, 1955, 
Goodman and Shiratori, 1964). The evidence for this concept 
has been recently summarised by Nestel and Couzens (1966.). 
The cholesterol esters synthesised in the plasma by the 
plasma enzyme acyltransferase (Glomset et al., 1962, Glomsetà 
1963) from free cholesterol and the fatty acids occupying the 
fi- position of lecithins account for an unknown portion of 
plasma cholesterol esters (Nestel and Couzens, 1966). 
Differentiation in the esterification of cholesterol esters 
In the rat liver, enzymes responsible for cholesterol ester 
synthesis have been shown to display a specific activity for the 
formation of cholesteryl oleate. Cholesteryl oleate was 
predominantly synthesised when rat liver was perfused in a 
medium containing albumin and an equimolar mixture of 
different fatty acids (Goodman et al., 1964). The 
esterification was in the order: cholesteryl oleate, palmitate, 
stearate and linoleate. This property of forming esters 
predominantly with oleic acid has also been demonstrated in 
in vivo experiments with rats. Oleate was the predominant 
cholesterol ester which accumulated in the rat liver irrespective 
of the fatty acid composition of the diet (Swell et al., 1964). When 
rats were injected with mevalonate.2 -C14, the rate of 
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appearance of the monounsaturated esters was greater than of 
any other esters (Goodman and Shiratori, 1964). 
In the rat, this specificity in relation to the formation of 
cholesteryl monounsaturated acids was associated with the 
specific activity of turnover of these esters in plasma and liver 
(Goodman et al., 1964). The turnover of cholesterol esters in 
rat plasma is determined also by the lipoprotein fraction and, 
in the fraction of density d > 1.063, all cholesterol esters have 
a slower turnover (Gidez et al., 1967). In man, plasma 
cholesterol ester turnover rates are not determined either by 
lipoprotein class or by the fatty acid moiety (Goodman, 1964; 
Nestel and Couzens, 1966). 
Formation of cholesteryl and phospholipid arachidonate 
There is evidence in the literature supporting the view that 
the formation of plasma cholesteryl arachidonate is connected 
with hormonal activity. 
Ellefson and Mason (1964) reported large increases in 
hepatic concentrations of cholesteryl and phospholipid arachidonate 
and of plasma arachidonate in hyperthyroid rats, and thought 
they were due to increased metabolism of linoleate to 
arachidonate under the influence of increased thyroid activity 
Other factors were also reported to influence the levels 
of plasma arachidonate. Increases in cholesteryl arachidonate 
were observed in fasted rats (Boyd, 1963; Alberts and Gordon, 
1962). A reduction in cholesteryl arachidonate was reported in 
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female rats (Boyd, 1963). Increases in 
cholesteryl arachidonate have recently been reported after 
treatment of depressed patients by electroconvulsive therapy 
(Cochran et al., 1965). Recently, Aftergood and Alfin. Slater 
(1965) have reported that, in the rat, conditions associated with 
low levels of plasma cholesterol were generally accompanied 
by higher total plasma arachidonate concentrations. 
Some authors have observed sex differences in the formation 
of arachidonic acid. Lyman et al., (1964) reported that female 
rats, and castrated male rats treated with oestrogen, maintained 
higher proportions of arachidonate in the plasma during 
essential fatty acid deficiency than intact males or testosterone... 
treated castrates. More recently, Aftergood and Alfin- Slater 
(1967) reported that stimulation of the conversion of linoleic to 
arachidonic acid during the incubation of rat plasma occurred 
only in plasma from female rats. These authors concluded from 
their results that the formation of arachidonic acid was related 
to the presence of acyltransferase in rat plasma, and that the 
transesterification process might be depressed by androgen or 
enhanced by oestrogen. 
Concluding remarks 
The observed increases in the percentage of cholesteryl 
oleate in association with high levels of serum FFA, or following 
rapid increases in serum FFA, may be related to the fact that 
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oleic acid is in these conditions supplied to the liver in higher 
proportions by the circulating fluids. If cholesteryl oleate 
is formed in greater amounts than other esters, after increases in 
serum FFA, and if it cannot be hydrolysed more rapidly than other 
esters (as shown in the rat), the conditions accompanied by 
repetitive increases in serum FFA may promote mainly the 
formation of cholesteryl oleate. 
The present study has shown that levels of cholesteryl and 
phospholipid arachidonate are materially influenced by, and 
controlled by, thyroid hormones. The effects of thyroid 
hormones on the formation of arachidonic acid may be mediated 
through endogenous noradrenaline, which leads to a similar 
response when infused It appears that the mechanism involved 
in the formation of plasma arachidonate is connected in some way 
with factors which influence the susceptibility of adipose tissue 
to catecholaminew stimulated FFA mobilisation. 
THE CONTRIBUTION OF THE PRESENT WORK TO THE 
PROBLEM OF ATHEROSCLEROSIS 
Increased fatty acid mobilisation may be involved in the 
development of atherosclerotic vascular disease by various 
mechanisms. The possible explanation presented by Carlson et al. 
(1965) illustrates schematically three main sites of action for 
increased fatty acid mobilisation. 
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Arterial vessel wall 
ru;. y. l ossihle sites of action for increased lipid mobilization 
in the deSelopinent of atherosclerosis. Schematically indicated 
is the possible effect of increased lipid uiohilization on the lipid 
content of the inti o u, on thronihogenesis ;nul on the hepatic 
formation of lipoproteins. 
From Carlson, Boberg and Hogstedt (1965) 
It is not known at present whether the hyperlipoproteinaemia 
seen in ischaemic heart disease promotes the development of the 
disease or is only a symptom (Carlson et al., 1965). A few 
studies will be cited which support the concept that plasma 
cholesterol esters may contribute to the development of 
atherosclerosis. 
Experiments with rabbits fed cholesterol have shown that the 
increases in serum cholesteryl oleate which resulted were 
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associated with the accumulation of cholesteryl oleate in aortic 
atheromatous plaques (Zilversmit et al., 1961). In the human, 
advanced atherosclerosis has been shown to be associated with 
relatively high proportions of cholesteryl linoleate in the walls 
and plaques (Böttcher et al., 1960; Mead and Gouze, 1961; 
Böttcher and Woodford, 1962). Evidence from other study 
on human aortic lipids has shown that areas of fatty streaks 
contained relatively more cholesteryl oleate than normal intima 
and media from the same aorta (Nelson et al., 1961). Also, it 
has been shown that the rate of exchange between arterial 
cholesterol esters and between plasma .cholesterol esters is 
slower in atherosclerotic segments (Chobanian and Hollander, 
1964). Thus, the studies of Zilversmit et al., (1961) and Nelson 
et al., (1961) indicate that cholesteryl oleate may contribute more 
than other cholesterol esters to the development of atherosclerosis. 
In several pathological conditions accompanied by an 
accumulation of cholesterol esters in tissues, marked 
accumulation of cholesteryl oleate has been reported. It 
predominated in the cholesterol esters in a bone marrow lesion 
in Hand-Schuller-Christian disease (Fredrickson et al., 1961), 
in tissues from patients with Tangier disease (an ex-lipoprotein 
deficiency Fredrickson et al., 1961) and in human 
xanthomata (Fletcher and Gloster, 1964). Thus, these studies 
indicate that cholesteryl oleate has a greater tendency to 
accumulate in various tissues than any other cholesterol ester. 
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The results of the present study aid the understanding of 
atherosclerosis and ischaemic heart disease by the following 
observations: 
1. It has demonstrated that patients with ischaemic heart disease 
have on average increased percentages of oleic acid in their 
serum FFA. This characteristic has not previously been 
described. This is also true when FFA are mobilised by such 
stimuli as thyroid hormones, fasting, HGH injections (associated 
with fasting), acute myocardial infarction or noradrenaline. 
It is interesting that the composition of serum FFA in 
patients after acute myocardial infarction and to lesser extent 
in patients with chronic ischaemic heart disease is similar to 
that induced by noradrenaline infusion or that observed in 
increased thyroid activity. Patients with chronic ischaemic 
heart disease have been reported as having a greater than 
normal secretion of noradrenaline (Arlow, 1945; Friedman et al.,, 
1960; Starich and Abbanelli, 1959; Gazes et al., 1959). It 
has been suggested that they react to stressful situations more 
frequently (Carlson et al., 1965) and with a greater 
mobilisation of plasma FFA; they had higher levels of plasma 
FFA after cigarette smoking (Kershbaum et al., 1961) and in 
response to the minor stress of testing their capacity to perform 
feats of mental arithmetic (Pecnik, 1962). The similarity of 
effects induced during a noradrenaline infusion with those which 
occur after acute myocardial infarction and in some patients 
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suffering from chronic ischaemic heart disease supports the 
concept that increased levels of plasma noradrenaline may be 
responsible for the changes in these patients. 
2. The absence of increases in triglyceride oleate corresponding 
to increases in free oleic acid in patients with chronic ischaemic 
heart disease permits one to speculate that in these patients, 
unlike normal healthy controls, the fatty acids carried back to 
adipose tissue, compared with the fatty acids removed from 
adipose tissue, are more saturated and less monounsaturated. 
This may be due in part either to disturbed carbohydrate 
metabolism, or to the slower rate of fatty acid transportation, as 
was discussed in relation to the hypothyroid state. 
3. Patients with chronic ischaemic heart disease have higher 
percentages of oleic and lower percentages of linoleic acid in 
serum cholesterol esters. These characteristics have been 
described earlier in association with hypercholesterolaemia, but 
not in association with conditions accompanied by or followed by, 
a higher mobilisation of serum FFA. As has already been 
stated, the increased availability, of oleic acid in the circulation, 
the increased specificity for formation of cholesteryl oleate, 
and lack of specificity for the turnover of cholesteryl oleate 
may create favourable conditions for the increased percentages 
of cholesteryl oleate. It is noteworthy that species that are 
less susceptible to atherosclerosis, such as the rat and dog, 
have less cholesteryl oleate in their serum cholesterol ester 
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fractions than has man. 
4. The fatty acid composition of serum lipids has been 
measured soon after myocardial infarction and on two 
consecutive subsequent days. The changes, not previously 
reported, which were observed here in the free and triglyceride 
fatty acids were similar in character to those of hyperthyroid 
patients. As in hyperthyroid patients, high values for free 
and triglyceride oleic acid were observed. In the cholesteryl 
fatty acids there were decreases in linoleic acid of the same 
magnitude as in hyperthyroid subjects; however, only in two out 
of the eight patients studied were there corresponding increases in 
cholesteryl arachidonate. The phospholipid fatty acid pattern 
resembled that of chronic hyperphospholipidaemia. On the later 
days of the illness, between the first and the second day increases 
in free and triglyceride oleate were observed. In the two patients 
most severely affected (one died on the third day and one was 
unconscious on the second day) there was a marked rise in 
saturated acids and a decrease in monounsaturated acids in the 
FFA fraction, unaccompanied by any significant changes in FFA 
linoleic acid which could obscure the higher degree of 
saturation observed. It is not known whether this different 
reaction in two of the eight subjects with myocardial infarction was 
associated with the severity of the illness. Much more evidence 
must be collected before any conclusions can be reached on the 
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sequence of changes in this disease. 
5. The question arises why, in all patients with chronic 
ischaemic heart disease having high levels of serum FFA, and in 
all those after an acute myocardial infarction, there is not a rise 
in cholesteryl or phospholipid arachidonate. Rises in 
phospholipid or phospholipid and cholesteryl arachidonate were 
observed after noradrenaline infusion. Could there be a deficient 
formation of arachidonic acid in these patients, as has been 
observed in hypothyroid subjects? 
It has been previously observed that there is a correlation 
between the levels of arachidonic acid in the serum cholesteryl 
esters and species susceptibility to atherosclerosis. Those 
species (rat and dog) with high levels of arachidonic acid in their 
serum cholesterol esters are known to be more resistant to the 
experimental production of atherosclerosis, while more 
susceptible species (man, chicken, goose, rabbit and guinea -pig) 
have low levels of this acid (Swell et al., 1960). Since 
hyperthyroid persons with high serum cholesteryl arachidonate 
are less susceptible to atherosclerosis than hypothyroid ones, 
the present observations support the theory developed by Swell 
et al., (1960). 
As yet it is impossible to extrapolate from speculations to 
conclusions. This thesis has concentrated on plasma levels, 
and now these findings must be related to adipose tissue and 
hepatic levels. Future studies on adipose tissue fatty acids, 
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the intracellular pool of FFA, responsiveness to lipolytic factors, 
cell permeability for fatty acid transport, and rates of 
esterification are all likely to yield valuable information on the 
factors responsible for the observations in this study. 
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(i) 
SUMMARY 
A modified technique for separation of serum free fatty 
acids (FFA), t riglycerides, phospholipids and cholesterol 
esters by adsorption chromatography on a system of two 
columns, silicic acid and Florisil, has been elaborated for 
preparing samples for gas-liquid chromatographic analysis of 
serum lipid fatty acids. 
An attempt was made to study the changes in fatty acid 
composition of the various lipids in response to factors 
influencing fatty acid mobilisation. The following stimuli 
of fatty acid mobilisation were investigated: thyroid hormone, 
human growth hormone (HGH),noradrenaline, prolonged fasting, 
and acute and chronic ischaemic heart disease. 
The effects of thyroid hormones were studied 1) after 
administration of LT3 to normal subjects; 2) after thyroid 
hormone therapy to hypothyroid subjects and 3) after antithyroid 
therapy to thyrotoxic subjects. 
The effects of HGH were studied 1) during the daily 
administration of HGH; 2) hourly after HGH injection; and 
3) in patients with acromegaly. 
The effects of noradrenaline were studied during its 
infusion. 
The effects of fasting were studied when an overnight fast 
was prolonged by 8 hours. 
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The effects of acute ischaemic heart disease were studied 
on the day of myocardial infarction and on two subsequent 
consecutive days. The effects of chronic ischaemic heart 
disease were studied in patients with angina pectoris, and 
those with a past history of myocardial infarction. One control 
group consisted of middle aged males, and a second of post- 
menopausal females. 
Percentage composition studies have revealed that increased 
mobilisation of serum FFA due to any of the adipokinetic factors 
studied was accompanied by statistically significant increases 
in the percentage composition of serum FFA oleic acid. These 
increases in oleic acid percentages were mostly accompanied 
by parallel decreases in the percentage of FFA saturated acids: 
stearic and palmitic acids. It is proposed that increases in 
the percentage of FFA oleic acid were due to its higher 
activity in transportation compared with saturated acids, in 
the aqueous medium of adipose cells and plasma. This is 
thought to be due to the physical properties of oleic acid, its 
greater hydrophilic property and also, possibly, its greater 
affinity for albumin. 
The changes in triglyceride fatty acids were not uniform for 
all the influences studied. Triglyceride oleate was significantly 
lowered by antithyroid therapy in hyperthyroid subjects, but no 
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(iii) 
significant increases could be proved as a result of thyroid 
therapy in hypothyroid subjects, thus suggesting that the 
increased incorporation of oleic acid into triglyceride fatty acids 
may be inhibited in some subjects. Administration of HGH 
did not affect triglyceride oleate; observations made during 
daily administration of HGH, and in the disease of acromegaly, 
suggest that HGH may promote a higher degree of saturation 
in triglyceride fatty acids. In subjects with acute myocardial 
infarction, the triglyceride fatty acid pattern resembled that of 
hyperthyroid subjects. In chronic ischaemic heart disease, 
the pattern of triglyceride fatty acids did not differ from 
normal. The lack of parallel increases in percentages of 
triglyceride oleate with increases in percentages of FFA oleic 
acid in patients with chronic ischaemic heart disease suggests 
that incorporation of oleic acid into triglyceride fatty acids in 
these patients is possibly lower. 
In the phospholipid fatty acids, similarly, no common pattern of 
changes was noted for the different stimuli studied. The 
percentage of phospholipid palmitate decreased significantly 
immediately after noradrenaline infusion. Opposite changes 
were noted after prolonged fasting. Equally high levels were 
observed shortly after myocardial infarction as in ischaemic 
patients with hyperphospholipidaemia. The percentage of 
phospholipid arachidonate increased significantly following 
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(iv) 
thyroid hormone therapy in hypothyroid subjects. Phospholipid 
arachidonate also showed an immediate rise during noradrenaline 
infusion. The latter observation supports the concept that 
thyroid hormone activity may be mediated through the action 
of endogenous catecholamines. 
The percentage composition studies on cholesteryl fatty 
acids suggest that changes in serum FFA concentrations (due to 
HGH daily dose, thyroid hormone and antithyroid therapy, acute 
myocardial infarction) produce in most cases directly..related 
changes in cholesteryl oleate percentages and inversely - related 
changes in cholesteryl linoleate. It is probable that the 
increased mobilisation of serum FFA, accompanied by 
predominant increases in FFA oleic acid, may promote the 
formation of cholesteryl oleate. Cholesteryl arachidonate was 
shown to be materially influenced and controlled by thyroid 
function: a significant increase in the percentage of 
cholesteryl arachidonate occurred after thyroid hormone therapy 
in hypothyroid subjects, and a significant decrease occurred 
after antithyroid therapy in thyrotoxic subjects; the 
thyrotoxic patients had percentage levels of cholesteryl 
arachidonate twice as high as those of the hypothyroid patients. 
The results agree with the suggestion of Ellefson and Mason 
(1964) that thyroid hormones stimulate an increased synthesis 
of arachidonic acid from linoleic acid. 
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(y) 
An attempt was made to discuss the results in relation to 
certain metabolic studies, and to postulate possible 
implications of the predominant increase in serum FFA oleic 
acid percentage at the time when fatty acids are mobilised 
from the storage SÍ tes. 
APPENDIX 
APPENDR TABLE I. 
The effect of administration of LT3 (7,.- ,3' -tr i. i.do- 2- chyrrnine)an thr percentage composition of s um escertfied 
fatty acids in 2 euthyroid subjects 
(Expressed as percentage of total fatty acids in the fraction) 
Fatty acid 
Subject short hand 
design. 






Triglyceride Fatty Acids Phoapholipid Patty Acids Cholecteryl Patty Acida 
Pre- On Pre- On Pre- On 
treatment treatment Days after treatment treatment Days after treatment treatment Deys after 
period days last dose period days last dose period days last dose 
3 5 7 3 9 3 5 7 3 9 3 5 7 3 9 3 5 7 3 9 






22 23 22 
3 3 4 
26 25 26 26 26 22 28 27 27 10 10 ll 11 10 9 9 
3 4 T T I T 1 1 1 3 3 3 3 3 3 3 
18:0 n.e. 6 5 7 5 3 4 5 15 15 17 16 16 16 15 1 2 1 1 1 1 2 
18:1 50 48 49 48 54 53 52 13 15 14 14 14 14 17 22 22 23 23 24 23 22 
18:2 16 16 16 17 15 13 12 29 27 23 25 21 24 24' 55 54 52 53 50 50 51 
18:3 T T T T T T T T T T T T T T T T I T T 1 
20:3 T T T T T T T 4 4 4 4 4 4 3 1 1 1 1 1 1 
20:4 2 2 2 3 2 1 1 13 13 16 19 15 14 13 7 7 8 8 10 11 10 
Pre- On Pre- On Pre- On Pre- On 
treatment treatment Days after treatment treatment Days after treatment treatment Days after treatment treatment Days after 
period days last dose period days last dose period days last dose period days last dose 
4 7 3 9 4 7 3 9 4 7 3 9 4 7 3 9 








29 24 29 31 30 32 29 25 10 11 11 10 11 10 
6 7 2 1 1 1 1 1 4 5 5 5 4 3 
18:0 5 4 3 3 3 4 16 17 16 15 16 14 2 2 2 1 I 1 
18:1 47 47 48 50 47 48 17 15 18 17 15 17 22 22 22 20 20 18 
18:2 12 12 12 12 14 22 22 20 19 21 25 50 49 49 51 48 58 
18:3 1 1 2 1 1 T T T T T T 2 1 T 1 T 
20:3 T T T I I T 3 3 3 4 4 3 1 1 1 1 3 1 
20:4 I 1 10 10 11 12 13 14 8 8 8 11 12 8 
Abbreviations: n.e.  - not estimated 
- trece amount 
The first position in the columns represents the concentration of total lipids 
in the serum: Total cholesterol concentrations in mg. /100 ml. 
Total phospholipld concentrations in mg. /100 ml. 
Total criglyceri de concentrations in mmoles /l. 
Total free fatty acids in pen/1. 
S ubject 
QS. 
: 4 via. tr. 
: 2 atha. tr. 
T.M. 
: 3 .ths. tr. 
7 laths. Cr. 
11 laths. tr. 
.J. 
: 1 lath. Cr. 
: 3 lathe, tr. 
S.M. 
; 14 days tr. 
II.T. 
: 6 lots. tr. 
: 11 sibs. tr. 
5.11. 
: 6 loca. tr. 
R.J. 











AcT[MDIS TAIIB 2. 
Effect of treetmen[ with thyroid hormones on the percentage colapoitlon of serum lipid 
fatty acids in 9 hypothyroid subjects. 
(axed 50.60) 








Untreated treatment Untreated treatment 
A I A I 
Mtoaphol ipid Cholaateryl 
fatty acida fatty acida 
On On 
Un treated treatment Untreated treatment 
A 
655 900 839 5.52 2.48 1.44 485 385 318 486 452 295 237 
16:0 32 33 23 26 28 26 26 28 33 27 27 32 13 12 12 13 
16:1 6 6 4 5 9 9 9 9 2 2 1 1 5 6 8 7 
18:0 13 13 13 13 5 6 3 4 17 18 19 17 l 1 1 l 
18:1 41 42 54 51 48 50 53 49 15 17 17 15 J2 31 30 27 
18:2 8 7 7 6 9 9 7 9 20 15 17 39 41 37 40 
1 8 : 3 + 20:0 T T T T 1 1 2 1 2 1 1 2 1 1 2 1 
20:3 - - - - 7 T T T 3 3 6 4 2 2 1 l 
20:4 1 1 T 2 2 2 2 2 10 10 14 13 6 7 9 9 
815 910 839 0.94 0.78 1.08 439 334 445 439 290 
'6:0 33 30 28 29 29 25 38 39 33 12 11 10 
16;1 4 3 4 6 5 4 1 l 1 5 5 5 
18:0 19 18 15 3 5 2 16 15 IS 1 1 7 
18:1 33 37 45 48 47 53 17 I8 16 22 22 20 
18:2 9 9 8 12 13 12 20 19 2J SS 55 58 
18:3 + 20:0 1 3 T 1 1 1 T T T T T I 
20:3 - - - - - - 1 1 2 T T T 
20:4 T T T 1 1 2 7 7 9 4 5 6 
n.a. 2.97 1.74 1.83 n.e, n.e, n.e. 432 279 243 
16:0 36 3: 25 JI 36 33 35 35 14 12 12 
16:1 5 7 3 5 6 7 1 2 2 4 6 4 
18:0 14 14 16 6 4 6 14 13 14 2 1 1 
18:1 34 41 45 45 44 46 16 15 15 26 24 24 
18:2 6 6 6 15 II 9 26 22 21 50 50 53 
18:3 + 20:0 1 1 T 3 1 T 2 2 2 T T T 
20:3 - - - T T T 2 4 3 T T T 
20:4 1 1 1 3 T 4 6 7 8 4 6 4 
580 770 1216 1126 2.91 2.72 0.95 1.42 352 318 320 337 405 398 320 330 
16:0 32 36 33 31 35 35 29 27 32 30 34 29 13 16 12 11 
16:1 6 5 4 4 8 8 8 6 2 2 2 1 10 11 5 4 
18:0 13 15 14 13 5 5 4 3 19 18 16 21 T 1 I 1 
18:1 39 37 44 44 LO 42 46 46 19 21 14 14 26 29 22 19 
18:2 9 7 6 6 7 8 9 17 15 16 20 24 45 40 52 53 
18:3 + 20:0 - - T 1 T T T T T T T T T T 7 T 
20:3 - - - - - - - - 2 3 3 2 2 2 2 2 
20:4 1 2 T 1 3 T 3 T 9 10 12 8 5 4 9 9 
1430 1538 1.82 0.94 270 251 330 320 
16:0 29 27 31 31 34 43 1: 
16:1 7 8 7 6 7 2 5 6 
18:0 12 12 4 3 14 12 1 1 
18:1 44 47 48 51 17 14 23 25 
18:2 9 6 10 10 18 16 47 44 
1813 + 20:0 T T T T 2 1 i I 
20:3 - - - - 1 T T 
2014 - - - - 11 11 7 8 
1.98 2.63 1.95 1.19 n.., n... n.a. n... 249 327 182 195 
16:0 30 29 27 25 25 26 26 27 29 28 35 9 9 12 ll 
16;1 4 4 5 4 4 5 10 1 1 T I 2 3 4 4 
18:0 13 20 16 5 5 5 3 16 16 15 16 1 l 1 1 
18:1 42 38 45 55 55 52 53 18 17 18 15 27 21 27 21 
18:2 10 8 6 ll II 11 8 24 23 23 17 52 54 44 54 
18:3 + 20:0 T T T - - - - 1 1 1 2 1 2 2 2 
20:) - - - - - - - 2 2 3 T T T T 
20:4 T T 2 2 2 2 2 10 10 11 12 7 8 10 10 
406 640 564 0.76 0.85 0.64 0.74 n.a. n.a. 227 262 259 242 217 219 
16:0 29 29 26 27 26 27 37 35 JO 31 )2 13 11 12 
16:1 3 8 6 7 7 7 7 1 2 2 1 3 4 5 
18:0 21 14 17 5 Il 5 5 17 16 15 18 2 1 1 
18:1 37 39 41 50 52 47 43 14 15 12 15 25 23 23 
18:2 10 9 9 10 10 12 Il 20 25 20 22 52 52 51 
I 8 : 3 + 20:0 - - - 1 1 l 2 T T T I I l 1 
20:3 - - - - - - - 2 1 7 2 T 1 1 
20:4 T T T T T T T 10 11 12 10 5 6 6 
520 490 683 602 1.66 1.36 1.10 1.60 337 300 170 220 311 294 224 236 
16:0 32 28 26 24 27 I6 30 27 )2 33 38 )7 10 9 12 13 
16:1 5 S 4 4 8 6 6 7 1 1 1 1 4 3 6 S 
18t0 15 13 11 14 3 3 I 2 10 11 16 13 23 21 16 21 
1811 42 42 50 46 49 32 52 53 20 20 16 16 25 25 26 26 
110 10 12 9 12 13 14 IO II 27 25 20 22 56 58 52 51 
20:3 2 2 2 2 2 2 2 2 2 1 2 3 2 2 2 2 
2014 T T T T T T T T 6 6 8 7 4 4 4 
4 
460 .. 1118 810 1.74 ..:6 2.51 2.51 101 .10 Ise :6. 756 760 161 164 
16:0 )I 32 28 32 31 29 31 29 35 33 32 33 IJ 14 14 
14 
16:1 7 7 5 5 8 6 7 7 3 2 2 I 8 7 8 4 
18:0 14 II 14 11 S 4 3 2 15 17 17 19 T T T 1 
18:1 46 44 52 47 49 51 54 53 20 19 19 19 28 27 30 30 
18:2 4 S S 4 7 e 5 3 19 18 1) 14 44 44 39 39 
20:3 T T T 2 - - T T T T T T T T 1 T 
20:4 T T T T T T T T 7 8 12 11 5 S 6 9 
The first poeltloe la the colwa repr ente the < centra[lon of 
total lipids t the earum: Total cholesterol c entratioat leg./100 al. 
Total psoep6ollpld cn e a:lone l es./100 a1. 
To:al tritiycerl6e cootemEratioms la meole/1. 
Total free fatty acid coace.trtinao in ulte/1. 
AMreatatl.ut T - trac. seras ... - met eattmeted 
APPENDIX TABLE 3. 
The effect of treatment with antithyroid agents on the percentage composition of serum lipid 
fatty acids in 4 thyrotoxic subjects (age 50 - 60). 
Fatty acid 
(Expressed as percentage of total fatty acids in the fraction) 
Triglyceride Phospholipid 
Free fatty acids fatty acids fatty acids 
Cholesteryl 
fatty acids 
Subjects short hand On On On On 
design. Untreated treatment Untreated treatment Untreated treatment Untreated treatment 
A B A B A B A B 
J.R. 
female 
n.e. 918 860 705 2.22 2.24 2.65 2.58 n.e. 212 302 142 168 310 214 
A : 5 mths. tr. 16:0 26 25 31 30 31 29 34 30 33 33 32 31 14 13 12 11 
B : 8 mtha. tr. 16:1 4 4 4 4 6 6 8 7 1 1 2 2 6 6 9 7 
18:0 14 13 13 16 3 2 3 3 19 20 16 17 3 2 1 T 
18:1 50 51 44 42 51 54 45 46 13 13 16 15 27 27 23 22 
18:2 5 6 7 7 9 8 9 12 17 16 20 24 41 43 50 55 
20:3 - - - - - - - - 6 6 4 3 1 1 T T 
20:4 T T T 1 T T T T 10 10 9 8 7 7 5 4 
J.H. 
male 
, 682 835 677 607 1.25 1.27 1.90 225 202 298 136 118 228 
A : 6 wks. tr. 16:0 25 24 60 33 23 24 26 28 31 31 30 31 11 11 9 9 
B : 3 mths. tr. 16:1 4 4 2 3 5 5 5 6 2 1 2 2 6 6 5 6 
18:0 13 15 21 17 3 4 6 5 15 16 15 15 1 2 1 1 
18:1 49 48 36 37 56 57 49 50 16 17 16 17 26 27 25 24 
18:2 7 6 7 8 9 8 11 10 18 19 24 23 44 42 51 51 
20:3 - - - - - - - 4 3 2 2 1 1 1 1 
20:4 1 2 3 1 2 1 2 2 13 13 10 9 10 10 8 7 
H.A. 
female 
770 910 588 627 1.01 1.02 1.20 1.85 236 220 n.e. 370 140 178 202 249 
A : 6 wks. tr. 16:0 24 25 29 28 26 24 26 25 25 27 33 31 12 12 12 9 
B : 3 mths. tr. 16:1 5 4 5 5 6 7 7 6 1 2 2 1 6 6 6 5 
18:0 f - 10 10 10 11 4 4 4 3 17 16 16 15 1 T 1 1 
18:1 47 48 45 44 48 50 50 44 17 17 16 13 21 23 24 19 
18:2 11 10 10 10 13 12 10 19 19 20 17 24 49 47 48 59 
20:3 - - - - - - - - 5 5 4 4 1 2 1 1 
20:4 2 2 1 1 2 2 2 2 15 14 11 11 9 9 8 6 
W.H. 
male 
1105 955 670 670 1.39 1.09 2.74 2.05 127 138 238 217 152 148 265 260 
A 3 8: 2 mths. tr. 16:0 28 28 29 29 28 28 30 30 36 36 34 34 11 12 13 11 
(Controlled 16:1 5 5 5 3 5 5 7 7 1 1 1 1 4 4 5 4 
metabolic 18:0 10 10 15 14 4 4 4 4 16 16 16 17 1 1 1 1 
conditions) 18:1 49 49 43 45 53 52 52 52 15 16 16 17 28 29 29 27 
18:2 8 8 7 7 10 10 8 8 16 15 18 18 45 43 45 44 
20:3 T T T T T T T T 4 5 3 3 1 T T 1 
20:4 T T T T T T T T 11 11 9 9 10 9 6 5 
Abbreviations: n.e. - not estimated 
T - trace amount 
The first position in the columns represents the concentration 
of total lipids in the serum: 
Total cholesterol concentrations in mg. /100 ml. 
Total phospholipid concentrations in mg. /100 ml. 
Total triglyceride concentrations in mmoles/1. 
Total free fatty acids in pEq /1. 
APPENDIX TABLE 4. 
Effect of treatment with antithyroid agents on the percentage composition of serum esterified 
fatty acids in 3 hyperthyroid women (age 20 - 30). 
(Expressed as percentage of total fatty acids in the fraction). 







Subjects short hand On On On On 
design. Untreated treatment Untreated treatment Untreated treatment Untreated treatment 
860 398 1.18 1.08 n.e. n.e. 172 197 
M.N. 16:0 27 27 30 25 11 7 
16:1 5 5 1 1 5 3 
5 weeks on 18 :0 7 5 17 15 1 1 
treatment 18:1 n.e. n.e. 49 44 15 14 22 19 
18:2 12 16 19 24 50 57 
20 :3 - - 3 2 T T 
20:4 2 2 15 18 12 12 
930 n.e. 1.15 1.89 n.e. n.e. 217 232 
N.L. 16:0 24 24 29 24 12 11 
16:1 4 5 1 1 5 5 
6 weeks on 18:0 3 4 18 16 1 1 
treatment 18:1 n.e. 51 48 17 16 24 23 
18:2 14 15 18 24 46 48 
20:3 - - 3 2 T T 
20:4 3 3 14 16 13 12 
1305 705 n.e. n.e. n.e. n.e. 136 217 
F.J. 16:0 25 23 13 
11 
16:1 1 1 4 
3 
7 weeks on 18:0 16 15 
1 1 
treatment 18:1 n.e. n.e. 16 15 
22 18 
18 :2 26 30 49 58 
20:3 3 2 - - 
20:4 13 13 
11 10 
Abbreviations: n.e. - not estimated 
T - trace amount 
The first position in the columns represents the concentration of 
total lipids in the serum: 
Total cholesterol concentration in mg. /100 ml. 
Total phospholipid concentrations in mg. /100 ml. 
Total triglyceride concentrations in mmoles /1. 
Total free fatty acids in pEq /1. 
fatty acid 






























APPENDIX TABLE 5. 
Longterm effects of daily administration of 8GN on the percentage cmpoeition of sense lipid fatty acids. 
(Measured 24 hours after each 8G8 injection). 
Pre- 
treatment 



















on- treatment dy, a 
1 2 3 4 3-5 
6vnd 
1 2 3 4 3-5 
andr 
1 2 3 4 3-5 
óvand 
454 448 678 487 459 393 369 598 2.25 1.46 2.44 2.18 n.e. 2.34 n.e. n.e. 
31 31 34 41 31 36 32 28 32 31 
12 It 8 6 12 2 2 1 1 2 
2 3 5 3 4 15 15 18 18 17 
45 47 45 46 42 19 16 17 20 18 
9 9 8 4 11 16 18 18 15 17 
- - - - - 2 4 4 3 4 
T T - T T 10 14 14 12 12 
479 523 684 553 479 338 367 688 1.34 0.90 0.70 0.84 1.44 1.80 
33 33 33 34 31 30 29 29 31 
8 8 8 6 7 2 2 2 2 
6 6 6 7 5 16 14 15 15 
43 43 42 42 47 19 17 16 15 
10 10 11 II 10 19 20 23 20 
- - 2 4 3 2 
T T T T T 12 13 13 14 
328 528 712 768 574 383 317 489 1.73 1.64 314 2.60 2.77 1.96 1.56 295 273 266 262 272 372 
34 33 36 35 36 34 33 39 37 36 39 37 33 35 
6 6 5 5 5 5 5 1 2 2 2 2 2 2 
2 2 4 3 3 2 2 14 14 11 13 13 14 14 
48 49 46 46 46 50 51 17 15 14 14 13 16 16 
9 9 9 9 9 8 9 17 18 22 20 21 21 20 
- - - -- - - 2 2 3 2 3 2 2 
1 T T 1 1 1 T 10 11 11 10 11 12 11 
541 763 812 655 710 687 610 695 1.37 1.56 1.8 2.20 L77 2.17 2.22 1.89 320 215 156 197 250 270 
Mean from Mean from 
2 days 2 days 
26 30 27 30 30 28 26 33 31 36 33 33 33 31 
9 8 7 7 6 7 9 2 2 1 1 1 2 2 
3 3 5 4 4 4 3 16 14 16 16 15 17 16 
52 50 50 49 49 49 51 18 19 16 16 19 18 21 
8 8 10 10 9 10 10 17 19 16 18 17 17 16 
- - - 4 4 5 5 4 4 4 
1 1 1 1 2 2 2 10 11 10 11 10 9 10 
Abbreviations: n.e. - not estimated 
T - trace mount 



















































198 180 170 152 
12 14 17 13 
6 7 6 7 
1 2 3 3 
24 24 34 24 
51 47 37 47 
T 
6 6 3 6 
222 236 232 212 210 208 195 
12 11 15 16 14 11 11 
6 5 6 6 6 6 5 
T T T 1 1 1 T 
23 24 31 29 24 21 24 
50 50 40 40 48 54 51 
2 2 2 2 2 T T 
9 9 7 8 8 8 9 
304 267 282 320 330 
Mean from 
2 days 
11 12 12 10 10 11 10 
8 9 8 7 8 8 8 
1 2 1 2 2 2 1 
28 29 27 29 27 26 25 
43 42 44 44 47 46 47 
- - - 
9 7 9 8 8 9 9 
The first position in the columns represents the concentration of total lipids in 
the serum: Total cholesterol concentrations in mg. /100 ml. 
Total phospholipid concentrations in mg. /I00 ml. 
Total triglyceride concentrations in ®oies /1. 
Total free fatty acids pEq /l. 
APPENDIX TABLE 6a. 
Short -term effects of NCH injection associated with fasting on percentage composition of germs lipid fatty acide. 
(Expressed as percentage of total fatty acids in the fraction). 
The short -term effects of HCH were measured 4 and 8 hours after the first HGH injection. 
Free fatty acids Triglyceride fatty acids 
Fatty acid. 





Phoepholipid fatty acids Cholesteryl fatty acids 
8 a.m. 12 noon 4 p.m. Next 8 a.a. 12 noon 4 p.m. Next 





v a C 
. . 
,tó&:;24-4. " á 'w " °41' 
e 
ÉW 
u ti ú.. a ti Ó aD "C 
523 629 463 1053 755 1305 880 
16:0 27 28 31 27 24 20 27 
16:1 3 2 3 5 4 4 5 
18:0 25 29 24 18 17 15 19 
18:1 33 29 33 42 45 52 41 
18:2 12 12 10 8 10 9 7 
20:3 T T T T T T T 
20:4 T T T T T T T 
950 1040 1026 1350 960 1748 960 
16:0 27 30 26 20 26 16 28 
16:1 4 4 6 4 4 4 4 
18:0 18 16 13 15 16 13 14 
18:1 44 43 48 55 46 58 47 
18:2 8 7 8 7 9 9 7 
20:3 T T T T T T T 
20:4 T T T T T T T 
700 564 600 710 700 1340 608 
16:0 25 28 32 28 37 26 32 
16:1 5 5 3 4 5 3 5 
18:0 23 18 14 13 11 12 16 
18:1 47 44 43 47 41 55 42 
18:2 6 5 6 6 4 5 6 
20:3 T T T T I T T 
20:4 T T T I T T T 
Abbreviations: T - trace amount 
Day of experiment. 
1.48 1.53 1.07 1.30 1.35 1.69 1.34 314 310 282 220 290 290 266 271 272 257 290 237 279 268 
33 33 32 32 29 29 33 28 28 27 31 29 28 34 12 11 12 11 8 11 11 
7 6 7 8 6 8 6 1 1 1 1 1 1 1 5 6 6 6 4 5 6 
5 5 4 5 4 5 6 15 16 18 18 18 18 15 1 1 1 1 1 1 1 
45 45 47 48 49 49 47 22 22 22 22 23 22 19 30 30 31 31 32 34 31 
9 10 10 9 12 10 9 19 19 16 17 15 16 19 43 44 45 41 46 39 41 
T T T T T T T 3 2 5 2 3 2 2 T 1 T T T T T 
T T T T T T T 12 12 11 10 12 13 10 7 7 6 6 8 9 7 
0.96 1.62 0.85 1.30 1.44 1.84 1.50 250 275 238 220 244 275 224 170 163 184 176 158 189 163 
29 29 29 27 27 32 30 33 30 35 38 29 32 33 13 13 11 10 12 11 12 
6 6 6 6 6 6 6 1 1 1 1 1 1 1 8 7 5 6 7 6 6 
4 3 3 5 4 3 4 14 15 13 14 12 15 13 1 1 1 1 1 2 1 
53 52 52 52 52 50 51 21 21 17 20 17 20 19 30 30 30 31 31 32 33 
9 9 10 11 10 9 10 19 15 18 15 19 17 19 43 42 44 40 42 44 40 
I T T T T I T 1 3 4 3 4 3 3 T T T 2 1 T T 
T T T T T T T 11 13 12 9 10 11 13 6 7 9 11 8 6 8 
2.61 2.43 2.51 1.95 2.50 1.85 1.85 213 223 192 157 175 200 186 157 164 150 159 163 163 191 
33 35 37 34 32 33 36 30 30 36 42 37 36 38 14 13 14 16 14 15 15 
7 10 7 9 7 8 7 1 1 2 2 3 2 1 9 8 9 7 8 9 12 
5 5 3 4 5 2 5 18 18 17 16 17 18 19 1 1 1 1 1 1 1 
48 44 51 47 49 50 46 22 22 22 18 20 19 18 35 34 36 34 35 34 34 
7 5 3 6 7 6 7 13 13 11 11 10 11 15 35 36 36 36 42 33 32 
I T T I T T T 2 3 2 3 3 3 3 T T T T T T T 
T T T T T T T 13 12 10 11 11 11 10 6 8 6 6 6 8 7 
The first position in the columns represents the c 
o 
n entratine of total lipids 
in the serum: Total cholesterol concentrations inmg. /100 ml. 
Total phospholipid concentrations in mg. /100 ml. 
Total triglyceride concentrations In stoles /1. 
Total free fatty acid concentration in IEq /1. 
APPENDIS TABLE 6b, 
The loot -tari affects of WE inlectiona on the percentage composition of ...um lipid fatty acids. 
(Eip d as percentage of total fatty acids in the fraction) 
The long -term effect. were measured 24 hour. after each of the two NOB injections. 
Fatty acid 
Free fatty acids Triglyceride fatty acids Phospholipid fatty acids Choleeteryl fatty acid 
Subject short hand Pre- On After last Pro- On After last Pre- On After last Pre- On After lest 
design. treatment treatment injection treatment treatment injection treatment treatment injection treatment treatment injection 
days days day. days days days days days 
1 2 2 1 2 2 1 2 2 1 2 2 
522 629 880 495 425 1.48 1.53 1.34 1.35 1.16 314 310 266 196 290 271 272 268 288 282 
B.O. 16:0 27 28 27 31 31 33 33 33 30 30 28 28 34 27 28 12 11 13 11 13 
male age 16:1 3 2 5 4 2 7 6 6 6 6 1 1 1 1 1 5 6 6 5 5 
45 18:0 25 29 19 18 24 5 5 6 5 7 15 16 15 16 17 1 1 1 1 1 
18:1 33 29 41 41 35 45 45 47 48 47 22 22 19 19 21 30 30 31 36 29 
18:2 12 12 7 6 8 9 10 9 10 10 19 19 19 20 20 43 44 41 40 43 
20:3 T T 2 T T 2 2 2 2 T 3 2 2 4 2 T 1 T T T 
20:4 T T T T T T T T T T 12 12 10 13 9 7 7 7 6 7 
950 1040 960 830 810 0.96 1.62 1.50 1.26 1.64 250 275 224 146 201 170 163 190 195 193 
8.1.. 16:0 27 30 28 28 26 29 29 30 31 31 33 30 33 35 31 13 13 12 13 14 
male age 16:1 4 4 4 5 5 6 6 6 5 5 1 1 1 1 1 8 7 6 6 6 
65 18:0 18 16 14 12 13 4 3 4 3 4 14 15 13 13 14 1 1 1 1 1 
18:1 44 43 47 50 48 53 52 51 50 50 21 21 19 17 18 30 30 33 31 30 
18:2 8 7 7 5 7 9 9 10 10 10 19 17 19 19 19 43 42 40 42 42 
20:3 T T T T T T T T T 2 3 3 3 4 2 2 2 2 T 
20:4 2 2 2 2 T 2 2 2 2 T 11 13 13 12 12 6 7 8 7 7 
700 564 600 628 300 2.61 2.43 1.85 1.95 1.85 213 223 186 160 220 157 164 191 206 175 
A.B. 16:0 25 28 32 32 37 33 35 36 34 33 30 30 38 28 35 14 13 15 17 14 
male age 16:1 5 5 5 4 8 7 10 7 10 8 1 1 1 1 1 9 8 12 7 6 
48 18:0 23 18 16 16 15 5 5 5 4 3 18 18 19 16 16 1 1 1 1 1 
18:1 47 44 42 43 34 48 44 46 47 50 22 22 18 22 17 35 34 34 34 31 
18:2 6 5 6 4 5 7 5 7 6 6 15 15 15 19 17 35 36 32 34 41 
20:3 T T T T T T T T T T 2 3 3 3 3 2 2 2 2 T 
20:4 MT T T T T T T T 13 12 10 12 11 6 8 7 6 7 
Abbreviations: T - trau amount The first position in the columns represent. the concentration of total lipide 
in the cerna: Total cholesterol concentrations in mg. /100 ml. 
Total phoepholipid concentrations in mg. /100 al. 
Total triglyceride concentrations in mmolee /1. 
Total free fatty acids in )Eq /1. 
APPENDIX TABLE 7. 
The percentage composition of serum lipid fatty acide in acromegalic and normal women (age 50 -60). 




Free fatty acide 
subjects Acromegaly 
Triglyceride fatty acide 
Normal subjects Acromegaly 
Phoepholipid fatty acids 





590 555 655 680 354 210 600 1.32 2.38 1.09 1.93 1.60 1.98 1.93 250 270 n.e. n.e. 266 321 238 248 246 250 235 186 
16:0 26 22 29 28 32 23 28 33 30 31 27 34 36 36 33 29 29 32 32 32 33 13 12 13 9 12 12 12 
16:1 4 4 5 5 4 2 3 5 8 6 4 5 5 6 1 1 2 2 1 1 1 6 8 6 4 5 5 8 
18:0 15 18 17 11 20 28 23 3 3 6 2 5 7 6 16 17 17 17 14 18 16 T 1 1 1 1 1 1 
18:1 44 48 42 43 33 37 39 48 47 49 43 43 44 45 15 18 20 11 15 17 21 24 26 26 15 20 26 30 
18:2 9 8 7 13 10 11 7 10 10 7 24 12 9 7 18 20 22 26 25 21 19 48 46 47 62 57 49 45 
20:3 - - - - - - - - - - 3 4 1 2 2 2 1 - - - - - - - 








47 42 53 55 55 37 39 42 16 19 23 13 16 18 22 30 34 32 19 25 31 38 
The statistically significant differences from these data are presented in Tables 15, 17, 19 and 21. 
Abbreviations: n.e. - not estimated The first position is the columns represente the concentration of total lipids in the 
serum: Total cholesterol concentrations in mg. /100ml. 
Total phoapholipid concentrations in mg. /100 ml. 
Total triglyceride concentrations in mmoles /1. 
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APPENDIS TABLE 9. 
Effects of prolongation of overnight feet by 8 hours on the percentage composition of serum Itpid fatty acids. 
(Expressed as percentage of total fatty acids in the fraction) 
Fatty acid 
S U B J E C i 5 Dean of 12 
short hand A 8 C D I F C H I J I L ubjecta 
design. TT Flt F F F F F F F F F F F F FF r FF 17---1- 17---P- F1 F2 
1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 
625 670 1218 1409 400 855 655 810 530 640 520 770 523 755 950 960 700 700 655 1010 680 1380 330 1210 
Free fatty 16:0 27 28 23 22 26 27 32 32 26 28 14 15 27 24 27 26 25 37 32 28 28 27 9 23 25 26 
acida 16:1 5 6 5 5 5 5 8 9 5 6 2 2 3 4 4 4 5 5 7 5 5 4 1 3 5 5 
18:0 19 12 13 11 13 11 12 10 14 14 22 17 25 17 18 16 23 11 14 13 11 15 31 15 18 14 
18:1 39 45 49 53 45 46 45 45 38 42 52 55 33 45 44 46 47 41 35 41 43 44 48 49 43 46 
18:2 10 10 11 9 11 11 6 6 12 8 11 11 12 10 8 9 6 4 9 9 14 11 13 9 11 9 
1.50 n.e. 1.90 1.70 1.31 n.e. 1.40 n.e. 1.30 n.e. 1.58 2.20 1.48 1.35 0.901.44 2.61 2.60 0.99 0.58 1.07 1.79 1.38 0.77 
Triglycertde 16:0 29 31 24 26 28 27 32 32 34 28 31 28 33 29 29 27 33 32 29 34 31 31 24 28 29 29 
fatty acids 16:1 5 5 7 7 6 4 8 9 4 3 6 4 7 6 6 6 7 7 6 
4 7 6 5 4 7 5 
18:0 4 3 3 2 3 3 4 2 6 5 5 4 5 4 4 4 5 5 4 2 4 2 5 4 4 3 
18:1 50 52 52 52 50 47 48 50 39 47 45 48 55 49 53 52 48 49 45 44 43 45 58 51 48 49 
18:2 11 14 13 13 14 16 8 8 17 17 16 15 9 12 9 10 7 7 16 10 15 14 9 14 11 12 
322 404 412 n.e. n.e. 337 335 314 290 250 244 213 175 n.e. n.e. 337 324 256 
Fhospbollpid 16:0 26 30 32 38 39 39 29 28 34 32 29 34 28 29 33 29 30 37 29 34 33 35 18 28 
30 33 
fatty acids 16:1 1 2 2 2 1 1 3 2 2 1 2 2 1 1 1 1 1 1 
1 1 1 1 1 1 1 1 
18:0 16 16 16 15 14 14 14 15 16 16 16 14 15 18 14 12 18 17 13 15 16 17 
18 16 16 15 
18:1 20 18 16 16 13 12 19 19 14 15 14 14 22 23 21 17 22 20 13 14 12 11 18 
16 17 16 
18:2 24 21 23 19 16 17 20 21 23 20 26 23 19 15 19 19 15 10 29 25 24 
21 26 23 22 19 
20:3 2 2 2 2 3 2 1 4 2 2 2 2 3 3 1 4 2 3 2 
2 3 3 3 3 2 3 
20:4 11 11 8 7 13 15 10 9 10 12 12 II 12 12 11 10 13 11 19 10 
II ll 13 14 11 11 
445 440 260 259 250 293 258 279 271 237 170 158 157 163 292 250 246 246 
184 185 
Cboluteryl 16:0 9 10 12 11 12 13 11 11 16 14 8 11 12 8 13 12 14 14 8 10 II 10 
11 12 11 11 
16:1 3 4 5 6 5 4 3 2 3 3 3 3 5 4 8 7 9 8 
3 4 3 3 3 4 4 5 
1 8 : 0 2 1 1 1 T 1 2 2 1 1 1 1 1 1 l 
1 I 1 T T 1 1 1 1 1 1 
18:1 23 22 22 20 26 25 24 26 25 25 25 25 30 32 30 31 35 35 
17 17 17 18 26 26 25 25 
18:2 56 55 56 56 48 45 43 43 48 49 52 52 43 46 43 42 35 42 
65 65 63 62 52 52 50 50 
20:4 6 9 4 5 9 12 6 8 7 7 7 8 7 8 6 8 
6 6 6 4 5 6 7 5 6 7 
Abbreviations: F1 - 15 hours of fasting (overnight fast) 
F2 - 23 hours of fasting 
n.a. - not estimated 
- trau amount 
Subjects I-F: Ischeamic heart disease, age 38 -50 
Subject. C-I: Convalescence after renal colic, age 45 -65 
Subjects J -L: Healthy, age 27 -50. 
The first poaitiun represents the concentration of total lipids in the serum: 
Total cholesterol concentration. in mg. /100 ml. 
Total phosphal i pid concentrations in mg. /100 ml. 
Total triglyceride concentrations a in moles /1. 
Total free fatty acida in 7IDq /1. 
The statistically significant changes are presented in Tables 14, 16, 18 and 20. 
APPENDIX TABLE 10. 
Effects of acute myocardial infarction on the percentage composition of serum lipid fatty acids 
(Expressed as percentage of total fatty acid. in the fraction). 
Subjects Fatty acid 
Free fatty acids Triglyceride fatty acids Phospholipid fatty acid. Chole.taryl fatty acids 



































(cerebral vascular episode 
with haemiplegia between the 











Isehamaic chest pain 
No M.I. 
Survived. 
1040 960 860 0.97 0.88 1.40 230 247 n.e. 250 229 n.e. 
16:0 31 26 28 31 30 29 29 32 36 11 12 12 
16:1 5 8 7 7 5 7 2 1 2 5 4 2 
18:0 13 15 15 3 4 6 16 14 15 T T 1 
18:1 44 49 44 47 47 47 15 14 14 19 21 22 
18:2 7 7 7 11 13 11 22 24 20 60 55 57 
20:3 - - - - - 3 3 3 - - - 
20:4 - - - - 13 12 11 6 8 6 
1210 915 850 n.e. 0.54 443 480 n.e. n.e. 258 n.e. 
16:0 30 29 25 35 31 32 39 40 37 11 10 14 
16:1 3 6 4 4 7 6 2 3 2 6 5 6 
18:0 13 11 14 3 2 2 13 12 13 T 1 1 
18:1 44 45 44 43 45 48 16 16 16 22 20 31 
18:2 8 7 7 11 13 10 16 16 16 51 49 44 
20:3 - - - - - 1 2 1 - - - 
20:4 - - - - - 15 16 15 10 16 15 
766 592 n.e. n.e. 1.35 1.52 n.e 289 214 217 207 
16:0 26 24 29 27 27 25 38 36 37 11 12 12 
16:1 6 4 3 7 5 5 1 1 2 5 5 5 
18:0 13 13 11 3 4 3 14 15 15 T 1 1 
18:1 48 52 50 51 53 53 16 15 14 29 27 28 
18:2 7 7 6 11 12 13 19 18 18 50 51 48 
20:3 - - - - - - 2 3 3 - - - 
20:4 - - - - - - 9 11 11 5 5 4 
854 780 1.38 1.76 n.e. 65 185 199 n.e. 
16:0 27 28 32 32 43 40 11 12 
16:1 4 2 6 6 2 1 6 6 
18:0 15 12 3 4 13 15 1 1 
18:1 48 46 50 47 17 18 29 33 
18:2 7 9 8 12 17 18 46 46 
20:3 - - - 1 1 - - 
20:4 - - 7 8 6 2 
1242 800 2.00 1.42 n.e, n.e. 215 209 
16:0 24 21 27 29 31 36 10 
16:1 4 3 5 5 2 2 5 5 
18:0 14 15 3 7 15 13 T T 
18:1 49 52 54 52 19 18 26 
28 
18:2 10 9 11 9 20 20 51 
48 
20:3 - - - - 2 2 - 
T 
20:4 - - - 11 9 7 
6 
1.58 2.03 212 .. 197 169 n.e, 
16:0 30 31 29 30 34 37 37 
12 11 11 
16:1 5 5 7 9 7 1 2 5 
6 4 
18:0 12 12 5 3 7 16 15 
1 1 1 
18:1 45 42 48 51 45 16 18 
24 29 29 
18:2 8 10 12 8 8 20 17 51 
45 48 
20:3 - - - - 2 2 - - - 
20:4 - - - 9 9 7 
8 7 
704 746 552 0.97 1.40 1.24 n.e, 290 257 
250 
16:0 22 29 24 26 33 29 23 34 28 11 
1: 
16:1 5 5 '5 5 7 5 1 1 1 5 
5 6 
18:0 14 11 15 3 3 3 21 16 15 
2 1 T 
18:1 54 47 49 49 51 50 20 20 23 30 
31 30 
18:2 6 8 6 17 7 12 21 17 23 
44 45 43 
20:3 - - - - 3 2 3 - - 
- 
20:4 - - - - 12 9 8 
8 5 6 
684 832 908 1.58 n.e. 47 n.e 154 
16:0 23 31 28 - 29 32 16 37 38 41 
13 12 12 
16:1 4 3 5 8 6 5 1 1 
1 6 6 5 
18:0 11 13 12 4 3 2 17 16 16 
1 1 1 
18:1 50 44 48 49 49 40 16 15 15 
30 27 31 
18:2 11 10 8 11 11 32 19 18 16 
43 47 45 
20:3 - - - - - 3 3 1 - 1 - 
20:4 - - - - - 5 8 9 9 7 
7 7 
2150 832 642 n,e. 2.01 2.27 197 198 264 
273 
16:0 27 22 25 29 26 27 34 30 30 12 
14 11 
16:1 6 6 7 8 6 8 1 2 2 
8 8 7 
18:0 7 12 6 3 4 5 19 15 17 
1 1 1 
18:1 54 56 56 51 52 55 16 19 
23 30 29 30 
18:2 6 7 6 8 11 12 18 19 18 
45 42 46 
20:3 - - - - - - 3 4 
3 - - - 




. - not estimated 
T - trace amount 
The first position in the columns represents the concentration 
of 
total lipide in the serum: 
Total cholesterol concentrations in mg. /100 ml. 
Total phoepholipid concentrations in mg. /100 ml. 
Total triglycerida concentrations in mnoles /1. 
Total free fatty acids )Eiq. /1. 
Appendix Fig. 1 The Correlation between changes in concentration of 
serum FFA and changes in percentage of FFA 
oleic and palmitic acids in response to treatment 
with thyroid hormones and antithyroid therapy 
Hypothyroid subjects treated with thyroid 
hormones 
Hyperthyroid subjects treated with . 
antithyroid therapy 
THYROID HORMONE ACTIVITY 
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Appendix Fig. 2 The correlation between changes in concentration 
of serum FFA and changes in percentage of 
FFA oleic and stearic acids in response to 
prolongation of overnight fast by 8 hours 
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Appendix Fig. 3 The correlation between changes in concentration 
of serum FFA and changes in percentage of FFA 
oleic and palmitic acids observed between the first 
and the second day after myocardial infarction 
o Patients severely ill 
(one died on the third day and the second 
developed a cerebral vascular episode 
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Many colour reactions for the determination of cholesterol have been described. 
Since a number of serum constituents, such as proteins, pigments etc. form coloured 
complexes with the reagents employed, methods in which cholesterol is isolated before 
estimation are the more desirable 1, 2. The classic Liebermann -Burchard reaction has 
several disadvantages, as the reaction is sensitive to light, dependent on temperature, 
and the resulting colour changes from minute to minute 3, 4. ZLATKIS et al.fi used 
ferric chloride in glacial acetic acid and concentrated sulphuric acid. TRINDER ° 
has found that different organic halides mixed with sulphuric acid give reddish 
colours with cholesterol and devised a method based upon the reaction between 
a mixture of acetyl chloride, concentrated sulphuric acid and solution of chole- 
sterol in ethylene dichloride. Recently SEARCY AND BERGQUIST ° described a CO- 
lorimetric method for the estimation of serum cholesterol based on the observation 
that a saturated solution of ferrous sulphate in glacial acetic acid and concentrated 
sulphuric acid develops an orange colour if added to an acetone -alcohol solution of 
cholesterol. 
This paper describes a method for the quantitation of total serum cholesterol 
using the extraction technique of ABELL et al.8 as modified by ANDERSON AND KEYS9 
and a colour development based on the reaction between an alcoholic solution of 
cholesterol and a mixture of glacial acetic acid and concentrated sulphuric acid. 
MATERIALS AND METHOD 
Reagents 
(i) Absolute alcohol, redistilled. (2) Glacial acetic acid, redistilled. (3) Concen- 
trated sulphuric acid, analytical reagent grade (B.D.H.). (4) Potassium hydroxide 
solution 33% (w /w), i.e. ro g of potassium hydroxide analytical reagent grade dis- 
solved in 20 ml of water. (5) Alcoholic potassium hydroxide solution made imme- 
diately before use by adding 6 ml of 33% KOH to 94 ml of absolute alcohol. (6) 
Petroleum ether b.p. 40_60 °, redistilled. (7) Standard cholesterol solution containing 
120 mg cholesterol (recrystallised once from glacial acetic acid, three times from 
absolute alcohol and dried to constant weight) in Zoo ml of absolute alcohol. This 
standard, containing 480 Fug /o.4 ml, is diluted with absolute alcohol to give 120 tug 
and 240 ,ug /o.4 ml. (8) Colour reagent : r vol. of concentrated sulphuric acid is added 
to 4 vols. of redistilled glacial acetic acid. The mixture is shaken and used after 
reaching room temperature. The reagent can be kept for 2 -3 days. 
Procedure 
Into a 15 -ml glass- stoppered tube containing 2 ml of freshly prepared alcoholic 
potassium hydroxide o.ZO ml of serum is carefully pipetted. After incubation at 
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37 -40° for 90 min and addition of 2 ml of water, the mixture is extracted twice with 
4 ml of freshly redistilled petroleum ether by shaking for 6o sec. Centrifugation for 
3 min at 1500 rev. /min helps separation of phases. The organic phase is transferred 
by Pasteur pipette into another dry glass- stoppered tube and the pipette is rinsed 
with a little petroleum ether, the washings being added to the organic phase. (The 
above extraction technique is identical with that used by ANDERSON AND KEYS9). The 
petroleum ether is evaporated at 60° in a vacuum with an air leak. The residue is 
placed in an air oven at 75 ± 1° for 3 min, removed and when slightly warm 0.4 ml 
of absolute alcohol is added to each tube. With each batch of determinations a 
blank with 0.4 ml of absolute alcohol and a series of 0.4 ml of alcoholic solutions 
containing 120, 24o and 480 ,ug of cholesterol are prepared in duplicate. 5 ml of the 
acetic sulphuric mixture is added to each tube. The tubes are stoppered and are 
immediately mixed by gently inverting a few times. The stoppered tubes are now 
incubated for 20 min at 75 ± 1 °. After cooling the tubes to room temperature, the 
optical density is read at 500 my. The colour is stable for 3 -4 h after incubation. The 
results are read off a graph constructed by plotting optical densities against cholesterol 
concentration of standards. 
RESULTS AND DISCUSSION 
The absorption spectrum 
The characteristic absorption spectrum obtained when using the finally adopted 
method shows a minor peak in the region of 385 -415 m,u, shallow at low concentra- 
tions of cholesterol, and a main peak at 500 mu. 
The effect of acetic acid and sulphuric acid proportions on the optical densities of standard 
solutions 
Standards containing 120, 240, 480 ,ug of cholesterol at 0.4 ml of absolute alcohol 
were mixed with 5 ml of colour reagent containing acetic acid and sulphuric acid in 
varying proportions. The absorption spectra show that with an increase in the pro- 
portion of acetic acid, there is a decrease in the optical density in the 385-415 region 
and a shift of the absorption maximum from 410 to 385 rnu associated with an in- 
crease in the extinction at 500 my, the colour being changed from yellow to red. 
Curves of optical density at 50o my plotted against concentration show that the 
optimal linearity is achieved with 4 : i (v/ v) acetic to sulphuric acid, Beer's law 
being obeyed within the range of concentration used. 
Influence of the nature of the solvent employed 
If dried cholesterol is treated with the colour reagent alone, the resulting mixture 
shows varying degrees of turbidity. After centrifugation, however, the clear super- 
natant shows absorption spectrum maxima at 500 my and 395 m,u. Formation 
of the orange -red colour occurs in the absence of any solvent, but to obtain a turbidity - 
free solution such as is necessary for spectrophotometry requires use of a solvent 
prior to addition of colour reagent. 
When cholesterol standards were dissolved in 0.4, 0.7, 1.0 ml of ethanol it was 
found that at 500 mu optimum linearity of the optical density /concentration curve 
was obtained when 0.4 ml of ethanol was used. 
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When, however, acetone -alcohol (i : i) was used as the solvent for the standards, 
the curve of optical density at 500 mu against concentration showed no such linearity. 
Effect of temperature and mixing procedure on colour development 
If a standard cholesterol solution is mixed with acetic acid followed by sulphuric 
acid, the mixing is accompanied by evolution of heat and the colour development is 
complete in about i5 min. If the colour reagent is mixed prior to adding it to the 
standard, the colour develops slowly, but on incubation at 75° for 20 min the colour 
develops fully and remains constant at room temperature for about 4 h. The character 
of the absorption spectrum is the same whichever technique is used, and the ultimate 
optical density is very similar. 
Optimal reproducibility was obtained by allowing the colour reagent to run 
down the side of the test tube and mixing it with the standard solution by gentle 
shaking. 
Effect of ferric and ferrous salts on the colour development 
Other authors have included ferricb or ferrous' salts in the colour reagent to 
enhance the development of colour. While investigating the present method, analytical 
grade reagents were used for preparation of colour reagent, without addition of either 
ferric or ferrous salts. Some characteristics of the absorption spectra and its changes 
under various conditions suggested that the presence of catalytic quantities of iron 
ordinarily present as impurity (up to ioo ,ug /Zoo ml) even in the analytical grade of 
sulphuric acid may be required for the colour development. 
Ferric salts: The influence of ferric iron in the colour formation was tested by 
using very dilute solutions of varying concentration of ferric ions (added as chloride) 
in redistilled glacial acetic acid. These solutions were used in the preparation of the 
colour reagent. Then 0.4 -ml portions of alcoholic solutions of cholesterol containing 
120, 240 and 480 ,ug of cholesterol were mixed with the colour reagent, incubated 
and the spectra of all samples were noted. Fig. i shows the results with 120 ,ug of 
cholesterol. The optical densities of standards at 500 mu increase slightly with in- 
creasing concentration of Fea+ in the colour reagent. However, there is a critical 
concentration in relation to the concentration of cholesterol. When. this is exceeded, 
there is a decrease in optical density at 50o m,u and the character of the absorption 
spectrum changes. The curve relating optical density at 500 mu to cholesterol con- 
centration is non -linear at the higher concentrations of Fea +. 
Ferrous sulphate: If colour is developed with a reagent incorporating acetic acid 
that has been saturated with ferrous sulphate, different results are obtained by using 
varying amounts of ferrous sulphate for saturation (Fig. 2). When 0.2, 0.5 and 1.0 g 
of ferrous sulphate are used for saturation of Zoo ml of glacial acetic acid the absorp- 
tion spectra show a close similarity to those obtained with low concentrations of 
ferric chloride. 
In all cases the optical density at 500 m, i was greater than in the absence of 
added ferrous sulphate; there appeared to be an optimum in this respect amount 
since the optical density was actually less when Z g FeSO4 was used than when only 
0.5 or o.2 g was used for saturation. However, the range linearity of the response 
was greatest in the absence of added ferrous sulphate. 
If ferrous sulphate were the substance which is responsible for colour develop- 
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ment, the character and degree of colour should be the same regardless of the quantity 
of ferrous sulphate used for saturation. It is, therefore, likely that the presence of 
other substances than ferrous sulphate, probably ferric impurities, is mainly re- 
sponsible for the increase of the extinction at 50o mu. This point was proved by the 
following experiment. 
ioo 
400 450 500 550 mp. 
Fig. r. Absorption spectra obtained by varying the concentration of ferric chloride in the glacial 
acetic acid in the reaction with 120 pg of cholesterol. The colour reagent with pure acetic acid 
(O - --p), with acetic acid containing 0.5 pg Fes+ /ml (0 - ), r pg Fe3 + /ml (x -x ), z pg 
Fes + /m1 (A - p), 5 µg Fe3 + /m1 (A- A). 
300 
jy/ -./ /µj / í \i\".\o 
>lx/ / C' o \ \ 
ó 
100L-0--*  
.o___o___o___o, í o  o__y 
t t 
400 450 500 550 rn)a. 
Fig. 2. Effect of saturation over different amounts of ferrous sulphate. Spectra of rzo pg of 
cholesterol with pure acetic acid (O - --0), with acetic acid saturated with ferrous sulphate 
using o.z giroo ml (S -e), 0.5 giroo ml (x -x) and r g /roo ml (A- A). 
One and the same sample (0.2 g) of ferrous sulphate was used consecutively for 
saturation of three separate 50 -ml aliquots of acetic acid. The saturation was accom- 
plished by shaking the mixture for 15 min under nitrogen to avoid presence of air. 
After centrifugation the three supernatant aliquots were used for preparation of the 
colour reagent. The spectra showed that the optical density at 500 mu using the 
first aliquot was higher than that using the second aliquot (Fig. 3). This is probably 
due to a higher concentration of ferric or other impurities in the aliquot used for the 
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first "washing" than for the second. The more soluble ferric salts, which are present 
as impurities in the ferrous sulphate salt were probably largely removed with the 
first portion of acetic acid. The third aliquot showed a slightly lower extinction at 
50o mu, the diminution being less than that between the first and second, but the 
extinction was still higher than with a colour reagent to which no ferrous sulphate had 
been added. This can be explained by supposing that the active impurity re -forms 
every time during the procedure of saturation, or that the ferrous iron present in the 
solution of glacial acetic acid in traces (ferrous sulphate is practically insoluble in 
glacial acetic acid) is oxidised during the reaction with acetic and sulphuric acid. 
700 
600 f°/ // 
o ,i /'\` 500 / / " % /f 
,ú 400 °/ /" ° /;/ 
á /- .ó O ó ,*/,..... i 300- ___, 
200 
100 450 500 550 mµ 
Fig. 3. Consecutive saturation of three 50-ml aliquots of glacial acetic acid with the same o.2 g 
FeSO4 and the effect of aeration. Spectra of 24o l,tg of cholesterol. The colour reagent contains pure 
acetic acid (O - --0); acetic acid used as first aliquot (first "washing ") (A- A); as second 
"washing" (X - X) ; as third "washing" ( - ) ; as "washing" of the aerated sample (A -A), 
To show how the presence of oxygen changes the property of ferrous sulphate 
used for the preparation of the colour reagent, 0.2 g of ferrous sulphate was washed 
with 5o ml of glacial acetic acid, centrifuged and the supernatant used as the "first 
washing ". A stream of oxygen was then blown into the washed ferrous sulphate for 
2 h. A fresh 50-ml aliquot of acetic acid was saturated with this ferrous sulphate and 
used for preparation of a colour reagent. This gave colour showing optical density 
slightly higher than the first washing (Fig. 3). This would also suggest that the increase 
of the colour reaction is due to presence of iron in the ferric state. 
Evaluation of the finally adopted method 
Reproducibility: On determining ro times the cholesterol content of 3 separate 
serum samples the results were as follows : 
TABLE I 
Mean Standard Coefficient 
(mg /zoo ml) deviation of variation 
Serum I 211 
Serum II 239 
Serum III 332 
± 2.9 1.42 
± 4.25 1.68 
± 4.65 1.5 
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Recoveries: Varying amounts of cholesterol standard solution in alcohol were 
added to 2 ml of alcoholic potassium hydroxide solution prior to adding o.i ml of 
serum, and the percentage recovery was determined. The results are given in Table II. 
TABLE II 












180 485 180 loo 
240 537 232 97 
Normal range 
52 normal sera were analysed with the present method. The average cholesterol 
concentration was 183 mg /loo ml of serum. The normal range calculated on the basis 
of ± 2 S.D. was found to be 115 -251 mg %. 
Comparison of results 
92 blood samples from normal and atherosclerotic patients were analysed using 
the ANDERSON AND KEYS extraction technique. The colour was developed by the 
reaction by the present procedure. 5o of the same 
samples were analysed by the method of SPERRY AND WEBB10. The results can be 
seen in Fig. 4a and b. No significant differences have been found between the results 



























100 200 300 400 t01Ó0 200 300 400 Present method Present method 
Fig. 4. (a)' Comparison between the results obtained by the method of ANDERSON AND KEYS 
and the present method. (b) Comparison between the results obtained by the method of SPERRY 
AND WEBB and the present method. 
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SUMMARY 
A colorimetric method for serum cholesterol estimation has been described. 
The extraction method of ABELL et al., as modified by ANDERSON AND KEYS, was 
adopted and the extracted cholesterol was determined by the colour reaction with 
mixture of acetic and sulphuric acids. The advantages of the method are: (Z) The 
stability of the optical density over a period of hours, (2) the stability of the reagent 
for 2 or 3 days, (3) the high degree of reproducibility of the results, and (4) the con- 
cordance with the method of ANDERSON AND KEYS using the colour reagent of Lie - 
bermann- Burchard and with that of SPERRY AND WEBB. 
A colour reaction obtained by the addition of colour reagent containing acetic 
acid and sulphuric acid to cholesterol and to cholesterol solutions has been studied, 
and the effect of ferric and ferrous iron on the colour formation was investigated. It 
was concluded that Fe3} in trace amounts was responsible for the efficacy of the 
colour reagent and that B.D.H. sulphuric acid (Analytical Grade) contained a suit- 
able concentration. 
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INTRODUCTION 
Ethyl -a -p- chlorophenoxyisobutyrate (CPIB) has been shown to lower serum chol- 
esterol and serum triglyceridesl, to reduce the Sf 0 -20 group of low- density lipo- 
proteins2 and serum free fatty acids3 and also, insofar as it is almost certainly the active 
component of Atromid (CPIB in combination with androsterone), to decrease the total 
exchangeable pool of lipoprotein and the catabolic rate of the protein4. 
This paper reports a small study of the effects of CPIB on the composition of 
certain serum esterified fatty acids. 
DESIGN OF STUDY 
Fasting blood samples were obtained from 20 men with ischaemic heart disease. The 
criteria for their selection have been outlined earlier in this symposiums. These men 
were placed in four groups and aliquots of serum from each man were pooled accord - 
preing to the groups indicated: 
Group A: 6 men without treatment; 
Group B: 3 men on CPIB 2 g daily for 8-14 weeks; 
Group C: 3 men on CPIB 2 g daily for 8-14 weeks; 
Group D: 6 men without treatment, but CPIB had been given until 4 -6 weeks 
previously. 
In the two remaining men, the effect of CPIB 2 g daily was studied sequentially. 
One of these (I.K.) had a fatty acid spectrum observed in other men with ischaemic 
heart disease; the second man (R.Z.) had abnormally high concentrations of eicosa- 
and docosa- unsaturated acids. The individual controls were taken one week and one 
day before treatment. 
METHODS 
A total lipid extract was prepared from serum by the method of FoLCH et al.6. 
The serum cholesterol was estimated by the method of JURAND AND ALBERT - 
RECHT7. Serum triglycerides were estimated by CARLSON'S modified method8. The 
lipids were separated by column chromatography using hydrated silicic acid for the 
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separation of phospholipids and hydrated florisil for the separation of cholesteryl and 
glyceryl esters. Intermethylation of these lipid fractions was undertaken according 
to the procedure of STOFFEL et al.9. The fatty acid composition of these methyl esters 
was then analysed by gas -liquid chromatography (using a Pye Argon chromatography . 
Full details of the analytical procedure adopted in this laboratory will be published 
separately. 
TABLE I 
FATTY ACID COMPOSITION OF CHOLESTERYL ESTERS IN MEN WITH ISCHAEMIC HEART 
DISEASE WITHOUT TREATMENT AND RECEIVING CPIB 
Fatty acids Pooled serum from 
(short -hand 6 men without 
designation) treatment 
Pooled serum from 2 groups of Pooled serum from 
3 men receiving CPIB 6 men one month 
after CPIB was 
Group 1 Group 2 stopped 
TOTAL CHOLESTEROL (mg /100 ml) 
287 250 267 310 
FATTY ACIDS (% of total) 
14 : 0 0.27 0.94 0.47 0.63 
16 : 0 8.32 9.40 9.20 8.60 
16 : 1 5.36 7.10 6.28 4.30 
18 : 0 0.14 0.90 1.03 0.37 
18 : 1 18.50 27.10 25.50 18.90 
18 : 2 56.00 41.60 46.00 57.70 
* tr 1.50 1.15 tr 
18:3 0.33 0.63 0.17 0.45 
20 : 3 0.59 0.59 0.34 0.77 
20 : 4 8.90 9.20 9.60 8.43 
20 : 5 + 22: 1 1.70 1.20 0.95 1.44 
Ratio 18 : 2/18: 1 3.10 1.57 1.73 3.05 
* Unknown. ECL on polyester = 19,20. 
RESULTS 
The principle changes in fatty acid composition derived from pooled serum samples 
are shown in Tables I -III. The similarity of the composition of fatty acids between 
Groups B and C (CPIB- treated), on the one hand, and Groups A and D (untreated) 
on the other, is worth emphasising. The changes in fatty acid composition derived 
from individual studies are shown in Tables IV -V. 
Cholesteryl esters 
(1) Pooled serum samples (Table I). The main changes in cholesteryl esters are an 
increase in the percentage composition of oleate, to a lesser extent of palmitoleate 
and also perhaps palmitate, and a decrease in linoleate. 
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TABLE II 
FATTY ACID COMPOSITION OF GLYCERYL ESTERS IN MEN WITH ISCHAEMIC HEART 
DISEASE WITHOUT TREATMENT AND RECEIVING CPIB 
Fatty acids Pooled serum from 
(short -hand 6 men without 
designation) treatment 
Pooled serum from 2 groups of 
3 men receiving CPIB 
Group 1 Group 2 
Pooled serum from 
6 men one month 
after CPIB was 
stopped 
TRIGLYCERIDES (mmoles/1) 
1.68 1.61 1.79 1.88 
FATTY ACIDS (% of total) 
14 : 0 2.08 2.10 1.87 3.10 
16 : 0 25.40 24.10 24.30 26.00 
16: 1 6.53 8.20 7.32 6.90 
18:0 4.27 3.19 2.48 3.60 
18: 1 42.50 43.00 45.80 39.00 
18 : 2 17.10 13.50 13.30 16.50 
* tr 0.50 0.82 0.49 
18:3 0.27 0.44 0.20 0.36 
20:0 0.26 0.30 0.20 0.12 
20 : ? 0.45 0.40 0.14 0.52 
20 : 2 0.20 0.10 0.10 0.20 
20:2 0.10 0.26 0.32 0.10 
20:3 0.20 0.10 0.15 0.30 
20 : 4 1.10 3.24 3.10 2.01 
20 : 5 + 22 : 1 0.52 0.60 0.60 0.50 
Ratio 18 : 2/18 : 1 0.40 0.31 0.28 0.42 
* Unknown. ECL on polyester = 19,20. 
TABLE III 
FATTY ACID COMPOSITION OF PHOSPHOLIPID ESTERS IN MEN WITH ISCHAEMIC HEART 
DISEASE WITHOUT TREATMENT AND RECEIVING CPIB 
Fatty acids Pooled serum from 
(short -hand 6 men without 
designation) treatment 
Pooled serum from 2 groups of 
3 men receiving CPIB 
Group 1 Group 2 
Pooled serum from 
6 men one month 





16:3 ? 18 : br 0.30 
18 : 0 13.40 
18 : 1 13.90 
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(2) Individual studies (Tables IV and V). The results of the sequential individual 
studies show the same changes as those observed from pooled serum. 
Triglyceride esters 
(1) Pooled serum samples (Table II). Although the results show a small increase 
in the percentage composition of oleate, palmitoleate and arachidonate with a small 
decrease in stearate and linoleate, it is difficult to conclude that these changes are 
solely due to the effect of CPIB because the usual spectrum of fatty acid composition 
of triglycerides shows a wide range of variability. 
(2) Individual studies (Tables IV and V). These results confirm that there is a small 
rise in oleate and arachidonate with a small decrease in stearate and linoleate. 
Phospholipid esters 
(1) Pooled serum samples (Table III). The main changes produced in phospholipid 
esters are an increase in oleate and palmitoleate and a decrease in stearate and in 
linoleate. 
(2) Individual studies (Tables IV and V). These results confirm the trends observed 
from pooled serum. 
DISCUSSION 
results should be regarded as preliminary in nature. There are obvious fallacies 
in studying groups of pooled serum from different men with ischaemic heart disease 
with a greater or lesser degree of atherosclerosis. Yet, most of the trends observed 
from pooled serum after CPIB treatment are confirmed by the individual studies. 
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SUMMARY 
Gas chromatographic analysis has been made of the esterified fatty acid composition 
of pooled sera obtained from men with ischaemic heart disease before, during and 
after the administration of CPIB, and of sera obtained from two men followed 
sequentially before and during CPIB treatment. The main changes were observed 
in serum cholesteryl and phospholipid esters. In both fractions, CPIS increased the 
oleate and palmitoleate content and decreased linoleate; phospholipid stearate was 
also decreased. The changes observed in triglycerides were less striking although the 
trends were the same as for cholesteryl and phospholipid esters and, in addition, 
glyceryl arachidonate increased after CPIB treatment. 
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RÉSUMÉ 
Il a été fait une analyse par chromatographie gazeuse de la composition en acides 
gras estérifiés de sérum recueilli chez des hommes avec cardiopathie ischémique, 
avant, pendant et après administration de CPIB ainsi que de sérum recueilli chez 
deux hommes suivis continuellement avant et pendant le traitement par le CPIB. On 
a noté les changements les plus importants dans le cholestéryle sérique et les esters 
de phospholipides. Dans les deux fractions, le CPIB a augmenté la teneur en oléate 
et en palmitoléate et diminué celle en linoléate; le stéarate phospholipidique a diminué 
aussi. Les changements observés dans les triglycérides étaient moins accusés bien que 
les tendances fussent les mêmes que pour les esters de cholestéryle et de phospholipides 
et que, de plus, l'arachidonate de glycéryle ait augmenté après traitement par le 
CPIB. 
ZUSAMMENFASSUNG 
Eine chromatographische Gasanalyse wurde gemacht von dem veresterten Fett - 
säuregemisch gepoolter Seren von Patienten mit ischämischem Herzleiden, vor 
während und nach der Verabreichung von CPIB; ebenfalls wurden Seren zweier 
Männer, die serienweise vor und während CPIB- Behandlung überprüft wurden, gas - 
chrolnatographisch untersucht. Die Hauptveränderungen wurden im Serumcholester- 
in und in den Esterphospholipoiden beobachtet. Bei beiden Fraktionen erhöhte CPIB 
den Oleinat- und Palmito- Oleinat- Gehalt und verringerte das Linoleat. Auch das 
Phospholipoid- Stereat war vermindert. Die Veränderungen der Triglyzeriden war 
weniger eindrucksvoll, obzwar die Tendenz dieselbe war wie die für Cholesterin und 
die Esterphospholipoiden, und auch das Glyzerin -Arachidonat nach CPIB- Behand- 
lung zunahm. 
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